<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>The effects of high perioperative inspiratory oxygen fraction for adult surgical patients - Wetterslev, J - 2015 | Cochrane Library</title> <meta content="The effects of high perioperative inspiratory oxygen fraction for adult surgical patients - Wetterslev, J - 2015 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008884.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="The effects of high perioperative inspiratory oxygen fraction for adult surgical patients - Wetterslev, J - 2015 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008884.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD008884.pub2" name="dc.identifier" scheme="DOI"/> <meta content="The effects of high perioperative inspiratory oxygen fraction for adult surgical patients" name="citation_title"/> <meta content="Jørn Wetterslev" name="citation_author"/> <meta content="Department 7812, Rigshospitalet, Copenhagen University Hospital" name="citation_author_institution"/> <meta content="wetterslev@ctu.dk" name="citation_author_email"/> <meta content="Christian S Meyhoff" name="citation_author"/> <meta content="Bispebjerg Hospital, University of Copenhagen" name="citation_author_institution"/> <meta content="Lars N Jørgensen" name="citation_author"/> <meta content="Bispebjerg Hospital, University of Copenhagen" name="citation_author_institution"/> <meta content="Christian Gluud" name="citation_author"/> <meta content="Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 7812, Rigshospitalet, Copenhagen University Hospital" name="citation_author_institution"/> <meta content="Jane Lindschou" name="citation_author"/> <meta content="Department 7812, Rigshospitalet, Copenhagen University Hospital" name="citation_author_institution"/> <meta content="Lars S Rasmussen" name="citation_author"/> <meta content="Rigshospitalet, University of Copenhagen" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="6" name="citation_issue"/> <meta content="10.1002/14651858.CD008884.pub2" name="citation_doi"/> <meta content="2015" name="citation_date"/> <meta content="2015/06/25" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008884.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008884.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008884.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Anesthesia; Cause of Death; Length of Stay; Oxygen [*administration &amp; dosage, *adverse effects]; Oxygen Inhalation Therapy [*adverse effects, methods, mortality]; Randomized Controlled Trials as Topic; Respiratory Insufficiency [*etiology]; Selection Bias; Surgical Procedures, Operative [*mortality]; Surgical Wound Infection [*etiology]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008884.pub2&amp;doi=10.1002/14651858.CD008884.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008884.pub2&amp;doi=10.1002/14651858.CD008884.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008884.pub2&amp;doi=10.1002/14651858.CD008884.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008884.pub2&amp;doi=10.1002/14651858.CD008884.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008884.pub2&amp;doi=10.1002/14651858.CD008884.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008884.pub2&amp;doi=10.1002/14651858.CD008884.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008884.pub2&amp;doi=10.1002/14651858.CD008884.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008884.pub2&amp;doi=10.1002/14651858.CD008884.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008884.pub2&amp;doi=10.1002/14651858.CD008884.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008884.pub2&amp;doi=10.1002/14651858.CD008884.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008884.pub2&amp;doi=10.1002/14651858.CD008884.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008884.pub2&amp;doi=10.1002/14651858.CD008884.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008884.pub2&amp;doi=10.1002/14651858.CD008884.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008884.pub2&amp;doi=10.1002/14651858.CD008884.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008884.pub2&amp;doi=10.1002/14651858.CD008884.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008884.pub2&amp;doi=10.1002/14651858.CD008884.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008884.pub2&amp;doi=10.1002/14651858.CD008884.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008884.pub2&amp;doi=10.1002/14651858.CD008884.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008884.pub2&amp;doi=10.1002/14651858.CD008884.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008884.pub2&amp;doi=10.1002/14651858.CD008884.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008884.pub2&amp;doi=10.1002/14651858.CD008884.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008884.pub2&amp;doi=10.1002/14651858.CD008884.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008884.pub2&amp;doi=10.1002/14651858.CD008884.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="Xx9QLps0";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD008884\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD008884\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008884\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD008884\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","pt","hr","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD008884.pub2",title:"The effects of high perioperative inspiratory oxygen fraction for adult surgical patients",firstPublishedDate:"Jun 25, 2015 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Anaesthesia Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=Xx9QLps0&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD008884.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD008884.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD008884.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD008884.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD008884.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD008884.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo para leigos&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]},{&quot;param&quot;: &quot;comments&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Comments&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD008884.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD008884.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD008884.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD008884.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>3872 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD008884.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008884.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008884.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008884.pub2/full#CD008884-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008884.pub2/full#CD008884-sec-0108"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008884.pub2/full#CD008884-sec-0015"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008884.pub2/full#CD008884-sec-0016"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008884.pub2/full#CD008884-sec-0021"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008884.pub2/full#CD008884-sec-0022"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008884.pub2/full#CD008884-sec-0045"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008884.pub2/full#CD008884-sec-0102"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008884.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008884.pub2/appendices#CD008884-sec-0113"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008884.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008884.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/table_n/CD008884StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/table_n/CD008884StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008884.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008884.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008884.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD008884.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD008884.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD008884.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2016 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">The effects of high perioperative inspiratory oxygen fraction for adult surgical patients</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD008884.pub2/information#CD008884-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Jørn Wetterslev</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD008884.pub2/information#CD008884-cr-0003">Christian S Meyhoff</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD008884.pub2/information#CD008884-cr-0004">Lars N Jørgensen</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD008884.pub2/information#CD008884-cr-0005">Christian Gluud</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD008884.pub2/information#CD008884-cr-0006">Jane Lindschou</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD008884.pub2/information#CD008884-cr-0007">Lars S Rasmussen</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/information/en#CD008884-sec-0141">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 25 June 2015 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD008884.pub2">https://doi.org/10.1002/14651858.CD008884.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD008884-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD008884-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD008884-abs-0005">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD008884-abs-0007">فارسی</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD008884-abs-0001" lang="en"> <section id="CD008884-sec-0001"> <h3 class="title" id="CD008884-sec-0001">Background</h3> <p>Available evidence on the effects of a high fraction of inspired oxygen (FIO<sub>2</sub>) of 60% to 90% compared with a routine fraction of inspired oxygen of 30% to 40%, during anaesthesia and surgery, on mortality and surgical site infection has been inconclusive. Previous trials and meta‐analyses have led to different conclusions on whether a high fraction of supplemental inspired oxygen during anaesthesia may decrease or increase mortality and surgical site infections in surgical patients. </p> </section> <section id="CD008884-sec-0002"> <h3 class="title" id="CD008884-sec-0002">Objectives</h3> <p>To assess the benefits and harms of an FIO<sub>2</sub> equal to or greater than 60% compared with a control FIO<sub>2</sub> at or below 40% in the perioperative setting in terms of mortality, surgical site infection, respiratory insufficiency, serious adverse events and length of stay during the index admission for adult surgical patients. </p> <p>We looked at various outcomes, conducted subgroup and sensitivity analyses, examined the role of bias and applied trial sequential analysis (TSA) to examine the level of evidence supporting or refuting a high FIO<sub>2</sub> during surgery, anaesthesia and recovery. </p> </section> <section id="CD008884-sec-0003"> <h3 class="title" id="CD008884-sec-0003">Search methods</h3> <p>We searched the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE, BIOSIS, International Web of Science, the Latin American and Caribbean Health Science Information Database (LILACS), advanced Google and the Cumulative Index to Nursing and Allied Health Literature (CINAHL) up to February 2014. We checked the references of included trials and reviews for unidentified relevant trials and reran the searches in March 2015. We will consider two studies of interest when we update the review. </p> </section> <section id="CD008884-sec-0004"> <h3 class="title" id="CD008884-sec-0004">Selection criteria</h3> <p>We included randomized clinical trials that compared a high fraction of inspired oxygen with a routine fraction of inspired oxygen during anaesthesia, surgery and recovery in individuals 18 years of age or older. </p> </section> <section id="CD008884-sec-0005"> <h3 class="title" id="CD008884-sec-0005">Data collection and analysis</h3> <p>Two review authors extracted data independently. We conducted random‐effects and fixed‐effect meta‐analyses, and for dichotomous outcomes, we calculated risk ratios (RRs). We used published data and data obtained by contacting trial authors. </p> <p>To minimize the risk of systematic error, we assessed the risk of bias of the included trials. To reduce the risk of random errors caused by sparse data and repetitive updating of cumulative meta‐analyses, we applied trial sequential analyses. We used Grades of Recommendation, Assessment, Development and Evaluation (GRADE) to assess the quality of the evidence. </p> </section> <section id="CD008884-sec-0006"> <h3 class="title" id="CD008884-sec-0006">Main results</h3> <p>We included 28 randomized clinical trials (9330 participants); in the 21 trials reporting relevant outcomes for this review, 7597 participants were randomly assigned to a high fraction of inspired oxygen versus a routine fraction of inspired oxygen. </p> <p>In trials with an overall low risk of bias, a high fraction of inspired oxygen compared with a routine fraction of inspired oxygen was not associated with all‐cause mortality (random‐effects model: RR 1.12, 95% confidence interval (CI) 0.93 to 1.36; GRADE: low quality) within the longest follow‐up and within 30 days of follow‐up (Peto odds ratio (OR) 0.99, 95% CI 0.61 to 1.60; GRADE: low quality). In a trial sequential analysis, the required information size was not reached and the analysis could not refute a 20% increase in mortality. Similarly, when all trials were included, a high fraction of inspired oxygen was not associated with all‐cause mortality to the longest follow‐up (RR 1.07, 95% CI 0.87 to 1.33) or within 30 days of follow‐up (Peto OR 0.83, 95% CI 0.54 to 1.29), both of very low quality according to GRADE. Neither was a high fraction of inspired oxygen associated with the risk of surgical site infection in trials with low risk of bias (RR 0.86, 95% CI 0.63 to 1.17; GRADE: low quality) or in all trials (RR 0.87, 95% CI 0.71 to 1.07; GRADE: low quality). A high fraction of inspired oxygen was not associated with respiratory insufficiency (RR 1.25, 95% CI 0.79 to 1.99), serious adverse events (RR 0.96, 95% CI 0.65 to 1.43) or length of stay (mean difference ‐0.06 days, 95% CI ‐0.44 to 0.32 days). </p> <p>In subgroup analyses of nine trials using preoperative antibiotics, a high fraction of inspired oxygen was associated with a decrease in surgical site infections (RR 0.76, 95% CI 0.60 to 0.97; GRADE: very low quality); a similar effect was noted in the five trials adequately blinded for the outcome assessment (RR 0.79, 95% CI 0.66 to 0.96; GRADE: very low quality). We did not observe an effect of a high fraction of inspired oxygen on surgical site infections in any other subgroup analyses. </p> </section> <section id="CD008884-sec-0007"> <h3 class="title" id="CD008884-sec-0007">Authors' conclusions</h3> <p>As the risk of adverse events, including mortality, may be increased by a fraction of inspired oxygen of 60% or higher, and as robust evidence is lacking for a beneficial effect of a fraction of inspired oxygen of 60% or higher on surgical site infection, our overall results suggest that evidence is insufficient to support the routine use of a high fraction of inspired oxygen during anaesthesia and surgery. Given the risk of attrition and outcome reporting bias, as well as other weaknesses in the available evidence, further randomized clinical trials with low risk of bias in all bias domains, including a large sample size and long‐term follow‐up, are warranted. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD008884-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD008884-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD008884-abs-0006">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD008884-abs-0008">فارسی</a> </li> <li class="section-language"> <a class="" href="full/hr#CD008884-abs-0004">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/pt#CD008884-abs-0003">Português</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD008884-abs-0002" lang="en"> <h3>The effects of giving adult patients a high inspiratory oxygen fraction around the time of surgery </h3> <p><b>Review question</b> </p> <p>The normal air that we breathe contains 21% oxygen. This systematic review assesses the beneficial and harmful effects of a percentage of inspired oxygen of 60% to 90% compared with a routine percentage of 30% to 40% given during anaesthesia, during surgery and in the immediate recovery period on the numbers of deaths and surgical site infections reported in adult surgical patients. </p> <p><b>Background</b> </p> <p>Reduced lung and circulatory function during surgery can lead to reduced levels of oxygen (hypoxia). Also, oxygen levels are often low in wounds at the end of surgery. This may impair bacterial killing and wound healing. Trials and previous meta‐analyses have led to different conclusions as to whether a high percentage of inspired oxygen during anaesthesia may decrease or increase the risk of death or surgical site infections. This systematic review used improved Cochrane methodology for carrying out systematic reviews to reassess available evidence derived from randomized clinical trials. </p> <p><b>Study characteristics</b> </p> <p>We identified 28 randomized clinical trials. Eight trials with 4918 participants reported on risk of death, and 15 trials with 7219 participants reported on surgical site infections within 14 to 30 days of surgery. Four trials reported serious adverse events, three trials respiratory insufficiency, nine trials length of stay during the associated hospital admission and one trial quality of life. All trials were conducted without direct industry funding. </p> <p>The number of participants in each trial ranged from 38 to 2012. The mean age of participants was 50 years (range 15 to 92 years) and 63% were women. Types of surgery included abdominal surgery (eight trials), caesarean section (four trials), breast surgery (one trial), orthopaedic surgery (two trials) and various other surgical procedures (four trials). </p> <p><b>Key results</b> </p> <p>A high percentage of inspired oxygen was not statistically associated with increased risk of death, or with a decrease in surgical site infections, in all trials that measured these outcomes, in trials of highest quality and in those with longest follow‐up. </p> <p>An increased risk of adverse events could not be proved right or wrong for a high percentage of inspired oxygen during anaesthesia and surgery. </p> <p><b>Quality and quantity of the evidence</b> </p> <p>Only five of the included trials had low risk of bias. The trials randomly assigned 9330 participants, of whom only 7537 participants provided data for this review. The number of participants required to detect or reject a 20% relative risk reduction in deaths was not reached; therefore the observed results were uncertain. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD008884-sec-0108" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD008884-sec-0108"></div> <h3 class="title" id="CD008884-sec-0109">Implications for practice</h3> <section id="CD008884-sec-0109"> <p>We could not exclude benefits or harms from use of a high inspired oxygen fraction (0.6 to 0.9) compared with a standard approach (0.3 to 0.4). Available randomized data do not suggest that either strategy is to be preferred. Further targeted research may provide definitive guidance in this area. As the risk of adverse events, including mortality, may be higher, and robust evidence for a beneficial effect on surgical site infection is lacking, overall our results suggest that evidence is insufficient to support the routine use of a high fraction of inspired oxygen beyond what is needed to maintain normal arterial oxygen saturation. </p> </section> <h3 class="title" id="CD008884-sec-0110">Implications for research</h3> <section id="CD008884-sec-0110"> <p>Additional RCTs are needed on the effects of a high fraction of inspired oxygen of 60% to 90% compared with 30% to 40% oxygen on mortality and on surgical site infection in all kinds of surgical patients. Before definitive conclusions can be drawn, we need more large trials with low risk of bias in all bias domains, testing effects of a fraction of 60% to 90% inspired oxygen versus 30% to 40% on patient important outcomes of all‐cause mortality, surgical site infection and health‐related quality of life. Future RCTs ought to be conducted with long‐term follow‐up and ought to stratify participants by type of surgery and documented risk factors for mortality and surgical site infection. Future trials ought to be designed according to the SPIRIT guidelines (<a href="./references#CD008884-bbs2-0074" title="ChanAW , TetzlaffJM , AltmanDG , LaupacisA , GøtzschePC , Krleža‐JerićK , et al. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Annals of Internal Medicine2013;158(3):200‐7. [DOI: 10.7326/0003‐4819‐158‐3‐201302050‐00583] ">Chan 2013</a>) and reported according to the CONSORT guidelines (<a href="http://www.consort-statement.org" target="_blank">www.consort‐statement.org</a>). Future trials also ought to report individual participant data, so that proper individual participant data meta‐analyses of the effects of a high fraction of inspired oxygen of 60% to 90% compared with 30% to 40% oxygen adjusted for relevant confounders can be conducted. Further, in future updates of this review, we will seek to conduct subgroup analyses of the effects of a high inspiratory fraction of oxygen in trials using regional anaesthesia compared with trials using only general anaesthesia. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD008884-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD008884-sec-0015"></div> <div class="table" id="CD008884-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Summary of findings in randomized clinical trials with overall low risk of bias and in all trials</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Fraction of inspired oxygen of 60% to 90% compared with 30% to 40% oxygen during anaesthesia, surgery and recovery</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> surgical patients with need for abdominal, caesarean section, orthopaedic or breast surgery </p> <p><b>Settings:</b> perioperative and postoperative </p> <p><b>Intervention:</b> high fraction of inspired oxygen of 60% to 90% during and after surgery and anaesthesia </p> <p><b>Comparison:</b> fraction of inspired oxygen of 30% to 40% during and after anaesthesia and surgery </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Number of participants<br/> (studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk*</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk<sup>#</sup> </b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Inspired fraction of oxygen (30% to 40%)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Inspired fraction of oxygen (60% to 90%)</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Mortality within the longest follow‐up in trials with overall low risk of bias</b> </p> <p>(follow‐up: 30 days to a median of 3.9 years)</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>High‐risk population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.12</b> </p> <p>(0.93 to 1.36)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>4758</p> <p>(3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low<sup>a</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>TSA (<a href="./full#CD008884-fig-0001">Figure 1</a>) shows that the required information size of 10,736 for a 20% RRI has not been achieved, and that no trial sequential monitoring boundaries have been crossed. The TSA adjusted CI for the RR is 0.73 to 1.60. The required information size is even greater for a lower effect on mortality than a 20% RRI. We therefore downgraded by 1 level for imprecision and by 1 level for attrition bias (<a href="./references#CD008884-fig-0008" title="">Analysis 1.2</a>; <a href="./references#CD008884-fig-0009" title="">Analysis 1.3</a>) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>185 per 1000</b> <br/> (168 to 203) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>208 per 1000</b> <br/> (190 to 226) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mortality within the longest follow‐up, irrespective of risk of bias</b> (14 days to median of 3.9 years) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>164 per 1000</b> <br/> (150 to 180) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>175 per 1000</b> <br/> (143 to 218) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>RR 1.07</b> </p> <p>(0.87 to 1.33)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4525</p> <p>(6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊝⊝⊝</p> <p><b>Very low<sup>b</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>TSA (<a href="./full#CD008884-fig-0002">Figure 2</a>) shows that the required information size for a 20% RRI has not been achieved, and that no trial sequential monitoring boundaries have been crossed. The required information size for a lower excess mortality than a 20% RRI is even greater. We therefore downgraded by 1 level for imprecision, by 1 level for high risk of attrition bias (<a href="./references#CD008884-fig-0008" title="">Analysis 1.2</a>; <a href="./references#CD008884-fig-0009" title="">Analysis 1.3</a>) and by 1 level for overall risk of bias </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mortality within 30 days of follow‐up with overall low risk of bias</b> </p> <p>(14 days to 30 days)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>18 per 1000</b> </p> <p>(13 to 25)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>18 per 1000</b> </p> <p>(13 to 25)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>POR 0.99</b> </p> <p>(0.61 to 1.60)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4758</p> <p>(3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊕⊝<br/> <b>Moderate<sup>c</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The required information size for a 20% RRI has not been reached, and no trial sequential monitoring boundaries have been crossed </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mortality within 30 days of follow‐up, irrespective of risk of bias</b> (14 days to 30 days) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>20 per 1000</b> </p> <p>(15 to 27)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>17 per 1000</b> </p> <p>(11 to 26)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>POR 0.83</b> </p> <p>(0.54 to 1.29)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4525</p> <p>(6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝<br/> <b>Low<sup>d</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>TSA shows that the required information size for a 20% RRI has not been achieved, and that no trial sequential monitoring boundaries have been crossed. The required information size for a lower excess mortality than a 20% RRI is even greater. We therefore downgraded by 1 level for imprecision and by 1 level for overall risk of bias </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Surgical site infection within 30 days in trials with low risk of bias</b> </p> <p>(14 days to 30 days)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>140 per 1000</b> </p> <p>(126 to 155)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>119 per 1000</b> </p> <p>(106 to 134)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>RR 0.86</b> </p> <p>(0.63 to 1.17)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4201</p> <p>(5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝<br/> <b>Low<sup>a</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>TSA (<a href="./full#CD008884-fig-0003">Figure 3</a>) shows that the required information size of 13,189 participants for a 20% RRR has not been achieved, and that no trial sequential monitoring boundaries have been crossed. The required information size is even greater for a lower effect on mortality than a 20% RRR. Best/worst and worst/best case scenarios indicate possible attrition bias. Therefore we downgraded by 1 level for imprecision and by 1 level for attrition bias </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Surgical site infection within 30 days, irrespective of risk of bias</b> (14 days to 30 days) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>129 per 1000</b> </p> <p>(118 to 140)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>112 per 1000</b> </p> <p>(92 to 138)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>RR 0.87</b> </p> <p>(0.71 to 1.07)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7229</p> <p>(15)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝<br/> <b>Low<sup>e</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>TSA (<a href="./full#CD008884-fig-0003">Figure 3</a>) shows that the required information size of 13,189 participants for a 20% RRR of surgical site infection has not been reached, and that no trial sequential monitoring boundaries have been crossed. The required information size for a lower effect on surgical site infection than a 20% RRR is even greater. As the result of overall risk of bias and imprecision, we downgraded by 2 levels </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Respiratory insufficiency</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>44 per 1000</b> </p> <p>(31 to 62)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>55 per 1000</b> </p> <p>(35 to 88)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>RR 1.25</b> </p> <p>(0.79 to 1.99)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1386</p> <p>(1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊕⊝<br/> <b>Moderate<sup>c</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Information size is too small to be conclusive. We downgraded by 1 level for imprecision</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>LCL:</b> Lower confidence limit; <b>MD:</b> Mean difference; <b>POR:</b> Peto odds ratio; <b>RR:</b> Risk ratio; <b>RRR:</b> relative risk reduction; <b>RRI:</b> relative risk increase; <b>TSA:</b> trial sequential analysis; <b>UCL:</b> Upper confidence limit. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence.<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p>*Mean of mortality in groups of included trials with 30% to 40% inspiratory fraction of oxygen. </p> <p>#Calculated from: RR × assumed risk (95% CL: LCL of RR × assumed risk to UCL of RR × assumed risk). </p> <p><sup>a</sup>Downgraded by 2 levels because of risk of attrition bias and imprecision. </p> <p><sup>b</sup>Downgraded by 3 levels because of risk of attrition bias, imprecision and overall risk of bias.<br/> <sup>c</sup>Downgraded by 1 level because of imprecision. </p> <p><sup>d</sup>Downgraded by 2 levels because of overall risk of bias and imprecision. </p> <p><sup>e</sup>Downgraded by 2 levels because of overall risk of bias and imprecision. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="figure" id="CD008884-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: 1 60% to 90% oxygen vs 30% to 40% oxygen perioperatively, outcome: 1.5 Surgical site infection stratified according to overall risk of bias in a random‐effects model." data-id="CD008884-fig-0001" src="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/image_n/nCD008884-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: 1 60% to 90% oxygen vs 30% to 40% oxygen perioperatively, outcome: 1.5 Surgical site infection stratified according to overall risk of bias in a random‐effects model. </p> </div> </div> </div> <div class="figure" id="CD008884-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Trial sequential analysis of the effect on mortality within the longest follow‐up in trials with overall low risk of bias. With an anticipated relative risk increase (RRI) of 20%, mortality in the control group of 15.7% with a type 1 error of 5% and a type 2 error of 20%, and diversity (D2) of 57%, the required information size is 10,736 participants. The cumulative Z‐curve does not cross the conventional boundary nor the trial sequential monitoring boundary for harm. The cumulative Z‐curve does not reach the futility area. Therefore evidence of an effect on all‐cause mortality based on trials with low risk of bias is lacking, and we cannot exclude a 20% RRI due to lack of data." data-id="CD008884-fig-0002" src="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/image_n/nCD008884-AFig-FIG04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Trial sequential analysis of the effect on mortality within the longest follow‐up in trials with overall low risk of bias. With an anticipated relative risk increase (RRI) of 20%, mortality in the control group of 15.7% with a type 1 error of 5% and a type 2 error of 20%, and diversity (D<sup>2</sup>) of 57%, the required information size is 10,736 participants. The cumulative Z‐curve does not cross the conventional boundary nor the trial sequential monitoring boundary for harm. The cumulative Z‐curve does not reach the futility area. Therefore evidence of an effect on all‐cause mortality based on trials with low risk of bias is lacking, and we cannot exclude a 20% RRI due to lack of data. </p> </div> </div> </div> <div class="figure" id="CD008884-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Trial sequential analysis of all trials reporting all‐cause mortality. With an anticipated relative risk increase (RRI) of 20%, mortality in the control group of 15.7% with a type 1 error of 5% and a type 2 error of 20% and diversity (D2) of 65%, the required information size is 13,264 participants. The cumulative Z‐curve does not cross the conventional boundaries nor the boundaries for benefit or harm. The cumulative Z‐curve does not reach the futility area. Therefore evidence of both beneficial and harmful effects on all‐cause mortality is lacking for all trials regardless of risk of bias and with varying time to follow‐up. We cannot exclude a 20% RRI or RRR due to lack of data." data-id="CD008884-fig-0003" src="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/image_n/nCD008884-AFig-FIG05.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Trial sequential analysis of all trials reporting all‐cause mortality. With an anticipated relative risk increase (RRI) of 20%, mortality in the control group of 15.7% with a type 1 error of 5% and a type 2 error of 20% and diversity (D<sup>2</sup>) of 65%, the required information size is 13,264 participants. The cumulative Z‐curve does not cross the conventional boundaries nor the boundaries for benefit or harm. The cumulative Z‐curve does not reach the futility area. Therefore evidence of both beneficial and harmful effects on all‐cause mortality is lacking for all trials regardless of risk of bias and with varying time to follow‐up. We cannot exclude a 20% RRI or RRR due to lack of data. </p> </div> </div> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD008884-sec-0016" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD008884-sec-0016"></div> <p>Trials by Greif et al (<a href="./references#CD008884-bbs2-0010" title="GreifR , AkçaO , HornEP , KurzA , SesslerDI , Outcomes Research Group. Supplemental perioperative oxygen to reduce the incidence of surgical‐wound infection. New England Journal of Medicine2000;342(3):161‐7. [PUBMED: 10639541] ">Greif 2000</a>) and by Belda et al (<a href="./references#CD008884-bbs2-0001" title="BeldaFJ , AguileraL , García de la AsunciónJ , AlbertiJ , VicenteR , FerrándizL , et al. Spanish Reduccion de la Tasa de Infeccion Quirurgica Group. Supplemental perioperative oxygen and the risk of surgical wound infection: a randomized controlled trial. JAMA2005;294(16):2035‐42. [PUBMED: 16249417] ">Belda 2005</a>) have suggested a significant reduction in the frequency of surgical wound infections within 30 days when 80% rather than 30% oxygen was given for inspiration during surgery and the first postoperative hours. On the other hand, the PROXI trial (<a href="./references#CD008884-bbs2-0016" title="MeyhoffCS , WetterslevJ , JorgensenLN , HennebergSW , HøgdallC , LundvallL , et al. PROXI Trial Group. Effect of high perioperative oxygen fraction on surgical site infection and pulmonary complications after abdominal surgery: the PROXI randomized clinical trial. JAMA2009;302(14):1543‐50. [PUBMED: 19826023] ">Meyhoff 2009</a>) found no significant differences and the trial of Mayzler et al (<a href="./references#CD008884-bbs2-0014" title="MayzlerO , WekslerN , DomchikS , KleinM , MizrahiS , GurmanGM . Does supplemental perioperative oxygen administration reduce the incidence of wound infection in elective colorectal surgery?. Minerva Anestesiology2005;71(1‐2):21‐5. [PUBMED: 15711503] ">Mayzler 2005</a>) was inconclusive because these studies had very low power. The trial by Gardella et al (<a href="./references#CD008884-bbs2-0006" title="GardellaC , GoltraLB , LaschanskyE , DroletteL , MagaretA , ChadwickHS , et al. High‐concentration supplemental perioperative oxygen to reduce the incidence of postcesarean surgical site infection: a randomized controlled trial. Obstetrics and Gynecology2008;112(3):545‐52. [PUBMED: 18757651] ">Gardella 2008</a>) was stopped early, as it was unlikely that investigators were going to show the anticipated difference if continued, and the trial by Pryor et al (<a href="./references#CD008884-bbs2-0018" title="PryorKO , FaheyTJ3rd , LienCA , GoldsteinPA . Surgical site infection and the routine use of perioperative hyperoxia in a general surgical population: a randomized controlled trial. JAMA2004;291(1):79‐87. [PUBMED: 14709579] ">Pryor 2004</a>) was stopped prematurely because the frequency of wound infection was more than doubled in the high oxygen fraction group. High inspiratory oxygen concentrations have been associated with adverse outcomes in a variety of emergency medical conditions, including exacerbation of chronic obstructive pulmonary disease (<a href="./references#CD008884-bbs2-0061" title="AustinMA , WillsKE , BlizzardL , WaltersEH , Wood‐BakerR . Effect of high flow oxygen on mortality in chronic obstructive pulmonary disease patients in prehospital setting: randomised controlled trial. BMJ2010;341:c5462. [DOI: 10.1136/bmj.c5462] ">Austin 2010</a>), myocardial infarction (<a href="./references#CD008884-bbs2-0070" title="CabelloJB , BurlsA , EmparanzaJI , BaylissS , QuinnT . Oxygen therapy for acute myocardial infarction. Cochrane Database of Systematic Reviews2013, Issue 8. [DOI: 10.1002/14651858.CD007160.pub3] ">Cabello 2013</a>), resuscitation after cardiac arrest (<a href="./references#CD008884-bbs2-0103" title="KilgannonJH , JonesAE , ShapiroNI , AngelosMG , MilcarekB , HunterK , et al. Emergency Medicine Shock Research Network (EMShockNet) Investigators. Association between arterial hyperoxia following resuscitation from cardiac arrest and in‐hospital mortality. JAMA2010;303(21):2165‐71. [DOI: 10.1001/jama.2010.707] ">Kilgannon 2010</a>) and traumatic brain injury (<a href="./references#CD008884-bbs2-0067" title="BrennerM , SteinD , HuP , KuferaJ , WoofordM , ScaleaT . Association between early hyperoxia and worse outcomes after traumatic brain injury. Archives of Surgery2012;147(11):1042‐6. [DOI: 10.1001/archsurg.2012.1560] ">Brenner 2012</a>). </p> <p>The ENIGMA trial provided long‐term follow‐up data for 83% of participants (<a href="./references#CD008884-bbs2-0108" title="LeslieK , MylesPS , ChanMTV , ForbesA , PaechMJ , PeytonP , et al. Nitrous oxide and long‐term morbidity and mortality in the ENIGMA trial. Anesthesia and Analgesia2011;112(2):387–93. [PUBMED: 20861416] ">Leslie 2011</a>) with an unadjusted hazard ratio (HR) for death with 80% oxygen compared with 30% oxygen of 1.09 (95% confidence interval (CI) 0.90 to 1.35). Recently Meyhoff et al (<a href="./references#CD008884-bbs2-0112" title="MeyhoffCS , JorgensenLN , WetterslevJ , SiersmaVD , RasmussenLS , PROXI Trial Group. Risk of new or recurrent cancer after a high perioperative inspiratory oxygen fraction during abdominal surgery. British Journal of Anaesthesia2014;2:1‐8. [PUBMED: 24860156] ">Meyhoff 2014</a>) reported long‐term follow‐up (median 3.9 years) from the PROXI trial with similar rates of new and recurrent cancer with 80% versus 30% oxygen during anaesthesia and surgery within the observation time. However, the HR for death, new cancer or recurrent cancer was increased with a high fraction of inspired oxygen (HR 1.19, 95% CI 1.01 to 1.42), indicating a median of 99 days shorter time to death or new or recurrent cancer. Accordingly evidence suggests that a high fraction of inspired oxygen during anaesthesia and surgery may be associated with an increased number of adverse events, as well as beneficial effects on surgical site infection (<a href="./references#CD008884-bbs2-0096" title="HovaguimianF , LysakowskiC , EliaN , TramèrMR . Effect of intraoperative high inspired oxygen fraction on surgical site infection, postoperative nausea and vomiting, and pulmonary function: systematic review and meta‐analysis of randomized controlled trials.. Anesthesiology2013;119(2):303‐16. [DOI: 10.1097/ALN.0b013e31829aaff4] ">Hovaguimian 2013</a>). </p> <p>At least one large trial (<a href="./references#CD008884-bbs2-0017" title="MylesPS , LeslieK , ChanMT , ForbesA , PaechMJ , PeytonP , et al. ENIGMA Trial Group. Avoidance of nitrous oxide for patients undergoing major surgery: a randomized controlled trial. Anesthesiology2007;107(2):221‐31. [PUBMED: 17667565] ">Myles 2007</a>) reported a lower rate of major complications with nitrous oxide‐free anaesthesia. However, recent data indicate that the presence of adjuvant nitrous oxide in the inhaled gas mixture during anaesthesia does not affect clinically important outcomes after surgery (<a href="./references#CD008884-bbs2-0080" title="FleischmannE , LenhardtR , KurzA , HerbstF , FülesdiB , GreifR , et al. Nitrous oxide and risk of surgical wound infection: a randomised trial. Lancet2005 Sep;366(9491):1101‐7. [PUBMED: 16182898] ">Fleischmann 2005</a>; <a href="./references#CD008884-bbs2-0098" title="ImbergerG , OrrA , ThorlundK , WetterslevJ , MylesP , MøllerAM . Does anaesthesia with nitrous oxide affect mortality or cardiovascular morbidity? A systematic review with meta‐analysis and trial sequential analysis. British Journal of Anaesthesia2014;112(3):410‐26. [DOI: 10.1093/bja/aet416.] ">Imberger 2014</a>; <a href="./references#CD008884-bbs2-0115" title="Myles . Laughing gas gets the all clear at last. Media release 2014; accessed 23rd June 2015:http://www.anzca.edu.au/communications/Media/pdfs/ENIGMA2_6May_2014%20pdf.pdf. ">Myles 2014</a>; <a href="./references#CD008884-bbs2-0116" title="MylesPS , LeslieK , ChanMT , ForbesA , PeytonPJ , Paech , et al. The safety of addition of nitrous oxide to general anaesthesia in at‐risk patients having major non‐cardiac surgery (ENIGMA‐II): a randomised, single‐blind trial. Lancet2014 Oct;384(9952):1446‐54. [PUBMED: 25142708] ">Myles 2014b</a>). </p> <p>We undertook this review to investigate all available evidence on benefits and harms for mortality and surgical site infection with an inspiratory fraction of oxygen of 60% to 90% compared with a routine fraction of 30% to 40% oxygen during anaesthesia, surgery and recovery. </p> <section id="CD008884-sec-0017"> <h3 class="title" id="CD008884-sec-0017">Description of the condition</h3> <p>According to the criteria of the Centers for Disease Control and Prevention (CDC), surgical site infection may consist of superficial or deep wound infection or intra‐abdominal organ or space infection (<a href="./references#CD008884-bbs2-0110" title="MangramAJ , HoranTC , PearsonML , SilverLC , JarvisWR . Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. Infection Control Hospital Epidemiology1999;20(4):250‐78. [PUBMED: 10219875] ">Mangram 1999</a>). The condition may or may not be accompanied by a positive bacterial culture. The CDC criteria (<a href="./references#CD008884-bbs2-0072" title="Center for Disease Control and Prevention. CDC: criteria for defining nosocomial pneumonia. http://www.cdc.gov/ncidod/dhqp/pdf/guidelines/SSI.pdf (accessed 2 July 2010). ">CDC 2009</a>) for diagnosing surgical site infection are listed in <a href="./appendices#CD008884-sec-0114">Appendix 1</a>. Surgical site infection is a common and serious complication following surgery, especially after abdominal surgery (<a href="./references#CD008884-bbs2-0075" title="CoelloR , CharlettA , WilsonJ , WardV , PearsonA , BorrielloP . Adverse impact of surgical site infections in English hospitals. Journal of Hospital Infection2005;60(2):93‐103. [PUBMED: 15866006] ">Coello 2005</a>). Surgical site infection may or may not be defined according to the criteria developed by the CDC (<a href="./references#CD008884-bbs2-0072" title="Center for Disease Control and Prevention. CDC: criteria for defining nosocomial pneumonia. http://www.cdc.gov/ncidod/dhqp/pdf/guidelines/SSI.pdf (accessed 2 July 2010). ">CDC 2009</a>). We evaluated the investigators' definitions of surgical site infection with respect to CDC criteria. </p> </section> <section id="CD008884-sec-0018"> <h3 class="title" id="CD008884-sec-0018">Description of the intervention</h3> <p>After induction of anaesthesia and tracheal intubation, participants randomly assigned to a high fraction of inspired oxygen (FIO<sub>2</sub>) were given an FIO<sub>2</sub> equal to or above 60% until the end of surgery. Additionally, in the first two hours following extubation, these participants might have breathed an FIO<sub>2</sub> equal to or above 60% as administered by means of a face mask with a reservoir and a high flow mixture of oxygen and air (around 16 L/min). Participants randomly assigned to the control FIO<sub>2</sub> were given an FIO<sub>2</sub> at or below 40% after tracheal intubation; after extubation, they received a high flow (around 16 L/min) mixture of oxygen and air through an identical face mask. </p> </section> <section id="CD008884-sec-0019"> <h3 class="title" id="CD008884-sec-0019">How the intervention might work</h3> <p>To prevent surgical site infection, it is essential to optimize perioperative conditions, as the first hours following bacterial contamination are pivotal for avoiding an established infection (<a href="./references#CD008884-bbs2-0095" title="HopfHW , HolmJ . Hyperoxia and infection. Best Practice and Research in Clinical Anaesthesiology2008;22(3):553‐69. [PUBMED: 18831303] ">Hopf 2008</a>; <a href="./references#CD008884-bbs2-0113" title="MilesAA , MilesEM , BurkeJ . The value and duration of defence reactions of the skin to the primary lodgement of bacteria. British Journal of Expert Pathology1957;38(1):79‐96. [PUBMED: 13413084] ">Miles 1957</a>). Oxygen tension is often low in wounds and in colorectal anastomoses at the end of surgery. This may reduce bacterial eradication, the body's defences against bacteria and tissue healing. Possible mechanisms occur via diminished oxidative killing by neutrophils and impaired tissue healing caused by reduced collagen formation, neovascularization and epithelialization (<a href="./references#CD008884-bbs2-0059" title="AllenDB , MaguireJJ , MahdavianM , WickeC , MarcocciL , ScheuenstuhlH , et al. Wound hypoxia and acidosis limit neutrophil bacterial killing mechanisms. Archives of Surgery1997;132(9):991‐6. [PUBMED: 9301612] ">Allen 1997</a>; <a href="./references#CD008884-bbs2-0062" title="BabiorBM . Oxygen‐dependent microbial killing by phagocytes (first of two parts). New England Journal of Medicine1978;298(12):659‐68. [PUBMED: 203852] ">Babior 1978</a>; <a href="./references#CD008884-bbs2-0094" title="HopfHW , HuntTK , WestJM , BlomquistP , GoodsonWH3rd , JensenJA , et al. Wound tissue oxygen tension predicts the risk of wound infection in surgical patients. Archives of Surgery1997;132(9):997‐1004. [PUBMED: 9301613] ">Hopf 1997</a>; <a href="./references#CD008884-bbs2-0095" title="HopfHW , HolmJ . Hyperoxia and infection. Best Practice and Research in Clinical Anaesthesiology2008;22(3):553‐69. [PUBMED: 18831303] ">Hopf 2008</a>; <a href="./references#CD008884-bbs2-0040" title="NiinikoskiJ . Oxygen and wound healing. Clinics in Plastic Surgery1977;4(3):361‐74. ">Niinikoski 1977</a>). Perioperative arterial and wound oxygen tension may be increased by a higher inspiratory oxygen fraction (<a href="./references#CD008884-bbs2-0010" title="GreifR , AkçaO , HornEP , KurzA , SesslerDI , Outcomes Research Group. Supplemental perioperative oxygen to reduce the incidence of surgical‐wound infection. New England Journal of Medicine2000;342(3):161‐7. [PUBMED: 10639541] ">Greif 2000</a>; <a href="./references#CD008884-bbs2-0094" title="HopfHW , HuntTK , WestJM , BlomquistP , GoodsonWH3rd , JensenJA , et al. Wound tissue oxygen tension predicts the risk of wound infection in surgical patients. Archives of Surgery1997;132(9):997‐1004. [PUBMED: 9301613] ">Hopf 1997</a>). However, wound oxygen tension is low in hypoperfused patients and may not increase much with a high fraction of inspiratory oxygen (<a href="./references#CD008884-bbs2-0084" title="GottrupF , FirminR , RabkinJ , HallidayBJ , HuntTK . Directly measured tissue oxygen tension and arterial oxygen tension assess tissue perfusion. Critical Care Medicine1987 Nov;15(11):1030‐6. [PUBMED: 3677745] ">Gottrup 1987</a>; <a href="./references#CD008884-bbs2-0100" title="JonssonK , JensenJA , GoodsonWH3rd , WestJM , HuntTK . Assessment of perfusion in postoperative patients using tissue oxygen measurements. British Journal of Surgery1987 Apr;74(4):263‐7. [PUBMED: 3580798] ">Jonsson 1987</a>). Further, many of the antibiotics used perioperatively are oxygen‐dependent in their effect; it is therefore possible that patients receiving a high FIO<sub>2</sub> will benefit more from these antibiotics than patients receiving antibiotics without an elevated oxygen fraction. Beneficial effects have also been reported for other outcomes such as improved healing of colorectal anastomoses (<a href="./references#CD008884-bbs2-0005" title="García‐BotelloSA , García‐GraneroE , LilloR , López‐MozosF , MillánM , LledóS . Randomized clinical trial to evaluate the effects of perioperative supplemental oxygen administration on the colorectal anastomosis. British Journal of Surgery2006;93(6):698‐706. [MEDLINE: 16703624] ">García‐Botello 2006</a>) and reduced postoperative nausea and vomiting (<a href="./references#CD008884-bbs2-0009" title="GreifR , LacinyS , RapfB , HickleRS , SesslerDI . Supplemental oxygen reduces the incidence of postoperative nausea and vomiting. Anesthesiology1999;91(5):1246‐52. ">Greif 1999</a>; <a href="./references#CD008884-bbs2-0026" title="TuranA , ApfelCC , KumpchM , DanzeisenO , EberhartLH , ForstH , et al. Does the efficacy of supplemental oxygen for the prevention of postoperative nausea and vomiting depend on the measured outcome, observational period or site of surgery. Anaesthesia2006;61(7):628‐33. [PUBMED: 16792606] ">Turan 2006</a>). </p> <p>Hyperoxia throughout the perioperative period may result in pulmonary complications, but this important aspect or oxygenation has been studied in only 30 patients (<a href="./references#CD008884-bbs2-0057" title="AkçaO , PodolskyA , EisenhuberE , PanzerO , HetzH , LamplK , et al. Comparable postoperative pulmonary atelectasis in patients given 30% or 80% oxygen during and 2 hours after colon resection. Anesthesiology1999;91(4):991‐8. ">Akca 1999b</a>). In a subgroup of participants from the trial by Greif et al (<a href="./references#CD008884-bbs2-0010" title="GreifR , AkçaO , HornEP , KurzA , SesslerDI , Outcomes Research Group. Supplemental perioperative oxygen to reduce the incidence of surgical‐wound infection. New England Journal of Medicine2000;342(3):161‐7. [PUBMED: 10639541] ">Greif 2000</a>), a statistically non‐significant trend towards larger areas of atelectasis (collapsed areas of the lung) in the 80% oxygen group was observed on computed tomography scans (<a href="./references#CD008884-bbs2-0057" title="AkçaO , PodolskyA , EisenhuberE , PanzerO , HetzH , LamplK , et al. Comparable postoperative pulmonary atelectasis in patients given 30% or 80% oxygen during and 2 hours after colon resection. Anesthesiology1999;91(4):991‐8. ">Akca 1999b</a>). The PROXI trial by Meyhoff et al (<a href="./references#CD008884-bbs2-0016" title="MeyhoffCS , WetterslevJ , JorgensenLN , HennebergSW , HøgdallC , LundvallL , et al. PROXI Trial Group. Effect of high perioperative oxygen fraction on surgical site infection and pulmonary complications after abdominal surgery: the PROXI randomized clinical trial. JAMA2009;302(14):1543‐50. [PUBMED: 19826023] ">Meyhoff 2009</a>) found no significant differences in proportions of atelectasis, pneumonia or respiratory failure, but a trend towards higher mortality was found in the 80% oxygen group. More specifically, a high inspiratory oxygen fraction has been associated with detrimental effects such as increased airway inflammation (<a href="./references#CD008884-bbs2-0071" title="CarpagnanoGE , KharitonovSA , Foschino‐BarbaroMP , RestaO , GramiccioniE , BarnesPJ . Supplementary oxygen in healthy subjects and those with COPD increases oxidative stress and airway inflammation. Thorax2004;59(12):1016‐9. [PUBMED: 15563698] ">Carpagno 2004</a>); poor regulation of blood glucose, which may affect healing (<a href="./references#CD008884-bbs2-0063" title="BandaliKS , BelangerMP , WittnichC . Does hyperoxia affect glucose regulation and transport in the newborn?. Journal of Thoracic Cardiovascular Surgery2003;126(6):1730‐5. [PUBMED: 14688680] ">Bandali 2003</a>); and decreased cardiac output/index (<a href="./references#CD008884-bbs2-0089" title="HartenJM , AndersonKJ , AngersonWJ , BoothMG , KinsellaJ . The effect of normobaric hyperoxia on cardiac index in healthy awake volunteers. Anaesthesia2003;58(9):885‐8. [PUBMED: 12911363] ">Harten 2003</a>). </p> </section> <section id="CD008884-sec-0020"> <h3 class="title" id="CD008884-sec-0020">Why it is important to do this review</h3> <p>Complications after surgery are numerous and range from minor problems to fatalities, especially after emergency and upper abdominal procedures. The proportion of patients developing surgical site infections varies across types of surgery and reaches 10% to 20% for open abdominal surgery (<a href="./references#CD008884-bbs2-0016" title="MeyhoffCS , WetterslevJ , JorgensenLN , HennebergSW , HøgdallC , LundvallL , et al. PROXI Trial Group. Effect of high perioperative oxygen fraction on surgical site infection and pulmonary complications after abdominal surgery: the PROXI randomized clinical trial. JAMA2009;302(14):1543‐50. [PUBMED: 19826023] ">Meyhoff 2009</a>; <a href="./references#CD008884-bbs2-0018" title="PryorKO , FaheyTJ3rd , LienCA , GoldsteinPA . Surgical site infection and the routine use of perioperative hyperoxia in a general surgical population: a randomized controlled trial. JAMA2004;291(1):79‐87. [PUBMED: 14709579] ">Pryor 2004</a>). Surgical site infection is a significant complication for all surgical patients and increases the risk of sepsis, admission to an intensive care unit (ICU), incisional hernia and hospital stay (<a href="./references#CD008884-bbs2-0085" title="GotzschePC . Why we need a broad perspective on meta‐analysis. It may be crucially important for patients. BMJ2000;321(7261):585–6. [PUBMED: 10977820] ">Gotzsche 2000</a>). Moreover, surgical site infection causes a heavy workload and an economic burden for hospitals as well as society. A high FIO<sub>2</sub> administered to surgical patients, equal to or greater than 60% oxygen, is an easily applied and inexpensive intervention with few known/unknown contraindications or adverse events. However, several trials have reported contradictory results, and the benefits and harms of an FIO<sub>2</sub> equal to or greater than 60%, as compared with a control FIO<sub>2</sub> at or below 40%, are presently uncertain. Although several meta‐analyses and reviews have been published (<a href="./references#CD008884-bbs2-0058" title="Al‐NiaimiA , SafdarN . Supplemental perioperative oxygen for reducing surgical site infection: a meta‐analysis. Journal of Evaluation of Clinical Practice2009;15(2):360‐5. [PUBMED: 19335497] ">Al‐Niaimi 2009</a>; <a href="./references#CD008884-bbs2-0034" title="ChuraJC , BoydA , ArgentaPA . Surgical site infections and supplemental perioperative oxygen in colorectal surgery patients: a systematic review. Surgical Infection2007;8(4):455‐61. [PUBMED: 17883362] ">Chura 2007</a>) they have not included recent trials, they have emphasized the fixed‐effect model and they have not assessed bias control according to the methods described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD008884-bbs2-0092" title="HigginsJPT , GreenS , editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1. [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane‐handbook.org. ">Higgins 2011</a>). Recently, several trials (<a href="./references#CD008884-bbs2-0004" title="DuggalN , PoddatooriV , NoroozkhaniS , CherryC , ParkT , CaugheyAB . Perioperative oxygen supplementation and surgical site infection after cesarean delivery. A randomized trial. Obstetrics &amp; Gynecology2013;122(1):79‐84. [DOI: 10.1097/AOG.0b013e318297ec6c] ">Duggal 2013</a>; <a href="./references#CD008884-bbs2-0021" title="SchietromaM , CeciliaEM , CarleiF , SistaF , DeSantisG , PiccioneF , et al. Prevention of anastomotic leakage after total gastrectomy with perioperative supplemental oxygen administration: a prospective randomized, double blind, controlled, single‐center trial. Annals of Surgical Oncology2013;20(5):584‐90. [DOI: 10.1245/s10434‐012‐2714‐7; PUBMED: 23099730] ">Schietroma 2013</a>; <a href="./references#CD008884-bbs2-0022" title="ScifresCM , LeightonBL , FogerteyPJ , MaconesGA , StamilioDM . Supplemental oxygen for the prevention of postcesarean infectious morbidity: a randomized controlled trial. American Journal of Obstetrics and Gynecology2011;205(3):267.e1‐9. [PUBMED: 22071059] ">Scifres 2011</a>; <a href="./references#CD008884-bbs2-0024" title="StallA , ParyaviE , GuptaR , ZadnikM , HuiE , O’TooleRV . Perioperative supplemental oxygen to reduce surgical site infection after open fixation of high‐risk fractures: a randomized controlled pilot trial. The Journal of Trauma and Acute Care Surgery2013;75(4):657‐63. [DOI: 10.1097/TA.0b0113e3182a1fe83] ">Stall 2013</a>; <a href="./references#CD008884-bbs2-0025" title="ThibonP , BorgeyF , BoutreuxS , HanouzJ‐L , LeCoutourX , ParientiJ‐J . Effect of perioperative oxygen supplementation on 30‐day surgical site infection rate in abdominal, gynecologic, and breast surgery. Anesthesiology2012;117:504–11. [MEDLINE: PMID: 22790961] ">Thibon 2012</a>) that tested the effects of an FIO<sub>2</sub> of 80% compared with 30% on the occurrence of surgical site infection have been published. Likewise, three meta‐analyses (<a href="./references#CD008884-bbs2-0096" title="HovaguimianF , LysakowskiC , EliaN , TramèrMR . Effect of intraoperative high inspired oxygen fraction on surgical site infection, postoperative nausea and vomiting, and pulmonary function: systematic review and meta‐analysis of randomized controlled trials.. Anesthesiology2013;119(2):303‐16. [DOI: 10.1097/ALN.0b013e31829aaff4] ">Hovaguimian 2013</a>; <a href="./references#CD008884-bbs2-0105" title="KlingelML , PatelSV . A meta‐analysis of the effect of inspired oxygen concentration on the incidence of surgical site infection following cesarean section. International Journal of Obstetric Anesthesia2013;22(2):104‐12. [DOI: 10.1016/j.ijoa.2013.01.001] ">Klingel 2013</a>; <a href="./references#CD008884-bbs2-0117" title="PatelSV1 , CoughlinSC , MalthanerRA . High‐concentration oxygen and surgical site infections in abdominal surgery: a meta‐analysis. Canadian Journal of Surgery2013;56(4):E82‐90. ">Patel 2012</a>) have been published within the past two years, and none of these have used stringent Cochrane methodology to assess risk of bias or to perform Grades of Recommendation, Assessment, Development and Evaluation (GRADE) of the overall quality of the evidence. Further, these meta‐analyses have not determined the information size required to detect or reject a 20% relative risk reduction (RRR) or increase (RRI), and they have not used trial sequential analysis (TSA) to assess whether sufficient evidence was obtained before the required information size was reached (<a href="./references#CD008884-bbs2-0135" title="WetterslevJ , ThorlundK , BrokJ , GluudC . Trial sequential analysis may establish when firm evidence is reached in cumulative meta‐analysis. Journal of Clinical Epidemiology2008;61(1):64‐75. [PUBMED: 18083463] ">Wetterslev 2008</a>; <a href="./references#CD008884-bbs2-0136" title="WetterslevJ , ThorlundK , BrokJ , GluudC . Estimating required information size by quantifying diversity in random‐effects model meta‐analyses. BMC Medical Research Methodology2009;9(86):1‐12. [PUBMED: 20042080] ">Wetterslev 2009</a>). These meta‐analyses therefore are prone to increased risk of random error due to sparse data and repetitive testing because of multiple updating, as new trials are included in the cumulative meta‐analyses. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD008884-sec-0021" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD008884-sec-0021"></div> <p>To assess the benefits and harms of an FIO<sub>2</sub> equal to or greater than 60% compared with a control FIO<sub>2</sub> at or below 40% in the perioperative setting in terms of mortality, surgical site infection, respiratory insufficiency, serious adverse events and length of stay during the index admission for adult surgical patients. </p> <p>We looked at various outcomes, conducted subgroup and sensitivity analyses, examined the role of bias and applied TSA (<a href="./references#CD008884-bbs2-0068" title="BrokJ , ThorlundK , GluudC , WetterslevJ . Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta‐analyses. Journal of Clinical Epidemiology2008;61(8):763‐9. [PUBMED: 18411040] ">Brok 2008</a>; <a href="./references#CD008884-bbs2-0069" title="BrokJ , ThorlundK , WetterslevJ , GluudC . Apparently conclusive meta‐analyses may be inconclusive ‐ Trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta‐analyses. International Journal of Epidemiology2009;38(1):287‐98. [PUBMED: 18824466] ">Brok 2009</a>; <a href="./references#CD008884-bbs2-0129" title="ThorlundK , DevereauxPJ , WetterslevJ , GuyattG , IoannidisJP , ThabaneL , et al. Can trial sequential monitoring boundaries reduce spurious inferences from meta‐analyses?. International Journal of Epidemiology2009;38(1):276‐86. [PUBMED: 18824467] ">Thorlund 2009</a>; <a href="./references#CD008884-bbs2-0135" title="WetterslevJ , ThorlundK , BrokJ , GluudC . Trial sequential analysis may establish when firm evidence is reached in cumulative meta‐analysis. Journal of Clinical Epidemiology2008;61(1):64‐75. [PUBMED: 18083463] ">Wetterslev 2008</a>; <a href="./references#CD008884-bbs2-0136" title="WetterslevJ , ThorlundK , BrokJ , GluudC . Estimating required information size by quantifying diversity in random‐effects model meta‐analyses. BMC Medical Research Methodology2009;9(86):1‐12. [PUBMED: 20042080] ">Wetterslev 2009</a>) to examine the level of evidence supporting or refuting a high FIO<sub>2</sub> during surgery, anaesthesia and recovery. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD008884-sec-0022" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD008884-sec-0022"></div> <section id="CD008884-sec-0023"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD008884-sec-0024"> <h4 class="title">Types of studies</h4> <p>We included randomized clinical trials (RCTs) without consideration of publication status, blinding status or language. We contacted investigators and study authors to retrieve relevant data. </p> <p>We included unpublished trials only if trial data and methodological descriptions were provided in written form or by direct contact with study authors. </p> <p>We excluded trials using quasi‐randomization and observational studies for the study of benefits. However, we were not able to establish an appendix enumerating the findings from observational studies regarding adverse events, as we did not find any. We excluded cross‐over trials even if they compared high FIO<sub>2</sub> with routine FIO<sub>2</sub> during the perioperative period. </p> </section> <section id="CD008884-sec-0025"> <h4 class="title">Types of participants</h4> <p>We included surgical patients 18 years of age or older who were undergoing elective or emergency surgery. </p> </section> <section id="CD008884-sec-0026"> <h4 class="title">Types of interventions</h4> <p>We compared a high FIO<sub>2</sub> of 60% or above with a control FIO<sub>2</sub> of 40% or below during surgery or both during surgery and during time spent in the postanaesthetic care unit. </p> </section> <section id="CD008884-sec-0027"> <h4 class="title">Types of outcome measures</h4> <section id="CD008884-sec-0028"> <h5 class="title">Primary outcomes</h5> <p> <ol id="CD008884-list-0001"> <li> <p>All‐cause mortality: assessed according to the longest follow‐up period for each trial.</p> </li> <li> <p>Surgical site infection within 30 days of follow‐up after surgery: defined by investigators of involved trials or according to the criteria of the CDC (<a href="./appendices#CD008884-sec-0114">Appendix 1</a>) as superficial or deep wound infection or intra‐abdominal organ or space infection (<a href="./references#CD008884-bbs2-0110" title="MangramAJ , HoranTC , PearsonML , SilverLC , JarvisWR . Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. Infection Control Hospital Epidemiology1999;20(4):250‐78. [PUBMED: 10219875] ">Mangram 1999</a>). </p> </li> </ol> </p> </section> <section id="CD008884-sec-0029"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD008884-list-0002"> <li> <p>All‐cause mortality within 30 days of follow‐up.</p> </li> <li> <p>Respiratory insufficiency: defined as the need for respiratory assistance provided as ventilator therapy or non‐invasive ventilation within the longest follow‐up period. </p> </li> <li> <p>Serious Adverse events: with a serious adverse event defined, according to the International Conference on Harmonisation Guidelines and the European Directive (<a href="./references#CD008884-bbs2-0077" title="European Parliament and the Council of the European Union. Directive 2001/20/EC of the European Parliament and of the Council of 4 April 2001 on the approximation of the laws, regulations and administrative provisions of the Member States relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use. Official Journal of the European Union http://eur‐lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2001:121:0034:0044:EN:PDF2001; Vol. L 121:34‐44. ">Directive 2001</a>), as "<i>any event that leads to death, was life‐threatening, required in‐patient hospitalisation or prolongation of existing hospitalisation, resulted in persistent or significant disability, and any important medical event, which may have jeopardised the patient or required intervention to prevent it</i>". All other adverse events were considered to be non‐serious events. </p> </li> <li> <p>Duration of postoperative hospitalizations.</p> </li> <li> <p>Quality of life as measured by the included trials.</p> </li> </ol> </p> </section> </section> </section> <section id="CD008884-sec-0030"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD008884-sec-0031"> <h4 class="title">Electronic searches</h4> <p>We searched the Cochrane Central Register of Controlled Trials (CENTRAL) (2014, Issue 2); SilverPlatter MEDLINE (WebSPIRS) (1950 to February 2014); SilverPlatter EMBASE (WebSPIRS) (1980 to February 2014); SilverPlatter BIOSIS (WebSPIRS) (1993 to February 2014); International Web of Science (1964 to February 2014); Latin American Caribbean Health Sciences Literature (LILACS via BIREME) (1982 to February 2014); the Chinese Biomedical Literature Database; advanced Google and the Cumulative Index to Nursing and Allied Health Literature (CINAHL via EBSCO host) (1980 to February 2014). We reran the searches in March 2015. We will consider studies of interest when we update the review. </p> <p>We performed systematic and sensitive searches to identify relevant RCTs without language or date restrictions. These searches were conducted within six months of the date the draft review was emailed to the editorial office. For specific information regarding our search strategies, please see the Appendices (<a href="./appendices#CD008884-sec-0116">Appendix 2</a>, MEDLINE; <a href="./appendices#CD008884-sec-0117">Appendix 3</a>, EMBASE; <a href="./appendices#CD008884-sec-0118">Appendix 4</a>, CENTRAL; <a href="./appendices#CD008884-sec-0119">Appendix 5</a>, Web of Science; <a href="./appendices#CD008884-sec-0120">Appendix 6</a>, CINAHL). </p> <p>We searched for ongoing clinical trials and unpublished studies on the following Internet sites. </p> <p> <ol id="CD008884-list-0003"> <li> <p><a href="http://Current Controlled Trials" target="_blank">Current Controlled Trials</a>. </p> </li> <li> <p><a href="http://ClinicalTrials.gov" target="_blank">ClinicalTrials.gov</a>. </p> </li> <li> <p><a href="http://www.centerwatch.com/" target="_blank">www.centerwatch.com</a>. </p> </li> </ol> </p> </section> <section id="CD008884-sec-0032"> <h4 class="title">Searching other resources</h4> <p>We handsearched the reference lists of reviews, randomized and non‐randomized studies and editorials to look for additional studies. Moreover, we contacted the main authors of studies and experts in this field to ask about missed, unreported or ongoing trials. </p> </section> </section> <section id="CD008884-sec-0033"> <h3 class="title" id="CD008884-sec-0033">Data collection and analysis</h3> <section id="CD008884-sec-0034"> <h4 class="title">Selection of studies</h4> <p>Two review authors (JW and CSM) independently evaluated all relevant trials and provided a detailed description of included and excluded articles under the sections <a href="./references#CD008884-sec-0148" title="">Characteristics of included studies</a> and <a href="./references#CD008884-sec-0149" title="">Characteristics of excluded studies</a>, respectively. We also provided a detailed description of our search results. </p> </section> <section id="CD008884-sec-0035"> <h4 class="title">Data extraction and management</h4> <p>We screened titles and abstracts to identify studies for eligibility. JW and CSM independently extracted and collected data on a standardized paper form (<a href="./appendices#CD008884-sec-0121">Appendix 7</a>). We were not blinded to the study author, institution or publication source of trials. We resolved disagreements by discussion. We approached all corresponding authors of included trials to ask for additional information relevant to the review's outcomes measures and risk of bias domains. For more specific information, please see the section <a href="#CD008884-sec-0140">Contributions of authors</a>. </p> </section> <section id="CD008884-sec-0036"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>We evaluated the validity and design characteristics of each trial. To draw conclusions about the overall risk of bias for an outcome, it is necessary to evaluate the trials for major sources of bias, also defined as domains (random sequence generation, allocation concealment, blinding, incomplete outcome data, selective outcome reporting and other sources of bias). The tool recommended by The Cochrane Collaboration for assessing risk of bias is neither a scale nor a checklist but rather a domain‐based evaluation. Any assessment of the overall risk of bias involves consideration of the relative importance of the different domains (<a href="./references#CD008884-bbs2-0092" title="HigginsJPT , GreenS , editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1. [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane‐handbook.org. ">Higgins 2011</a>). </p> <p>Even the most realistic assessment of the validity of a trial may involve subjectivity, as it is impossible to know the extent of bias (or even the true risk of bias) in a given trial. Some domains affect the risk of bias across outcomes in a trial, for example, sequence generation and allocation sequence concealment; others such as blinding and incomplete outcome data may present different risks of bias for different outcomes within a trial. Thus, the risk of bias is not the same for all outcomes in a trial. We performed separate sensitivity analyses for patient‐reported outcomes (subjective outcomes) and for mortality (<a href="./references#CD008884-bbs2-0092" title="HigginsJPT , GreenS , editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1. [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane‐handbook.org. ">Higgins 2011</a>). </p> <p>We defined trials as having low risk of bias only if they adequately fulfilled the criteria listed in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD008884-bbs2-0092" title="HigginsJPT , GreenS , editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1. [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane‐handbook.org. ">Higgins 2011</a>) and reproduced in <a href="./appendices#CD008884-sec-0125">Appendix 8</a>; we performed summary assessments of the risk of bias for each important outcome (across domains) within and across studies and prepared a 'Risk of bias graph' and a 'Risk of bias summary figure' (<a href="./references#CD008884-bbs2-0092" title="HigginsJPT , GreenS , editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1. [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane‐handbook.org. ">Higgins 2011</a>). </p> <p>We presented results for all outcomes including adverse events in <a href="./full#CD008884-tbl-0001">summary of findings Table for the main comparison</a>(<a href="./references#CD008884-bbs2-0092" title="HigginsJPT , GreenS , editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1. [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane‐handbook.org. ">Higgins 2011</a>). </p> <p>As no sufficiently well‐designed formal statistical method was available by which to combine the results of trials with high and low risk of bias, the principal approach to incorporating risk of bias assessments into Cochrane reviews is to restrict meta‐analyses to trials with low (or lower) risk of bias (<a href="./references#CD008884-bbs2-0092" title="HigginsJPT , GreenS , editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1. [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane‐handbook.org. ">Higgins 2011</a>). We used the risk of bias (ROB) table described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i>, section 8.5 (<a href="./references#CD008884-bbs2-0092" title="HigginsJPT , GreenS , editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1. [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane‐handbook.org. ">Higgins 2011</a>), as a tool for assessing risk of bias in included trials. We assessed risk of bias in the different domains as described in <a href="./appendices#CD008884-sec-0125">Appendix 8</a>. </p> </section> <section id="CD008884-sec-0037"> <h4 class="title">Measures of treatment effect</h4> <p>We reported length of stay in hospital after surgery, in days, as a continuous outcome, and the intervention effect as the mean difference with 95% confidence interval. All other outcomes are dichotomous and were reported as risk ratios (RRs) with 95% confidence limits. For mortality, we calculated the Peto odds ratio (POR). We also calculated the risk difference (RD) with 95% confidence interval and subsequently numbers needed to treat for an additional beneficial outcome, when possible. </p> </section> <section id="CD008884-sec-0038"> <h4 class="title">Unit of analysis issues</h4> <p>Numbers of events in all binary meta‐analyses and days in the meta‐analysis of length of stay in hospital after surgery. </p> </section> <section id="CD008884-sec-0039"> <h4 class="title">Dealing with missing data</h4> <p>We contacted all first study authors and contact persons for trials with missing data to retrieve the relevant data. We performed a modified intention‐to‐treat (ITT) analysis, including, if possible, all randomly assigned participants who underwent surgery, or who did not withdraw their consent before surgery. </p> <p>Intention‐to‐treat analysis is recommended to minimize bias in the design, follow‐up and analysis of efficacy of RCTs. It yields a pragmatic estimate of the benefit of a change in treatment policy rather than a measure of the potential benefit in patients who receive treatment exactly as planned (<a href="./references#CD008884-bbs2-0093" title="HollisS , CampbellF . What is meant by intention to treat analysis? Survey of published randomised controlled trials. BMJ1999;319(7211):670‐4. [PUBMED: 10480822] ">Hollis 1999</a>). Full application of ITT is possible only when complete outcome data are available for all randomly assigned participants. Despite the fact that about half of all published reports of RCTs state that ITT analysis was used, handling of deviations from randomized allocation varies widely, and in many trials data for the primary outcome variable are missing. Methods used to deal with this are generally inadequate, potentially leading to bias (<a href="./references#CD008884-bbs2-0093" title="HollisS , CampbellF . What is meant by intention to treat analysis? Survey of published randomised controlled trials. BMJ1999;319(7211):670‐4. [PUBMED: 10480822] ">Hollis 1999</a>). </p> <p>Performing an ITT analysis in a systematic review is not straightforward, as review authors must decide how to handle outcome data that are missing from contributing trials (<a href="./references#CD008884-bbs2-0082" title="GambleC , HollisS . Uncertainty method improved on best‐worst case analysis in a binary meta‐analysis. Journal of Clinical Epidemiology2005;58(6):579‐88. [PUBMED: 15878471] ">Gamble 2005</a>). No consensus has been reached regarding how missing data should be handled in ITT analyses, and different approaches may be appropriate in different situations (<a href="./references#CD008884-bbs2-0092" title="HigginsJPT , GreenS , editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1. [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane‐handbook.org. ">Higgins 2011</a>; <a href="./references#CD008884-bbs2-0093" title="HollisS , CampbellF . What is meant by intention to treat analysis? Survey of published randomised controlled trials. BMJ1999;319(7211):670‐4. [PUBMED: 10480822] ">Hollis 1999</a>). </p> <p>In cases of missing data, for our primary outcomes we used a 'complete‐case analysis' by simply excluding all participants for whom the outcome was missing from the analysis. Additionally, we conducted sensitivity analyses for our primary outcomes by applying best/worst and worst/best case scenarios. </p> <p>Best case scenarios included the following: All participants lost to follow‐up in the high FIO<sub>2</sub> group survived, and all participants lost to follow‐up in the FIO<sub>2</sub> below 40% group died; all participants lost to follow‐up in the high FIO<sub>2</sub> group did not have a surgical site infection, and all participants lost to follow‐up in the FIO<sub>2</sub> below 40% group did have a surgical site infection. Worst case scenarios included these: All participants lost to follow‐up in the high FIO<sub>2</sub> group died, and all participants lost to follow‐up in the FIO<sub>2</sub> below 40% group survived; all participants lost to follow‐up in the high FIO<sub>2</sub> group had a surgical site infection, and all participants lost to follow‐up in the FIO<sub>2</sub> below 40% group did not have a surgical site infection. </p> <p>Selective outcome reporting occurs when non‐significant results are selectively withheld from publication (<a href="./references#CD008884-bbs2-0073" title="ChanAW , HróbjartssonA , HaahrMT , GøtzschePC , AltmanDG . Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. JAMA2004;291(20):2457‐65. [PUBMED: 15161896] ">Chan 2004</a>). It is defined as selection, on the basis of results, of a subset of the original recorded variables for inclusion in the publication of a trial. The most important types of selective outcome reporting are selective omission of outcomes from reports; selective choice of data for an outcome; selective reporting of analyses using the same data; selective reporting of subsets of data and selective underreporting of data (<a href="./references#CD008884-bbs2-0092" title="HigginsJPT , GreenS , editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1. [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane‐handbook.org. ">Higgins 2011</a>8). Statistical methods developed to detect within‐study selective reporting are still in their infancy stage. We explored selective outcome reporting by comparing publications with their protocols, when the latter were available. </p> </section> <section id="CD008884-sec-0040"> <h4 class="title">Assessment of heterogeneity</h4> <p>We quantified the degree of heterogeneity observed in the results by using diversity (D<sup>2</sup>) (<a href="./references#CD008884-bbs2-0136" title="WetterslevJ , ThorlundK , BrokJ , GluudC . Estimating required information size by quantifying diversity in random‐effects model meta‐analyses. BMC Medical Research Methodology2009;9(86):1‐12. [PUBMED: 20042080] ">Wetterslev 2009</a>) and inconsistency factor (I<sup>2</sup>) statistics, which can be interpreted as the proportion of the total variation observed between trials that is attributable to differences between trials rather than to sampling error (chance) (<a href="./references#CD008884-bbs2-0090" title="HigginsJP , ThompsonSG . Quantifying heterogeneity in a meta‐analysis. Statistics in Medicine2002;15(11):1539‐58. [PUBMED: 12111919] ">Higgins 2002</a>). P value ≤ 0.10 indicates significant heterogeneity, and suggested I<sup>2</sup> statistic thresholds for low, moderate and high heterogeneity are 25% to 49%, 50% to 74% and ≥ 75%, respectively (<a href="./references#CD008884-bbs2-0091" title="HigginsJP , ThompsonSG , DeeksJJ , AltmanDG . Measuring inconsistency in meta‐analyses. BMJ2003;327(7414):557‐60. [PUBMED: 12958120] ">Higgins 2003</a>). If I<sup>2</sup> = 0, we reported results using the random‐effects model only. In the case of I<sup>2</sup> &gt; 0, we reported results using both random‐effects and fixed‐effect models. However, we believed that using a fixed‐effect model offered little value in cases of substantial heterogeneity, which may be present in this review because of inclusion of various patient types, as well as variable adjuvant gases, definitions of surgical site infection and outcome reporting. So we emphasized the results from the random‐effects model analysis unless a few trials dominated the meta‐analysis (e.g. &gt; 50% of the accumulated fixed weight percentage). Additionally, in cases of I<sup>2</sup> &gt; 0 (for mortality and surgical site infection outcomes), we sought to determine the cause of heterogeneity by performing meta‐regression analyses and relevant subgroup and sensitivity analyses. We aimed to combine trial results in a meta‐analysis only when clinical heterogeneity was low to moderate. </p> </section> <section id="CD008884-sec-0041"> <h4 class="title">Assessment of reporting biases</h4> <p>Publication bias occurs when publication of research results depends on their nature and direction (<a href="./references#CD008884-bbs2-0076" title="DickersinK . The existence of publication bias and risk factors for its occurrence. JAMA1990;263(10):1359‐85. [PUBMED: 2406472] ">Dickersin 1990</a>). We examined this by providing funnel plots to detect publication bias or differences between smaller and larger studies (small study effects), expressed as asymmetry of the funnel plot (<a href="./references#CD008884-bbs2-0079" title="EggerM , Davey SmithG , SchneiderM , MinderC . Bias in meta‐analysis detected by a simple, graphical test. BMJ1997;315(7109):629‐34. [PUBMED: 9310563] ">Egger 1997</a>). In cases of asymmetry, we applied the Arcsine‐Thompson test as proposed by Rücker (<a href="./references#CD008884-bbs2-0122" title="RückerG , SchwarzerG , CarpenterJ . Arcsine test for publication bias in meta‐analyses with binary outcomes. Statistics in Medicine2008;27(5):746‐63. [PUBMED: 17592831] ">Rücker 2008</a>). </p> <p>Funding bias is defined as bias in the design, outcome and reporting of industry‐sponsored research showing that a drug has a favourable outcome (<a href="./references#CD008884-bbs2-0064" title="BekelmanJE , LiY , GrossCP . Scope and impact of financial conflicts of interest in biomedical research: a systematic review. JAMA2003;289(4):454‐65. [PUBMED: 12533125] ">Bekelman 2003</a>). Relationships between industry, scientific investigators and academic institutions are widespread and often result in conflicts of interest (<a href="./references#CD008884-bbs2-0064" title="BekelmanJE , LiY , GrossCP . Scope and impact of financial conflicts of interest in biomedical research: a systematic review. JAMA2003;289(4):454‐65. [PUBMED: 12533125] ">Bekelman 2003</a>). We conducted a sensitivity analysis to examine the role of funding bias when relevant (see <a href="#CD008884-sec-0044">Sensitivity analysis</a>). </p> </section> <section id="CD008884-sec-0042"> <h4 class="title">Data synthesis</h4> <p>We used Review Manager software (<a href="./references#CD008884-bbs2-0120" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan) Version 5.3.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 5.3.3</a>) for statistical analysis. We calculated risk ratios (RRs) with 95% confidence intervals (CIs) for dichotomous variables (binary outcomes). We also calculated risk differences (RDs) (<a href="./references#CD008884-bbs2-0102" title="KeusF , WeterslevJ , GluudC , GooszenHG , vanLaarhovenCJHM . Robustness assessments are needed to reduce bias in meta‐analyses including zero‐event randomized trials. American Journal of Gastroenterology2009;104(3):546‐51. [PUBMED: PubMed: PMID: 19262513] ">Keus 2009</a>); if results were similar, we reported only RRs. Additionally, we calculated mean differences (MDs) as measures of absolute change with 95% CIs for continuous outcomes. We used D<sup>2</sup> (<a href="./references#CD008884-bbs2-0136" title="WetterslevJ , ThorlundK , BrokJ , GluudC . Estimating required information size by quantifying diversity in random‐effects model meta‐analyses. BMC Medical Research Methodology2009;9(86):1‐12. [PUBMED: 20042080] ">Wetterslev 2009</a>) and I<sup>2</sup> statistics (<a href="./references#CD008884-bbs2-0090" title="HigginsJP , ThompsonSG . Quantifying heterogeneity in a meta‐analysis. Statistics in Medicine2002;15(11):1539‐58. [PUBMED: 12111919] ">Higgins 2002</a>) to describe heterogeneity among the included trials. We explored causes of substantial heterogeneity by performing meta‐regression using Comprehensive Meta‐Analysis (CMA, version one) and Stata, version 13. We used the Chi<sup>2</sup> test to provide an indication of heterogeneity between studies, with P value ≤ 0.10 considered significant. </p> <p>Adverse events may be rare but serious, and hence important (<a href="./references#CD008884-bbs2-0127" title="SuttonAJ , CooperNJ , LambertPC , JonesDR , AbramsKR , SweetingMJ . Meta‐analysis of rare and adverse event data. Expert Review in Pharmacoeconomics Outcomes Research2002;2:367‐79. [PUBMED: 19807443] ">Sutton 2002</a>), when meta‐analysis is applied to combined results from several trials reporting binary outcomes (i.e. event or no event). First, we applied the Peto odds ratio (POR) in cases of small event proportions. Most meta‐analytical software packages do not include options for analyses to calculate RRs when included trials have 'zero events' in both arms (intervention vs control). Exempting these trials from calculations of RRs and CIs may lead to overestimation of a treatment effect, as the control event proportion may be overestimated. Thus we performed a sensitivity analysis by applying empirical continuity corrections to our zero event trials, as proposed by Sweeting et al (<a href="./references#CD008884-bbs2-0102" title="KeusF , WeterslevJ , GluudC , GooszenHG , vanLaarhovenCJHM . Robustness assessments are needed to reduce bias in meta‐analyses including zero‐event randomized trials. American Journal of Gastroenterology2009;104(3):546‐51. [PUBMED: PubMed: PMID: 19262513] ">Keus 2009</a>; <a href="./references#CD008884-bbs2-0128" title="SweetingMJ , SuttonAJ , LambertPC . What to add to nothing? Use of avoidance of continuity corrections in meta‐analysis of sparse data. Statistics in Medicine2004;23(9):1351‐75. [PUBMED: 15116347] ">Sweeting 2004</a>), by applying an imaginary small mortality in both arms (<a href="./references#CD008884-bbs2-0092" title="HigginsJPT , GreenS , editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1. [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane‐handbook.org. ">Higgins 2011</a>). We used trial sequential analysis (TSA) (<a href="./references#CD008884-bbs2-0130" title="ThorlundK , EngstrømJ , WetterslevJ , BrokJ , ImbergerG , GluudC . User Manual for Trial Sequential Analysis (TSA). Copenhagen Trial Unit, Centre for Clinical Intervention Research, Copenhagen, Denmark.2011:www.ctu.dk/tsa. ">Thorlund 2011</a>). </p> <p>Meta‐analyses may result in type 1 errors as the result of sparse data and repeated significance testing following updates with new trials (<a href="./references#CD008884-bbs2-0068" title="BrokJ , ThorlundK , GluudC , WetterslevJ . Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta‐analyses. Journal of Clinical Epidemiology2008;61(8):763‐9. [PUBMED: 18411040] ">Brok 2008</a>; <a href="./references#CD008884-bbs2-0069" title="BrokJ , ThorlundK , WetterslevJ , GluudC . Apparently conclusive meta‐analyses may be inconclusive ‐ Trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta‐analyses. International Journal of Epidemiology2009;38(1):287‐98. [PUBMED: 18824466] ">Brok 2009</a>; <a href="./references#CD008884-bbs2-0129" title="ThorlundK , DevereauxPJ , WetterslevJ , GuyattG , IoannidisJP , ThabaneL , et al. Can trial sequential monitoring boundaries reduce spurious inferences from meta‐analyses?. International Journal of Epidemiology2009;38(1):276‐86. [PUBMED: 18824467] ">Thorlund 2009</a>; <a href="./references#CD008884-bbs2-0135" title="WetterslevJ , ThorlundK , BrokJ , GluudC . Trial sequential analysis may establish when firm evidence is reached in cumulative meta‐analysis. Journal of Clinical Epidemiology2008;61(1):64‐75. [PUBMED: 18083463] ">Wetterslev 2008</a>; <a href="./references#CD008884-bbs2-0136" title="WetterslevJ , ThorlundK , BrokJ , GluudC . Estimating required information size by quantifying diversity in random‐effects model meta‐analyses. BMC Medical Research Methodology2009;9(86):1‐12. [PUBMED: 20042080] ">Wetterslev 2009</a>). Systematic errors from trials with high risk of bias, outcome reporting bias, publication bias, early stopping for benefit and small trial bias may result in spurious P values. </p> <p>In a single trial, interim analysis increases the risk of type 1 errors. To avoid type 1 errors, group sequential monitoring boundaries (<a href="./references#CD008884-bbs2-0107" title="LanKKG , DeMetsDL . Discrete sequential boundaries for clinical trials. Biometrika1983;70:659‐63. ">Lan 1983</a>) are applied to show whether a trial could be terminated early because of a sufficiently small P value, that is, when the cumulative Z‐curve crosses the monitoring boundary. Sequential monitoring boundaries can be applied to meta‐analyses as well and are called trial sequential monitoring boundaries (TSMB). In TSA, the addition of each trial to a cumulative meta‐analysis is regarded as an interim meta‐analysis and reveals whether additional trials are needed (<a href="./references#CD008884-bbs2-0092" title="HigginsJPT , GreenS , editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1. [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane‐handbook.org. ">Higgins 2011</a>; <a href="./references#CD008884-bbs2-0130" title="ThorlundK , EngstrømJ , WetterslevJ , BrokJ , ImbergerG , GluudC . User Manual for Trial Sequential Analysis (TSA). Copenhagen Trial Unit, Centre for Clinical Intervention Research, Copenhagen, Denmark.2011:www.ctu.dk/tsa. ">Thorlund 2011</a>; <a href="./references#CD008884-bbs2-0135" title="WetterslevJ , ThorlundK , BrokJ , GluudC . Trial sequential analysis may establish when firm evidence is reached in cumulative meta‐analysis. Journal of Clinical Epidemiology2008;61(1):64‐75. [PUBMED: 18083463] ">Wetterslev 2008</a>). So far several meta‐analyses and reviews have been published, providing an increasing quantity of trial results as new trials have been published (<a href="./references#CD008884-bbs2-0058" title="Al‐NiaimiA , SafdarN . Supplemental perioperative oxygen for reducing surgical site infection: a meta‐analysis. Journal of Evaluation of Clinical Practice2009;15(2):360‐5. [PUBMED: 19335497] ">Al‐Niaimi 2009</a>; <a href="./references#CD008884-bbs2-0034" title="ChuraJC , BoydA , ArgentaPA . Surgical site infections and supplemental perioperative oxygen in colorectal surgery patients: a systematic review. Surgical Infection2007;8(4):455‐61. [PUBMED: 17883362] ">Chura 2007</a>; <a href="./references#CD008884-bbs2-0043" title="QadanM , AkçaO , MahidSS , HornungCA , PolkHCJr . Perioperative supplemental oxygen therapy and surgical site infection: a meta‐analysis of randomized controlled trials. Archives of Surgery2009;144(4):359‐66. [MEDLINE: 19380650] ">Qadan 2009</a>). Therefore adjusting new meta‐analyses for multiple testing on accumulating data seems appropriate for controlling the overall type 1 error risk in cumulative meta‐analysis (<a href="./references#CD008884-bbs2-0118" title="PogueJM , YusufS . Cumulating evidence from randomized trials: utilizing sequential monitoring boundaries for cumulative meta‐analysis. Controlled Clinical Trials1997;18(6):580‐93. [PUBMED: 9408720] ">Pogue 1997</a>; <a href="./references#CD008884-bbs2-0119" title="PogueJ , YusufS . Overcoming the limitations of current meta‐analysis of randomised controlled trials. Lancet1998;351(9095):45‐52. [PUBMED: 9433436] ">Pogue 1998</a>; <a href="./references#CD008884-bbs2-0129" title="ThorlundK , DevereauxPJ , WetterslevJ , GuyattG , IoannidisJP , ThabaneL , et al. Can trial sequential monitoring boundaries reduce spurious inferences from meta‐analyses?. International Journal of Epidemiology2009;38(1):276‐86. [PUBMED: 18824467] ">Thorlund 2009</a>; <a href="./references#CD008884-bbs2-0135" title="WetterslevJ , ThorlundK , BrokJ , GluudC . Trial sequential analysis may establish when firm evidence is reached in cumulative meta‐analysis. Journal of Clinical Epidemiology2008;61(1):64‐75. [PUBMED: 18083463] ">Wetterslev 2008</a>). </p> <p>In TSA if the cumulative Z‐curve crosses the boundary, a sufficient level of evidence is reached and no further trials may be needed. However, evidence is insufficient to allow a conclusion if the Z‐curve does not cross the boundary or does not surpass the required information size. To construct the TSMB, the required information size is needed and will be calculated as the least number of participants needed in a well‐powered single trial (<a href="./references#CD008884-bbs2-0068" title="BrokJ , ThorlundK , GluudC , WetterslevJ . Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta‐analyses. Journal of Clinical Epidemiology2008;61(8):763‐9. [PUBMED: 18411040] ">Brok 2008</a>; <a href="./references#CD008884-bbs2-0119" title="PogueJ , YusufS . Overcoming the limitations of current meta‐analysis of randomised controlled trials. Lancet1998;351(9095):45‐52. [PUBMED: 9433436] ">Pogue 1998</a>; <a href="./references#CD008884-bbs2-0130" title="ThorlundK , EngstrømJ , WetterslevJ , BrokJ , ImbergerG , GluudC . User Manual for Trial Sequential Analysis (TSA). Copenhagen Trial Unit, Centre for Clinical Intervention Research, Copenhagen, Denmark.2011:www.ctu.dk/tsa. ">Thorlund 2011</a>; <a href="./references#CD008884-bbs2-0135" title="WetterslevJ , ThorlundK , BrokJ , GluudC . Trial sequential analysis may establish when firm evidence is reached in cumulative meta‐analysis. Journal of Clinical Epidemiology2008;61(1):64‐75. [PUBMED: 18083463] ">Wetterslev 2008</a>). We adjusted the required information size for heterogeneity by using the diversity adjustment factor (<a href="./references#CD008884-bbs2-0136" title="WetterslevJ , ThorlundK , BrokJ , GluudC . Estimating required information size by quantifying diversity in random‐effects model meta‐analyses. BMC Medical Research Methodology2009;9(86):1‐12. [PUBMED: 20042080] ">Wetterslev 2009</a>). We applied TSA, as it prevents an increase in the risk of type 1 errors (&lt; 5%) due to potential multiple updating and testing on accumulating data whenever new trial results are included in a cumulative meta‐analysis (<a href="./references#CD008884-bbs2-0118" title="PogueJM , YusufS . Cumulating evidence from randomized trials: utilizing sequential monitoring boundaries for cumulative meta‐analysis. Controlled Clinical Trials1997;18(6):580‐93. [PUBMED: 9408720] ">Pogue 1997</a>; <a href="./references#CD008884-bbs2-0119" title="PogueJ , YusufS . Overcoming the limitations of current meta‐analysis of randomised controlled trials. Lancet1998;351(9095):45‐52. [PUBMED: 9433436] ">Pogue 1998</a>). This provided important information to permit estimation of the level of evidence on the experimental intervention (<a href="./references#CD008884-bbs2-0118" title="PogueJM , YusufS . Cumulating evidence from randomized trials: utilizing sequential monitoring boundaries for cumulative meta‐analysis. Controlled Clinical Trials1997;18(6):580‐93. [PUBMED: 9408720] ">Pogue 1997</a>; <a href="./references#CD008884-bbs2-0119" title="PogueJ , YusufS . Overcoming the limitations of current meta‐analysis of randomised controlled trials. Lancet1998;351(9095):45‐52. [PUBMED: 9433436] ">Pogue 1998</a>; <a href="./references#CD008884-bbs2-0129" title="ThorlundK , DevereauxPJ , WetterslevJ , GuyattG , IoannidisJP , ThabaneL , et al. Can trial sequential monitoring boundaries reduce spurious inferences from meta‐analyses?. International Journal of Epidemiology2009;38(1):276‐86. [PUBMED: 18824467] ">Thorlund 2009</a>), and to determine the need for additional trials and their required sample sizes (<a href="./references#CD008884-bbs2-0135" title="WetterslevJ , ThorlundK , BrokJ , GluudC . Trial sequential analysis may establish when firm evidence is reached in cumulative meta‐analysis. Journal of Clinical Epidemiology2008;61(1):64‐75. [PUBMED: 18083463] ">Wetterslev 2008</a>; <a href="./references#CD008884-bbs2-0136" title="WetterslevJ , ThorlundK , BrokJ , GluudC . Estimating required information size by quantifying diversity in random‐effects model meta‐analyses. BMC Medical Research Methodology2009;9(86):1‐12. [PUBMED: 20042080] ">Wetterslev 2009</a>; <a href="./references#CD008884-bbs2-0140" title="WetterslevJ , MeyhoffCS , JørgensenLN , GluudC , RasmussenLS . The effects of high perioperative inspiratory oxygen fraction for adult surgical patients. Cochrane Database of Systematic Reviews2010, Issue 12. [DOI: 10.1002/14651858.CD008884] ">Wetterslev 2010</a>; <a href="./references#CD008884-bbs2-0137" title="WetterslevJ , EngstrømJ , GluudC , ThorlundK . Trials sequential analysis: methods and software for cumulative meta‐analyses. Cochrane Methods. Cochrane Database Systematic Reviews2012;Supplement(3):29‐31. [ISSN 2044‐4702] ">Wetterslev 2012</a>; <a href="./references#CD008884-bbs2-0138" title="WetterslevJ , EngstrømJ , GluudC , ThorlundK . Trials sequential analysis: reply to Higgins on TSA for cumulative meta‐analyses. Cochrane Methods. Cochrane Database Systematic Reviews2012;Supplement(3):29‐31. ">Wetterslev 2012b</a>). We applied TSMB according to an information size suggested by trials with low risk of bias (<a href="./references#CD008884-bbs2-0135" title="WetterslevJ , ThorlundK , BrokJ , GluudC . Trial sequential analysis may establish when firm evidence is reached in cumulative meta‐analysis. Journal of Clinical Epidemiology2008;61(1):64‐75. [PUBMED: 18083463] ">Wetterslev 2008</a>; <a href="./references#CD008884-bbs2-0136" title="WetterslevJ , ThorlundK , BrokJ , GluudC . Estimating required information size by quantifying diversity in random‐effects model meta‐analyses. BMC Medical Research Methodology2009;9(86):1‐12. [PUBMED: 20042080] ">Wetterslev 2009</a>) and an a priori 20% relative risk reduction (RRR) of surgical site infection, using a control event proportion suggested by large observational studies and by the pooled estimate of event proportions in the control groups of included trials. As mortality seemed low in trials conducted when the protocol was finished, and hence the ability to detect small intervention effects was lacking, we also performed a TSA using an information size estimated for an a priori 35% RRR of mortality (<a href="./references#CD008884-bbs2-0135" title="WetterslevJ , ThorlundK , BrokJ , GluudC . Trial sequential analysis may establish when firm evidence is reached in cumulative meta‐analysis. Journal of Clinical Epidemiology2008;61(1):64‐75. [PUBMED: 18083463] ">Wetterslev 2008</a>; <a href="./references#CD008884-bbs2-0136" title="WetterslevJ , ThorlundK , BrokJ , GluudC . Estimating required information size by quantifying diversity in random‐effects model meta‐analyses. BMC Medical Research Methodology2009;9(86):1‐12. [PUBMED: 20042080] ">Wetterslev 2009</a>). </p> </section> <section id="CD008884-sec-0043"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We conducted the following subgroup analyses by assessing the benefits and harms of a high FIO<sub>2</sub> for surgical site infection. </p> <p> <ol id="CD008884-list-0004"> <li> <p>Trials using inspiratory oxygen with or without nitrous oxide.</p> </li> <li> <p>Trials using inspiratory oxygen with an FIO<sub>2</sub> of 80% or higher compared with trials using an FIO<sub>2</sub> equal to or greater than 60% but lower than 80%. </p> </li> <li> <p>Trials using a high FIO<sub>2</sub> only during surgery or during both surgery and postoperative care. </p> </li> <li> <p>Participants undergoing abdominal surgery according to type of surgery, that is, all kinds of abdominal surgery, procedures requiring laparotomy, upper laparotomy if possible, lower laparotomy if possible or laparoscopic procedures. </p> </li> <li> <p>Type of surgery (abdominal, orthopaedic, other).</p> </li> <li> <p>Whether follow‐up for surgical site infection lasted 14 or fewer days or more than 14 days. </p> </li> </ol> </p> <p>We made inferences from subgroup analyses in terms of implications for clinical practice only if the overall analysis of one of the co‐primary outcomes became statistically significant. When analyses of co‐primary outcomes did not become statistically significant, we referenced them in <a href="#CD008884-sec-0110">Implications for research</a> to provide hypotheses for future research. </p> <p>We compared intervention effects in subgroups using a test of interaction (<a href="./references#CD008884-bbs2-0060" title="AltmanDG , BlandJM . Interaction revisited: the difference between two estimates. BMJ2003;326(7382):219. [PUBMED: 12543843] ">Altman 2003</a>). P value &lt; 0.05 was considered indicative of a significant interaction between the high FIO<sub>2</sub> effect on surgical site infection and the subgroup category (<a href="./references#CD008884-bbs2-0092" title="HigginsJPT , GreenS , editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1. [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane‐handbook.org. ">Higgins 2011</a>; Chapters 9.6.1 and 9.7). </p> <p>We explored causes of moderate to high heterogeneity using meta‐regression, including mean age of the trial population at baseline. We planned to explore causes of moderate to high heterogeneity using meta‐regression with the following co‐variates: mean body mass index (BMI) of the trial population at baseline; fraction of participants with diabetes in the trial population at baseline; fraction of smokers in the trial population at baseline; and fraction of participants with a contaminated or dirty infected surgical field during surgery; however, because data were lacking in the included trials, this was not possible. </p> </section> <section id="CD008884-sec-0044"> <h4 class="title">Sensitivity analysis</h4> <p> <ol id="CD008884-list-0005"> <li> <p>We compared estimates of the pooled intervention effect in trials with low risk of bias versus estimates from trials with high risk of bias (i.e. trials with at least one unclear or high risk of bias component). </p> </li> <li> <p>We compared estimates of the pooled intervention effect in trials based on different components of risk of bias (random sequence generation, allocation concealment, blinding, follow‐up, intention to treat). </p> </li> <li> <p>We assessed benefits and harms of high FIO<sub>2</sub> by conducting a continuity correction of trials with zero events. </p> </li> <li> <p>We assessed benefits and harms of high FIO<sub>2</sub> by conducting sensitivity analyses excluding the smallest or the largest trial. </p> </li> <li> <p>We assessed benefits and harms of high FIO<sub>2</sub> by excluding data from trials published only as abstracts. </p> </li> <li> <p>We assessed benefits and harms of high FIO<sub>2</sub> by excluding data from trials with commercial funding. </p> </li> </ol> </p> <p>We calculated RRs with 95% CIs and applied a complete case analysis, when possible, to sensitivity and subgroup analyses based on the co‐primary outcomes of mortality and surgical site infection. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD008884-sec-0045" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD008884-sec-0045"></div> <section id="CD008884-sec-0046"> <h3 class="title">Description of studies</h3> <section id="CD008884-sec-0047"> <h4 class="title">Results of the search</h4> <p>We identified a total of 2148 references of possible interest by searching the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE, the Cumulative Index to Nursing and Allied Health Literature (CINAHL), the Chinese Database of Randomized Trials and reference lists. We identified two additional ongoing trials by searching databases of ongoing trials (<a href="./references#CD008884-bbs2-0055" title="Supplemental perioperative oxygen to reduce the incidence of post‐caesarean wound infection. Ongoing study2011. ">Osvaldo 2011</a>; <a href="./references#CD008884-bbs2-0056" title="Supplemental oxygen and risk of surgical site infection (PORSSI). Ongoing study2010. ">Santa Clara Valley Health</a>). We will include data from these two trials in future updates of this review. We excluded 403 duplicates and 1701 clearly irrelevant references upon reading the abstracts. Accordingly, we retrieved 59 references for further assessment. Of these, we excluded 26 references describing 26 studies because they were not randomized trials or did not fulfil the inclusion criteria of our review. We listed reasons for exclusion in the <a href="./references#CD008884-sec-0149" title="">Characteristics of excluded studies</a> table. We reran the search in March 2015 and found 40 citations, one of which was a duplicate from a previous search; we excluded 37 trials. We will consider two studies of interest when we update the review. </p> <p>In total, 28 RCTs described in 33 references fulfilled our inclusion criteria (<a href="#CD008884-fig-0004">Figure 4</a>). The included trials consisted of a total of 9330 participants; 7537 participants provided data for the outcomes analysed in this review. </p> <div class="figure" id="CD008884-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Trial flow diagram. We reran the search in March 2015. We found two studies of interest, which we will consider when we update the review." data-id="CD008884-fig-0004" src="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/image_n/nCD008884-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Trial flow diagram. We reran the search in March 2015. We found two studies of interest, which we will consider when we update the review. </p> </div> </div> </div> <p>We approached 28 corresponding or first study authors to request missing or unclear information and received answers from 10 of them. </p> <p>We presented detailed descriptions in the <a href="./references#CD008884-sec-0148" title="">Characteristics of included studies</a> table and in the appendices. A summary overview follows. </p> </section> <section id="CD008884-sec-0048"> <h4 class="title">Included studies</h4> <section id="CD008884-sec-0049"> <h5 class="title">Trial characteristics</h5> <p>Eight of the 28 trials, with 4918 participants (<a href="./references#CD008884-bbs2-0001" title="BeldaFJ , AguileraL , García de la AsunciónJ , AlbertiJ , VicenteR , FerrándizL , et al. Spanish Reduccion de la Tasa de Infeccion Quirurgica Group. Supplemental perioperative oxygen and the risk of surgical wound infection: a randomized controlled trial. JAMA2005;294(16):2035‐42. [PUBMED: 16249417] ">Belda 2005</a>; <a href="./references#CD008884-bbs2-0010" title="GreifR , AkçaO , HornEP , KurzA , SesslerDI , Outcomes Research Group. Supplemental perioperative oxygen to reduce the incidence of surgical‐wound infection. New England Journal of Medicine2000;342(3):161‐7. [PUBMED: 10639541] ">Greif 2000</a>; <a href="./references#CD008884-bbs2-0016" title="MeyhoffCS , WetterslevJ , JorgensenLN , HennebergSW , HøgdallC , LundvallL , et al. PROXI Trial Group. Effect of high perioperative oxygen fraction on surgical site infection and pulmonary complications after abdominal surgery: the PROXI randomized clinical trial. JAMA2009;302(14):1543‐50. [PUBMED: 19826023] ">Meyhoff 2009</a>; <a href="./references#CD008884-bbs2-0017" title="MylesPS , LeslieK , ChanMT , ForbesA , PaechMJ , PeytonP , et al. ENIGMA Trial Group. Avoidance of nitrous oxide for patients undergoing major surgery: a randomized controlled trial. Anesthesiology2007;107(2):221‐31. [PUBMED: 17667565] ">Myles 2007</a>; <a href="./references#CD008884-bbs2-0018" title="PryorKO , FaheyTJ3rd , LienCA , GoldsteinPA . Surgical site infection and the routine use of perioperative hyperoxia in a general surgical population: a randomized controlled trial. JAMA2004;291(1):79‐87. [PUBMED: 14709579] ">Pryor 2004</a>; <a href="./references#CD008884-bbs2-0021" title="SchietromaM , CeciliaEM , CarleiF , SistaF , DeSantisG , PiccioneF , et al. Prevention of anastomotic leakage after total gastrectomy with perioperative supplemental oxygen administration: a prospective randomized, double blind, controlled, single‐center trial. Annals of Surgical Oncology2013;20(5):584‐90. [DOI: 10.1245/s10434‐012‐2714‐7; PUBMED: 23099730] ">Schietroma 2013</a>; <a href="./references#CD008884-bbs2-0024" title="StallA , ParyaviE , GuptaR , ZadnikM , HuiE , O’TooleRV . Perioperative supplemental oxygen to reduce surgical site infection after open fixation of high‐risk fractures: a randomized controlled pilot trial. The Journal of Trauma and Acute Care Surgery2013;75(4):657‐63. [DOI: 10.1097/TA.0b0113e3182a1fe83] ">Stall 2013</a>; <a href="./references#CD008884-bbs2-0027" title="WilliamsN , GloverM , CrispC , ActonA , McKennaD . Randomized controlled trial of the effect of 30% versus 80% fraction of inspired oxygen on caesarean delivery surgical site infection. American Journal of Perinatology2013;30(9):781‐6. [DOI: 10.1055/s‐0032‐1333405] ">Williams 2013</a>), reported on mortality; 15 trials reported on surgical site infections (<a href="./references#CD008884-bbs2-0001" title="BeldaFJ , AguileraL , García de la AsunciónJ , AlbertiJ , VicenteR , FerrándizL , et al. Spanish Reduccion de la Tasa de Infeccion Quirurgica Group. Supplemental perioperative oxygen and the risk of surgical wound infection: a randomized controlled trial. JAMA2005;294(16):2035‐42. [PUBMED: 16249417] ">Belda 2005</a>; <a href="./references#CD008884-bbs2-0003" title="BickelA , GurevitsM , VamosR , IvryS , EitanA . Perioperative hyperoxygenation and wound site infection following surgery for acute appendicitis: a randomized, prospective, controlled trial. Archives of Surgery2011;146(4):464‐70. [PUBMED: 21502457] ">Bickel 2011</a>; <a href="./references#CD008884-bbs2-0004" title="DuggalN , PoddatooriV , NoroozkhaniS , CherryC , ParkT , CaugheyAB . Perioperative oxygen supplementation and surgical site infection after cesarean delivery. A randomized trial. Obstetrics &amp; Gynecology2013;122(1):79‐84. [DOI: 10.1097/AOG.0b013e318297ec6c] ">Duggal 2013</a>; <a href="./references#CD008884-bbs2-0006" title="GardellaC , GoltraLB , LaschanskyE , DroletteL , MagaretA , ChadwickHS , et al. High‐concentration supplemental perioperative oxygen to reduce the incidence of postcesarean surgical site infection: a randomized controlled trial. Obstetrics and Gynecology2008;112(3):545‐52. [PUBMED: 18757651] ">Gardella 2008</a>; <a href="./references#CD008884-bbs2-0007" title="GolfamF . Effects of supplemental oxygen for prevention of wound infection after breast surgery. International Journal of Infectious Diseases2011;15(1):S55. [DOI: http://dx.doi.org/10.1016/S1201‐9712(11)60189‐6] ">Golfam 2011</a>; <a href="./references#CD008884-bbs2-0010" title="GreifR , AkçaO , HornEP , KurzA , SesslerDI , Outcomes Research Group. Supplemental perioperative oxygen to reduce the incidence of surgical‐wound infection. New England Journal of Medicine2000;342(3):161‐7. [PUBMED: 10639541] ">Greif 2000</a>; <a href="./references#CD008884-bbs2-0014" title="MayzlerO , WekslerN , DomchikS , KleinM , MizrahiS , GurmanGM . Does supplemental perioperative oxygen administration reduce the incidence of wound infection in elective colorectal surgery?. Minerva Anestesiology2005;71(1‐2):21‐5. [PUBMED: 15711503] ">Mayzler 2005</a>; <a href="./references#CD008884-bbs2-0016" title="MeyhoffCS , WetterslevJ , JorgensenLN , HennebergSW , HøgdallC , LundvallL , et al. PROXI Trial Group. Effect of high perioperative oxygen fraction on surgical site infection and pulmonary complications after abdominal surgery: the PROXI randomized clinical trial. JAMA2009;302(14):1543‐50. [PUBMED: 19826023] ">Meyhoff 2009</a>; <a href="./references#CD008884-bbs2-0017" title="MylesPS , LeslieK , ChanMT , ForbesA , PaechMJ , PeytonP , et al. ENIGMA Trial Group. Avoidance of nitrous oxide for patients undergoing major surgery: a randomized controlled trial. Anesthesiology2007;107(2):221‐31. [PUBMED: 17667565] ">Myles 2007</a>; <a href="./references#CD008884-bbs2-0018" title="PryorKO , FaheyTJ3rd , LienCA , GoldsteinPA . Surgical site infection and the routine use of perioperative hyperoxia in a general surgical population: a randomized controlled trial. JAMA2004;291(1):79‐87. [PUBMED: 14709579] ">Pryor 2004</a>; <a href="./references#CD008884-bbs2-0021" title="SchietromaM , CeciliaEM , CarleiF , SistaF , DeSantisG , PiccioneF , et al. Prevention of anastomotic leakage after total gastrectomy with perioperative supplemental oxygen administration: a prospective randomized, double blind, controlled, single‐center trial. Annals of Surgical Oncology2013;20(5):584‐90. [DOI: 10.1245/s10434‐012‐2714‐7; PUBMED: 23099730] ">Schietroma 2013</a>; <a href="./references#CD008884-bbs2-0022" title="ScifresCM , LeightonBL , FogerteyPJ , MaconesGA , StamilioDM . Supplemental oxygen for the prevention of postcesarean infectious morbidity: a randomized controlled trial. American Journal of Obstetrics and Gynecology2011;205(3):267.e1‐9. [PUBMED: 22071059] ">Scifres 2011</a>; <a href="./references#CD008884-bbs2-0024" title="StallA , ParyaviE , GuptaR , ZadnikM , HuiE , O’TooleRV . Perioperative supplemental oxygen to reduce surgical site infection after open fixation of high‐risk fractures: a randomized controlled pilot trial. The Journal of Trauma and Acute Care Surgery2013;75(4):657‐63. [DOI: 10.1097/TA.0b0113e3182a1fe83] ">Stall 2013</a>; <a href="./references#CD008884-bbs2-0025" title="ThibonP , BorgeyF , BoutreuxS , HanouzJ‐L , LeCoutourX , ParientiJ‐J . Effect of perioperative oxygen supplementation on 30‐day surgical site infection rate in abdominal, gynecologic, and breast surgery. Anesthesiology2012;117:504–11. [MEDLINE: PMID: 22790961] ">Thibon 2012</a>; <a href="./references#CD008884-bbs2-0027" title="WilliamsN , GloverM , CrispC , ActonA , McKennaD . Randomized controlled trial of the effect of 30% versus 80% fraction of inspired oxygen on caesarean delivery surgical site infection. American Journal of Perinatology2013;30(9):781‐6. [DOI: 10.1055/s‐0032‐1333405] ">Williams 2013</a>); three reported on serious adverse events (SAEs) (<a href="./references#CD008884-bbs2-0016" title="MeyhoffCS , WetterslevJ , JorgensenLN , HennebergSW , HøgdallC , LundvallL , et al. PROXI Trial Group. Effect of high perioperative oxygen fraction on surgical site infection and pulmonary complications after abdominal surgery: the PROXI randomized clinical trial. JAMA2009;302(14):1543‐50. [PUBMED: 19826023] ">Meyhoff 2009</a>; <a href="./references#CD008884-bbs2-0017" title="MylesPS , LeslieK , ChanMT , ForbesA , PaechMJ , PeytonP , et al. ENIGMA Trial Group. Avoidance of nitrous oxide for patients undergoing major surgery: a randomized controlled trial. Anesthesiology2007;107(2):221‐31. [PUBMED: 17667565] ">Myles 2007</a>; <a href="./references#CD008884-bbs2-0018" title="PryorKO , FaheyTJ3rd , LienCA , GoldsteinPA . Surgical site infection and the routine use of perioperative hyperoxia in a general surgical population: a randomized controlled trial. JAMA2004;291(1):79‐87. [PUBMED: 14709579] ">Pryor 2004</a>); three on respiratory insufficiency (<a href="./references#CD008884-bbs2-0012" title="KotaniN , HashimotoH , SesslerDI , MuraokaM , HashibaE , KubotaT , et al. Supplemental intraoperative oxygen augments antimicrobial and proinflammatory responses of alveolar macrophages. Anesthesiology2000;93(1):15‐25. [PUBMED: 10861141] ">Kotani 2000</a>; <a href="./references#CD008884-bbs2-0016" title="MeyhoffCS , WetterslevJ , JorgensenLN , HennebergSW , HøgdallC , LundvallL , et al. PROXI Trial Group. Effect of high perioperative oxygen fraction on surgical site infection and pulmonary complications after abdominal surgery: the PROXI randomized clinical trial. JAMA2009;302(14):1543‐50. [PUBMED: 19826023] ">Meyhoff 2009</a>; <a href="./references#CD008884-bbs2-0028" title="ZorembaM , DetteF , HuneckeT , BrauneckerS , WulfH . The influence of perioperative oxygen concentration on postoperative lung function in moderately obese adults. European Journal of Anaesthesiology2010;27(6):501‐7. [MEDLINE: 19550338] ">Zoremba 2010</a>); seven on length of stay during the index admission (LOS) (<a href="./references#CD008884-bbs2-0001" title="BeldaFJ , AguileraL , García de la AsunciónJ , AlbertiJ , VicenteR , FerrándizL , et al. Spanish Reduccion de la Tasa de Infeccion Quirurgica Group. Supplemental perioperative oxygen and the risk of surgical wound infection: a randomized controlled trial. JAMA2005;294(16):2035‐42. [PUBMED: 16249417] ">Belda 2005</a>; <a href="./references#CD008884-bbs2-0003" title="BickelA , GurevitsM , VamosR , IvryS , EitanA . Perioperative hyperoxygenation and wound site infection following surgery for acute appendicitis: a randomized, prospective, controlled trial. Archives of Surgery2011;146(4):464‐70. [PUBMED: 21502457] ">Bickel 2011</a>; <a href="./references#CD008884-bbs2-0006" title="GardellaC , GoltraLB , LaschanskyE , DroletteL , MagaretA , ChadwickHS , et al. High‐concentration supplemental perioperative oxygen to reduce the incidence of postcesarean surgical site infection: a randomized controlled trial. Obstetrics and Gynecology2008;112(3):545‐52. [PUBMED: 18757651] ">Gardella 2008</a>; <a href="./references#CD008884-bbs2-0010" title="GreifR , AkçaO , HornEP , KurzA , SesslerDI , Outcomes Research Group. Supplemental perioperative oxygen to reduce the incidence of surgical‐wound infection. New England Journal of Medicine2000;342(3):161‐7. [PUBMED: 10639541] ">Greif 2000</a>; <a href="./references#CD008884-bbs2-0016" title="MeyhoffCS , WetterslevJ , JorgensenLN , HennebergSW , HøgdallC , LundvallL , et al. PROXI Trial Group. Effect of high perioperative oxygen fraction on surgical site infection and pulmonary complications after abdominal surgery: the PROXI randomized clinical trial. JAMA2009;302(14):1543‐50. [PUBMED: 19826023] ">Meyhoff 2009</a>; <a href="./references#CD008884-bbs2-0017" title="MylesPS , LeslieK , ChanMT , ForbesA , PaechMJ , PeytonP , et al. ENIGMA Trial Group. Avoidance of nitrous oxide for patients undergoing major surgery: a randomized controlled trial. Anesthesiology2007;107(2):221‐31. [PUBMED: 17667565] ">Myles 2007</a>; <a href="./references#CD008884-bbs2-0018" title="PryorKO , FaheyTJ3rd , LienCA , GoldsteinPA . Surgical site infection and the routine use of perioperative hyperoxia in a general surgical population: a randomized controlled trial. JAMA2004;291(1):79‐87. [PUBMED: 14709579] ">Pryor 2004</a>); one on quality of life (<a href="./references#CD008884-bbs2-0009" title="GreifR , LacinyS , RapfB , HickleRS , SesslerDI . Supplemental oxygen reduces the incidence of postoperative nausea and vomiting. Anesthesiology1999;91(5):1246‐52. ">Greif 1999</a>); 10 only on outcomes that were not relevant to this review (<a href="./references#CD008884-bbs2-0002" title="BhatnagarS , MishraS , GuptaM , SinghalAK , MandalAS . Effects of different concentrations of intraoperative supplemental oxygen on post‐operative nausea and vomiting (PONV) in patients undergoing modified radical mastectomy. Internet Journal of Anesthesiology2005;9(12):1‐6. ">Bhatnagar 2005</a>; <a href="./references#CD008884-bbs2-0008" title="GollV , AkçaO , GreifR , FreitagH , ArkiliçCF , ScheckT , et al. Ondansetron is no more effective than supplemental intraoperative oxygen for prevention of postoperative nausea and vomiting. Anesthesia and Analgesia2001;92(1):112‐7. [PUBMED: 11133611] ">Goll 2001</a>; <a href="./references#CD008884-bbs2-0011" title="JorisJL , PothNJ , DjamadarAM , SesslerDI , HamoirEE , DefêchereuxTR , et al. Supplemental oxygen does not reduce postoperative nausea and vomiting after thyroidectomy. British Journal of Anaesthesia2003;91(6):857‐61. [PUBMED: 14633758 ] ">Joris 2003</a>; <a href="./references#CD008884-bbs2-0015" title="McKeenDM , ArellanoR , O'ConnellC . Supplemental oxygen does not prevent postoperative nausea and vomiting after gynecological laparoscopy. Canadian Journal of Anaesthesia2009;56(9):651‐7. [DOI: 10.1007/s12630‐009‐9136‐4] ">McKeen 2009</a>; <a href="./references#CD008884-bbs2-0019" title="PurhonenS , TurunenM , RuohoahoUM , NiskanenM , HynynenM . Supplemental oxygen does not reduce the incidence of postoperative nausea and vomiting after ambulatory gynecologic laparoscopy. Anesthesia and Analgesia2003;96(1):91‐6. [PUBMED: 12505931] ">Purhonen 2003</a>; <a href="./references#CD008884-bbs2-0020" title="PurhonenS , NiskanenM , WüstefeldM , HirvonenE , HynynenM . Supplemental 80% oxygen does not attenuate post‐operative nausea and vomiting after breast surgery. Acta Anaesthesiologica Scandinavica2006;50(1):26‐31. [PUBMED: 16451147] ">Purhonen 2006</a>; <a href="./references#CD008884-bbs2-0023" title="ŠimurinaT , MraovićB , MikulandraS , SonickiZ , SulenN , DukićB , et al. Effects of high intraoperative inspired oxygen on postoperative nausea and vomiting in gynecologic laparoscopic surgery. Journal of Clinical Anesthesia2010;22(7):492‐8. [DOI: 10.1016/j.jclinane.2009.10.013] ">Simurina 2010</a>; <a href="./references#CD008884-bbs2-0026" title="TuranA , ApfelCC , KumpchM , DanzeisenO , EberhartLH , ForstH , et al. Does the efficacy of supplemental oxygen for the prevention of postoperative nausea and vomiting depend on the measured outcome, observational period or site of surgery. Anaesthesia2006;61(7):628‐33. [PUBMED: 16792606] ">Turan 2006</a>) ; eight only on nausea and vomiting (<a href="./references#CD008884-bbs2-0002" title="BhatnagarS , MishraS , GuptaM , SinghalAK , MandalAS . Effects of different concentrations of intraoperative supplemental oxygen on post‐operative nausea and vomiting (PONV) in patients undergoing modified radical mastectomy. Internet Journal of Anesthesiology2005;9(12):1‐6. ">Bhatnagar 2005</a>; <a href="./references#CD008884-bbs2-0008" title="GollV , AkçaO , GreifR , FreitagH , ArkiliçCF , ScheckT , et al. Ondansetron is no more effective than supplemental intraoperative oxygen for prevention of postoperative nausea and vomiting. Anesthesia and Analgesia2001;92(1):112‐7. [PUBMED: 11133611] ">Goll 2001</a>; <a href="./references#CD008884-bbs2-0011" title="JorisJL , PothNJ , DjamadarAM , SesslerDI , HamoirEE , DefêchereuxTR , et al. Supplemental oxygen does not reduce postoperative nausea and vomiting after thyroidectomy. British Journal of Anaesthesia2003;91(6):857‐61. [PUBMED: 14633758 ] ">Joris 2003</a>; <a href="./references#CD008884-bbs2-0015" title="McKeenDM , ArellanoR , O'ConnellC . Supplemental oxygen does not prevent postoperative nausea and vomiting after gynecological laparoscopy. Canadian Journal of Anaesthesia2009;56(9):651‐7. [DOI: 10.1007/s12630‐009‐9136‐4] ">McKeen 2009</a>; <a href="./references#CD008884-bbs2-0019" title="PurhonenS , TurunenM , RuohoahoUM , NiskanenM , HynynenM . Supplemental oxygen does not reduce the incidence of postoperative nausea and vomiting after ambulatory gynecologic laparoscopy. Anesthesia and Analgesia2003;96(1):91‐6. [PUBMED: 12505931] ">Purhonen 2003</a>; <a href="./references#CD008884-bbs2-0020" title="PurhonenS , NiskanenM , WüstefeldM , HirvonenE , HynynenM . Supplemental 80% oxygen does not attenuate post‐operative nausea and vomiting after breast surgery. Acta Anaesthesiologica Scandinavica2006;50(1):26‐31. [PUBMED: 16451147] ">Purhonen 2006</a>; <a href="./references#CD008884-bbs2-0023" title="ŠimurinaT , MraovićB , MikulandraS , SonickiZ , SulenN , DukićB , et al. Effects of high intraoperative inspired oxygen on postoperative nausea and vomiting in gynecologic laparoscopic surgery. Journal of Clinical Anesthesia2010;22(7):492‐8. [DOI: 10.1016/j.jclinane.2009.10.013] ">Simurina 2010</a>; <a href="./references#CD008884-bbs2-0026" title="TuranA , ApfelCC , KumpchM , DanzeisenO , EberhartLH , ForstH , et al. Does the efficacy of supplemental oxygen for the prevention of postoperative nausea and vomiting depend on the measured outcome, observational period or site of surgery. Anaesthesia2006;61(7):628‐33. [PUBMED: 16792606] ">Turan 2006</a>; <a href="./references#CD008884-bbs2-0013" title="MackintoshN , GertschMC , HopfHW , PaceNL , WhiteJ , MorrisR , et al. High intraoperative inspired oxygen does not increase postoperative supplemental oxygen requirements. Anesthesiology2012;117(2):271‐9. [MEDLINE: 22569132] ">Mackintosh 2012</a>; <a href="./references#CD008884-bbs2-0005" title="García‐BotelloSA , García‐GraneroE , LilloR , López‐MozosF , MillánM , LledóS . Randomized clinical trial to evaluate the effects of perioperative supplemental oxygen administration on the colorectal anastomosis. British Journal of Surgery2006;93(6):698‐706. [MEDLINE: 16703624] ">García‐Botello 2006</a>); one on requirements for postoperative supplemental oxygen (<a href="./references#CD008884-bbs2-0013" title="MackintoshN , GertschMC , HopfHW , PaceNL , WhiteJ , MorrisR , et al. High intraoperative inspired oxygen does not increase postoperative supplemental oxygen requirements. Anesthesiology2012;117(2):271‐9. [MEDLINE: 22569132] ">Mackintosh 2012</a>); and one on intestinal pH (ph<sub>i</sub>) and carbon dioxide (CO<sub>2</sub>) gaps (<a href="./references#CD008884-bbs2-0005" title="García‐BotelloSA , García‐GraneroE , LilloR , López‐MozosF , MillánM , LledóS . Randomized clinical trial to evaluate the effects of perioperative supplemental oxygen administration on the colorectal anastomosis. British Journal of Surgery2006;93(6):698‐706. [MEDLINE: 16703624] ">García‐Botello 2006</a>). All 28 trials used a parallel‐group design, and the 18 trials that provided data on the outcomes selected for this review used a two‐parallel group design. These trials were published from 1999 to 2013. All were conducted without direct funding by industry; however, two trials reported that a company was involved in their design (<a href="./references#CD008884-bbs2-0001" title="BeldaFJ , AguileraL , García de la AsunciónJ , AlbertiJ , VicenteR , FerrándizL , et al. Spanish Reduccion de la Tasa de Infeccion Quirurgica Group. Supplemental perioperative oxygen and the risk of surgical wound infection: a randomized controlled trial. JAMA2005;294(16):2035‐42. [PUBMED: 16249417] ">Belda 2005</a>; <a href="./references#CD008884-bbs2-0025" title="ThibonP , BorgeyF , BoutreuxS , HanouzJ‐L , LeCoutourX , ParientiJ‐J . Effect of perioperative oxygen supplementation on 30‐day surgical site infection rate in abdominal, gynecologic, and breast surgery. Anesthesiology2012;117:504–11. [MEDLINE: PMID: 22790961] ">Thibon 2012</a>). Seven trials were conducted in Europe (<a href="./references#CD008884-bbs2-0001" title="BeldaFJ , AguileraL , García de la AsunciónJ , AlbertiJ , VicenteR , FerrándizL , et al. Spanish Reduccion de la Tasa de Infeccion Quirurgica Group. Supplemental perioperative oxygen and the risk of surgical wound infection: a randomized controlled trial. JAMA2005;294(16):2035‐42. [PUBMED: 16249417] ">Belda 2005</a>; <a href="./references#CD008884-bbs2-0005" title="García‐BotelloSA , García‐GraneroE , LilloR , López‐MozosF , MillánM , LledóS . Randomized clinical trial to evaluate the effects of perioperative supplemental oxygen administration on the colorectal anastomosis. British Journal of Surgery2006;93(6):698‐706. [MEDLINE: 16703624] ">García‐Botello 2006</a>; <a href="./references#CD008884-bbs2-0010" title="GreifR , AkçaO , HornEP , KurzA , SesslerDI , Outcomes Research Group. Supplemental perioperative oxygen to reduce the incidence of surgical‐wound infection. New England Journal of Medicine2000;342(3):161‐7. [PUBMED: 10639541] ">Greif 2000</a>; <a href="./references#CD008884-bbs2-0016" title="MeyhoffCS , WetterslevJ , JorgensenLN , HennebergSW , HøgdallC , LundvallL , et al. PROXI Trial Group. Effect of high perioperative oxygen fraction on surgical site infection and pulmonary complications after abdominal surgery: the PROXI randomized clinical trial. JAMA2009;302(14):1543‐50. [PUBMED: 19826023] ">Meyhoff 2009</a>; <a href="./references#CD008884-bbs2-0021" title="SchietromaM , CeciliaEM , CarleiF , SistaF , DeSantisG , PiccioneF , et al. Prevention of anastomotic leakage after total gastrectomy with perioperative supplemental oxygen administration: a prospective randomized, double blind, controlled, single‐center trial. Annals of Surgical Oncology2013;20(5):584‐90. [DOI: 10.1245/s10434‐012‐2714‐7; PUBMED: 23099730] ">Schietroma 2013</a>; <a href="./references#CD008884-bbs2-0025" title="ThibonP , BorgeyF , BoutreuxS , HanouzJ‐L , LeCoutourX , ParientiJ‐J . Effect of perioperative oxygen supplementation on 30‐day surgical site infection rate in abdominal, gynecologic, and breast surgery. Anesthesiology2012;117:504–11. [MEDLINE: PMID: 22790961] ">Thibon 2012</a>; <a href="./references#CD008884-bbs2-0028" title="ZorembaM , DetteF , HuneckeT , BrauneckerS , WulfH . The influence of perioperative oxygen concentration on postoperative lung function in moderately obese adults. European Journal of Anaesthesiology2010;27(6):501‐7. [MEDLINE: 19550338] ">Zoremba 2010</a>); seven in North America (<a href="./references#CD008884-bbs2-0004" title="DuggalN , PoddatooriV , NoroozkhaniS , CherryC , ParkT , CaugheyAB . Perioperative oxygen supplementation and surgical site infection after cesarean delivery. A randomized trial. Obstetrics &amp; Gynecology2013;122(1):79‐84. [DOI: 10.1097/AOG.0b013e318297ec6c] ">Duggal 2013</a>; <a href="./references#CD008884-bbs2-0006" title="GardellaC , GoltraLB , LaschanskyE , DroletteL , MagaretA , ChadwickHS , et al. High‐concentration supplemental perioperative oxygen to reduce the incidence of postcesarean surgical site infection: a randomized controlled trial. Obstetrics and Gynecology2008;112(3):545‐52. [PUBMED: 18757651] ">Gardella 2008</a>; <a href="./references#CD008884-bbs2-0013" title="MackintoshN , GertschMC , HopfHW , PaceNL , WhiteJ , MorrisR , et al. High intraoperative inspired oxygen does not increase postoperative supplemental oxygen requirements. Anesthesiology2012;117(2):271‐9. [MEDLINE: 22569132] ">Mackintosh 2012</a>; <a href="./references#CD008884-bbs2-0018" title="PryorKO , FaheyTJ3rd , LienCA , GoldsteinPA . Surgical site infection and the routine use of perioperative hyperoxia in a general surgical population: a randomized controlled trial. JAMA2004;291(1):79‐87. [PUBMED: 14709579] ">Pryor 2004</a>; <a href="./references#CD008884-bbs2-0022" title="ScifresCM , LeightonBL , FogerteyPJ , MaconesGA , StamilioDM . Supplemental oxygen for the prevention of postcesarean infectious morbidity: a randomized controlled trial. American Journal of Obstetrics and Gynecology2011;205(3):267.e1‐9. [PUBMED: 22071059] ">Scifres 2011</a>; <a href="./references#CD008884-bbs2-0024" title="StallA , ParyaviE , GuptaR , ZadnikM , HuiE , O’TooleRV . Perioperative supplemental oxygen to reduce surgical site infection after open fixation of high‐risk fractures: a randomized controlled pilot trial. The Journal of Trauma and Acute Care Surgery2013;75(4):657‐63. [DOI: 10.1097/TA.0b0113e3182a1fe83] ">Stall 2013</a>; <a href="./references#CD008884-bbs2-0027" title="WilliamsN , GloverM , CrispC , ActonA , McKennaD . Randomized controlled trial of the effect of 30% versus 80% fraction of inspired oxygen on caesarean delivery surgical site infection. American Journal of Perinatology2013;30(9):781‐6. [DOI: 10.1055/s‐0032‐1333405] ">Williams 2013</a>); three in the Middle East (<a href="./references#CD008884-bbs2-0003" title="BickelA , GurevitsM , VamosR , IvryS , EitanA . Perioperative hyperoxygenation and wound site infection following surgery for acute appendicitis: a randomized, prospective, controlled trial. Archives of Surgery2011;146(4):464‐70. [PUBMED: 21502457] ">Bickel 2011</a>; <a href="./references#CD008884-bbs2-0007" title="GolfamF . Effects of supplemental oxygen for prevention of wound infection after breast surgery. International Journal of Infectious Diseases2011;15(1):S55. [DOI: http://dx.doi.org/10.1016/S1201‐9712(11)60189‐6] ">Golfam 2011</a>; <a href="./references#CD008884-bbs2-0014" title="MayzlerO , WekslerN , DomchikS , KleinM , MizrahiS , GurmanGM . Does supplemental perioperative oxygen administration reduce the incidence of wound infection in elective colorectal surgery?. Minerva Anestesiology2005;71(1‐2):21‐5. [PUBMED: 15711503] ">Mayzler 2005</a>); one in Australia, Hong Kong and the People's Republic of China (<a href="./references#CD008884-bbs2-0017" title="MylesPS , LeslieK , ChanMT , ForbesA , PaechMJ , PeytonP , et al. ENIGMA Trial Group. Avoidance of nitrous oxide for patients undergoing major surgery: a randomized controlled trial. Anesthesiology2007;107(2):221‐31. [PUBMED: 17667565] ">Myles 2007</a>); and one in Japan (<a href="./references#CD008884-bbs2-0012" title="KotaniN , HashimotoH , SesslerDI , MuraokaM , HashibaE , KubotaT , et al. Supplemental intraoperative oxygen augments antimicrobial and proinflammatory responses of alveolar macrophages. Anesthesiology2000;93(1):15‐25. [PUBMED: 10861141] ">Kotani 2000</a>). Twentysix trials were conducted in high‐income countries (<a href="./references#CD008884-bbs2-0001" title="BeldaFJ , AguileraL , García de la AsunciónJ , AlbertiJ , VicenteR , FerrándizL , et al. Spanish Reduccion de la Tasa de Infeccion Quirurgica Group. Supplemental perioperative oxygen and the risk of surgical wound infection: a randomized controlled trial. JAMA2005;294(16):2035‐42. [PUBMED: 16249417] ">Belda 2005</a>; <a href="./references#CD008884-bbs2-0003" title="BickelA , GurevitsM , VamosR , IvryS , EitanA . Perioperative hyperoxygenation and wound site infection following surgery for acute appendicitis: a randomized, prospective, controlled trial. Archives of Surgery2011;146(4):464‐70. [PUBMED: 21502457] ">Bickel 2011</a>; <a href="./references#CD008884-bbs2-0004" title="DuggalN , PoddatooriV , NoroozkhaniS , CherryC , ParkT , CaugheyAB . Perioperative oxygen supplementation and surgical site infection after cesarean delivery. A randomized trial. Obstetrics &amp; Gynecology2013;122(1):79‐84. [DOI: 10.1097/AOG.0b013e318297ec6c] ">Duggal 2013</a>; <a href="./references#CD008884-bbs2-0006" title="GardellaC , GoltraLB , LaschanskyE , DroletteL , MagaretA , ChadwickHS , et al. High‐concentration supplemental perioperative oxygen to reduce the incidence of postcesarean surgical site infection: a randomized controlled trial. Obstetrics and Gynecology2008;112(3):545‐52. [PUBMED: 18757651] ">Gardella 2008</a>; <a href="./references#CD008884-bbs2-0010" title="GreifR , AkçaO , HornEP , KurzA , SesslerDI , Outcomes Research Group. Supplemental perioperative oxygen to reduce the incidence of surgical‐wound infection. New England Journal of Medicine2000;342(3):161‐7. [PUBMED: 10639541] ">Greif 2000</a>; <a href="./references#CD008884-bbs2-0014" title="MayzlerO , WekslerN , DomchikS , KleinM , MizrahiS , GurmanGM . Does supplemental perioperative oxygen administration reduce the incidence of wound infection in elective colorectal surgery?. Minerva Anestesiology2005;71(1‐2):21‐5. [PUBMED: 15711503] ">Mayzler 2005</a>; <a href="./references#CD008884-bbs2-0016" title="MeyhoffCS , WetterslevJ , JorgensenLN , HennebergSW , HøgdallC , LundvallL , et al. PROXI Trial Group. Effect of high perioperative oxygen fraction on surgical site infection and pulmonary complications after abdominal surgery: the PROXI randomized clinical trial. JAMA2009;302(14):1543‐50. [PUBMED: 19826023] ">Meyhoff 2009</a>; <a href="./references#CD008884-bbs2-0017" title="MylesPS , LeslieK , ChanMT , ForbesA , PaechMJ , PeytonP , et al. ENIGMA Trial Group. Avoidance of nitrous oxide for patients undergoing major surgery: a randomized controlled trial. Anesthesiology2007;107(2):221‐31. [PUBMED: 17667565] ">Myles 2007</a>; <a href="./references#CD008884-bbs2-0018" title="PryorKO , FaheyTJ3rd , LienCA , GoldsteinPA . Surgical site infection and the routine use of perioperative hyperoxia in a general surgical population: a randomized controlled trial. JAMA2004;291(1):79‐87. [PUBMED: 14709579] ">Pryor 2004</a>; <a href="./references#CD008884-bbs2-0021" title="SchietromaM , CeciliaEM , CarleiF , SistaF , DeSantisG , PiccioneF , et al. Prevention of anastomotic leakage after total gastrectomy with perioperative supplemental oxygen administration: a prospective randomized, double blind, controlled, single‐center trial. Annals of Surgical Oncology2013;20(5):584‐90. [DOI: 10.1245/s10434‐012‐2714‐7; PUBMED: 23099730] ">Schietroma 2013</a>; <a href="./references#CD008884-bbs2-0022" title="ScifresCM , LeightonBL , FogerteyPJ , MaconesGA , StamilioDM . Supplemental oxygen for the prevention of postcesarean infectious morbidity: a randomized controlled trial. American Journal of Obstetrics and Gynecology2011;205(3):267.e1‐9. [PUBMED: 22071059] ">Scifres 2011</a>; <a href="./references#CD008884-bbs2-0024" title="StallA , ParyaviE , GuptaR , ZadnikM , HuiE , O’TooleRV . Perioperative supplemental oxygen to reduce surgical site infection after open fixation of high‐risk fractures: a randomized controlled pilot trial. The Journal of Trauma and Acute Care Surgery2013;75(4):657‐63. [DOI: 10.1097/TA.0b0113e3182a1fe83] ">Stall 2013</a>; <a href="./references#CD008884-bbs2-0025" title="ThibonP , BorgeyF , BoutreuxS , HanouzJ‐L , LeCoutourX , ParientiJ‐J . Effect of perioperative oxygen supplementation on 30‐day surgical site infection rate in abdominal, gynecologic, and breast surgery. Anesthesiology2012;117:504–11. [MEDLINE: PMID: 22790961] ">Thibon 2012</a>; <a href="./references#CD008884-bbs2-0027" title="WilliamsN , GloverM , CrispC , ActonA , McKennaD . Randomized controlled trial of the effect of 30% versus 80% fraction of inspired oxygen on caesarean delivery surgical site infection. American Journal of Perinatology2013;30(9):781‐6. [DOI: 10.1055/s‐0032‐1333405] ">Williams 2013</a>;<a href="./references#CD008884-bbs2-0012" title="KotaniN , HashimotoH , SesslerDI , MuraokaM , HashibaE , KubotaT , et al. Supplemental intraoperative oxygen augments antimicrobial and proinflammatory responses of alveolar macrophages. Anesthesiology2000;93(1):15‐25. [PUBMED: 10861141] ">Kotani 2000</a>; <a href="./references#CD008884-bbs2-0028" title="ZorembaM , DetteF , HuneckeT , BrauneckerS , WulfH . The influence of perioperative oxygen concentration on postoperative lung function in moderately obese adults. European Journal of Anaesthesiology2010;27(6):501‐7. [MEDLINE: 19550338] ">Zoremba 2010</a>; <a href="./references#CD008884-bbs2-0008" title="GollV , AkçaO , GreifR , FreitagH , ArkiliçCF , ScheckT , et al. Ondansetron is no more effective than supplemental intraoperative oxygen for prevention of postoperative nausea and vomiting. Anesthesia and Analgesia2001;92(1):112‐7. [PUBMED: 11133611] ">Goll 2001</a>; <a href="./references#CD008884-bbs2-0011" title="JorisJL , PothNJ , DjamadarAM , SesslerDI , HamoirEE , DefêchereuxTR , et al. Supplemental oxygen does not reduce postoperative nausea and vomiting after thyroidectomy. British Journal of Anaesthesia2003;91(6):857‐61. [PUBMED: 14633758 ] ">Joris 2003</a>; <a href="./references#CD008884-bbs2-0015" title="McKeenDM , ArellanoR , O'ConnellC . Supplemental oxygen does not prevent postoperative nausea and vomiting after gynecological laparoscopy. Canadian Journal of Anaesthesia2009;56(9):651‐7. [DOI: 10.1007/s12630‐009‐9136‐4] ">McKeen 2009</a>; <a href="./references#CD008884-bbs2-0019" title="PurhonenS , TurunenM , RuohoahoUM , NiskanenM , HynynenM . Supplemental oxygen does not reduce the incidence of postoperative nausea and vomiting after ambulatory gynecologic laparoscopy. Anesthesia and Analgesia2003;96(1):91‐6. [PUBMED: 12505931] ">Purhonen 2003</a>; <a href="./references#CD008884-bbs2-0020" title="PurhonenS , NiskanenM , WüstefeldM , HirvonenE , HynynenM . Supplemental 80% oxygen does not attenuate post‐operative nausea and vomiting after breast surgery. Acta Anaesthesiologica Scandinavica2006;50(1):26‐31. [PUBMED: 16451147] ">Purhonen 2006</a>; <a href="./references#CD008884-bbs2-0023" title="ŠimurinaT , MraovićB , MikulandraS , SonickiZ , SulenN , DukićB , et al. Effects of high intraoperative inspired oxygen on postoperative nausea and vomiting in gynecologic laparoscopic surgery. Journal of Clinical Anesthesia2010;22(7):492‐8. [DOI: 10.1016/j.jclinane.2009.10.013] ">Simurina 2010</a>; <a href="./references#CD008884-bbs2-0026" title="TuranA , ApfelCC , KumpchM , DanzeisenO , EberhartLH , ForstH , et al. Does the efficacy of supplemental oxygen for the prevention of postoperative nausea and vomiting depend on the measured outcome, observational period or site of surgery. Anaesthesia2006;61(7):628‐33. [PUBMED: 16792606] ">Turan 2006</a>; <a href="./references#CD008884-bbs2-0013" title="MackintoshN , GertschMC , HopfHW , PaceNL , WhiteJ , MorrisR , et al. High intraoperative inspired oxygen does not increase postoperative supplemental oxygen requirements. Anesthesiology2012;117(2):271‐9. [MEDLINE: 22569132] ">Mackintosh 2012</a>; <a href="./references#CD008884-bbs2-0005" title="García‐BotelloSA , García‐GraneroE , LilloR , López‐MozosF , MillánM , LledóS . Randomized clinical trial to evaluate the effects of perioperative supplemental oxygen administration on the colorectal anastomosis. British Journal of Surgery2006;93(6):698‐706. [MEDLINE: 16703624] ">García‐Botello 2006</a>), and two in a developing country (<a href="./references#CD008884-bbs2-0007" title="GolfamF . Effects of supplemental oxygen for prevention of wound infection after breast surgery. International Journal of Infectious Diseases2011;15(1):S55. [DOI: http://dx.doi.org/10.1016/S1201‐9712(11)60189‐6] ">Golfam 2011</a>; <a href="./references#CD008884-bbs2-0002" title="BhatnagarS , MishraS , GuptaM , SinghalAK , MandalAS . Effects of different concentrations of intraoperative supplemental oxygen on post‐operative nausea and vomiting (PONV) in patients undergoing modified radical mastectomy. Internet Journal of Anesthesiology2005;9(12):1‐6. ">Bhatnagar 2005</a>). </p> </section> <section id="CD008884-sec-0050"> <h5 class="title">Participants</h5> <p>A total of 7597 participants were randomly assigned to an FIO<sub>2</sub> of 60% or more versus 30% to 40% in the 18 trials reporting on outcomes for this review (<a href="./references#CD008884-bbs2-0001" title="BeldaFJ , AguileraL , García de la AsunciónJ , AlbertiJ , VicenteR , FerrándizL , et al. Spanish Reduccion de la Tasa de Infeccion Quirurgica Group. Supplemental perioperative oxygen and the risk of surgical wound infection: a randomized controlled trial. JAMA2005;294(16):2035‐42. [PUBMED: 16249417] ">Belda 2005</a>; <a href="./references#CD008884-bbs2-0003" title="BickelA , GurevitsM , VamosR , IvryS , EitanA . Perioperative hyperoxygenation and wound site infection following surgery for acute appendicitis: a randomized, prospective, controlled trial. Archives of Surgery2011;146(4):464‐70. [PUBMED: 21502457] ">Bickel 2011</a>; <a href="./references#CD008884-bbs2-0004" title="DuggalN , PoddatooriV , NoroozkhaniS , CherryC , ParkT , CaugheyAB . Perioperative oxygen supplementation and surgical site infection after cesarean delivery. A randomized trial. Obstetrics &amp; Gynecology2013;122(1):79‐84. [DOI: 10.1097/AOG.0b013e318297ec6c] ">Duggal 2013</a>; <a href="./references#CD008884-bbs2-0006" title="GardellaC , GoltraLB , LaschanskyE , DroletteL , MagaretA , ChadwickHS , et al. High‐concentration supplemental perioperative oxygen to reduce the incidence of postcesarean surgical site infection: a randomized controlled trial. Obstetrics and Gynecology2008;112(3):545‐52. [PUBMED: 18757651] ">Gardella 2008</a>; <a href="./references#CD008884-bbs2-0007" title="GolfamF . Effects of supplemental oxygen for prevention of wound infection after breast surgery. International Journal of Infectious Diseases2011;15(1):S55. [DOI: http://dx.doi.org/10.1016/S1201‐9712(11)60189‐6] ">Golfam 2011</a>; <a href="./references#CD008884-bbs2-0009" title="GreifR , LacinyS , RapfB , HickleRS , SesslerDI . Supplemental oxygen reduces the incidence of postoperative nausea and vomiting. Anesthesiology1999;91(5):1246‐52. ">Greif 1999</a>; <a href="./references#CD008884-bbs2-0010" title="GreifR , AkçaO , HornEP , KurzA , SesslerDI , Outcomes Research Group. Supplemental perioperative oxygen to reduce the incidence of surgical‐wound infection. New England Journal of Medicine2000;342(3):161‐7. [PUBMED: 10639541] ">Greif 2000</a>; <a href="./references#CD008884-bbs2-0012" title="KotaniN , HashimotoH , SesslerDI , MuraokaM , HashibaE , KubotaT , et al. Supplemental intraoperative oxygen augments antimicrobial and proinflammatory responses of alveolar macrophages. Anesthesiology2000;93(1):15‐25. [PUBMED: 10861141] ">Kotani 2000</a>; <a href="./references#CD008884-bbs2-0014" title="MayzlerO , WekslerN , DomchikS , KleinM , MizrahiS , GurmanGM . Does supplemental perioperative oxygen administration reduce the incidence of wound infection in elective colorectal surgery?. Minerva Anestesiology2005;71(1‐2):21‐5. [PUBMED: 15711503] ">Mayzler 2005</a>; <a href="./references#CD008884-bbs2-0016" title="MeyhoffCS , WetterslevJ , JorgensenLN , HennebergSW , HøgdallC , LundvallL , et al. PROXI Trial Group. Effect of high perioperative oxygen fraction on surgical site infection and pulmonary complications after abdominal surgery: the PROXI randomized clinical trial. JAMA2009;302(14):1543‐50. [PUBMED: 19826023] ">Meyhoff 2009</a>; <a href="./references#CD008884-bbs2-0017" title="MylesPS , LeslieK , ChanMT , ForbesA , PaechMJ , PeytonP , et al. ENIGMA Trial Group. Avoidance of nitrous oxide for patients undergoing major surgery: a randomized controlled trial. Anesthesiology2007;107(2):221‐31. [PUBMED: 17667565] ">Myles 2007</a>; <a href="./references#CD008884-bbs2-0018" title="PryorKO , FaheyTJ3rd , LienCA , GoldsteinPA . Surgical site infection and the routine use of perioperative hyperoxia in a general surgical population: a randomized controlled trial. JAMA2004;291(1):79‐87. [PUBMED: 14709579] ">Pryor 2004</a>; <a href="./references#CD008884-bbs2-0021" title="SchietromaM , CeciliaEM , CarleiF , SistaF , DeSantisG , PiccioneF , et al. Prevention of anastomotic leakage after total gastrectomy with perioperative supplemental oxygen administration: a prospective randomized, double blind, controlled, single‐center trial. Annals of Surgical Oncology2013;20(5):584‐90. [DOI: 10.1245/s10434‐012‐2714‐7; PUBMED: 23099730] ">Schietroma 2013</a>; <a href="./references#CD008884-bbs2-0022" title="ScifresCM , LeightonBL , FogerteyPJ , MaconesGA , StamilioDM . Supplemental oxygen for the prevention of postcesarean infectious morbidity: a randomized controlled trial. American Journal of Obstetrics and Gynecology2011;205(3):267.e1‐9. [PUBMED: 22071059] ">Scifres 2011</a>; <a href="./references#CD008884-bbs2-0024" title="StallA , ParyaviE , GuptaR , ZadnikM , HuiE , O’TooleRV . Perioperative supplemental oxygen to reduce surgical site infection after open fixation of high‐risk fractures: a randomized controlled pilot trial. The Journal of Trauma and Acute Care Surgery2013;75(4):657‐63. [DOI: 10.1097/TA.0b0113e3182a1fe83] ">Stall 2013</a>; <a href="./references#CD008884-bbs2-0025" title="ThibonP , BorgeyF , BoutreuxS , HanouzJ‐L , LeCoutourX , ParientiJ‐J . Effect of perioperative oxygen supplementation on 30‐day surgical site infection rate in abdominal, gynecologic, and breast surgery. Anesthesiology2012;117:504–11. [MEDLINE: PMID: 22790961] ">Thibon 2012</a>; <a href="./references#CD008884-bbs2-0027" title="WilliamsN , GloverM , CrispC , ActonA , McKennaD . Randomized controlled trial of the effect of 30% versus 80% fraction of inspired oxygen on caesarean delivery surgical site infection. American Journal of Perinatology2013;30(9):781‐6. [DOI: 10.1055/s‐0032‐1333405] ">Williams 2013</a>; <a href="./references#CD008884-bbs2-0028" title="ZorembaM , DetteF , HuneckeT , BrauneckerS , WulfH . The influence of perioperative oxygen concentration on postoperative lung function in moderately obese adults. European Journal of Anaesthesiology2010;27(6):501‐7. [MEDLINE: 19550338] ">Zoremba 2010</a>), and three trials described as using an FIO<sub>2</sub> of less than 80% (<a href="./references#CD008884-bbs2-0004" title="DuggalN , PoddatooriV , NoroozkhaniS , CherryC , ParkT , CaugheyAB . Perioperative oxygen supplementation and surgical site infection after cesarean delivery. A randomized trial. Obstetrics &amp; Gynecology2013;122(1):79‐84. [DOI: 10.1097/AOG.0b013e318297ec6c] ">Duggal 2013</a>; <a href="./references#CD008884-bbs2-0017" title="MylesPS , LeslieK , ChanMT , ForbesA , PaechMJ , PeytonP , et al. ENIGMA Trial Group. Avoidance of nitrous oxide for patients undergoing major surgery: a randomized controlled trial. Anesthesiology2007;107(2):221‐31. [PUBMED: 17667565] ">Myles 2007</a>; <a href="./references#CD008884-bbs2-0027" title="WilliamsN , GloverM , CrispC , ActonA , McKennaD . Randomized controlled trial of the effect of 30% versus 80% fraction of inspired oxygen on caesarean delivery surgical site infection. American Journal of Perinatology2013;30(9):781‐6. [DOI: 10.1055/s‐0032‐1333405] ">Williams 2013</a>). The number of participants in each trial ranged from 38 to 2012 (median 222; interquartile ratio (IQR) 147 to 564). One trial included a minor proportion of participants 15 to 17 years of age (<a href="./references#CD008884-bbs2-0003" title="BickelA , GurevitsM , VamosR , IvryS , EitanA . Perioperative hyperoxygenation and wound site infection following surgery for acute appendicitis: a randomized, prospective, controlled trial. Archives of Surgery2011;146(4):464‐70. [PUBMED: 21502457] ">Bickel 2011</a>). The approximate weighted mean age of participants was 50 years (range 15 to 92 years). The approximate mean proportion of women was 63%. </p> <p>Seven trials included mainly colorectal and abdominal surgical patients (<a href="./references#CD008884-bbs2-0001" title="BeldaFJ , AguileraL , García de la AsunciónJ , AlbertiJ , VicenteR , FerrándizL , et al. Spanish Reduccion de la Tasa de Infeccion Quirurgica Group. Supplemental perioperative oxygen and the risk of surgical wound infection: a randomized controlled trial. JAMA2005;294(16):2035‐42. [PUBMED: 16249417] ">Belda 2005</a>; <a href="./references#CD008884-bbs2-0005" title="García‐BotelloSA , García‐GraneroE , LilloR , López‐MozosF , MillánM , LledóS . Randomized clinical trial to evaluate the effects of perioperative supplemental oxygen administration on the colorectal anastomosis. British Journal of Surgery2006;93(6):698‐706. [MEDLINE: 16703624] ">García‐Botello 2006</a>; <a href="./references#CD008884-bbs2-0010" title="GreifR , AkçaO , HornEP , KurzA , SesslerDI , Outcomes Research Group. Supplemental perioperative oxygen to reduce the incidence of surgical‐wound infection. New England Journal of Medicine2000;342(3):161‐7. [PUBMED: 10639541] ">Greif 2000</a>; <a href="./references#CD008884-bbs2-0014" title="MayzlerO , WekslerN , DomchikS , KleinM , MizrahiS , GurmanGM . Does supplemental perioperative oxygen administration reduce the incidence of wound infection in elective colorectal surgery?. Minerva Anestesiology2005;71(1‐2):21‐5. [PUBMED: 15711503] ">Mayzler 2005</a>; <a href="./references#CD008884-bbs2-0016" title="MeyhoffCS , WetterslevJ , JorgensenLN , HennebergSW , HøgdallC , LundvallL , et al. PROXI Trial Group. Effect of high perioperative oxygen fraction on surgical site infection and pulmonary complications after abdominal surgery: the PROXI randomized clinical trial. JAMA2009;302(14):1543‐50. [PUBMED: 19826023] ">Meyhoff 2009</a>; <a href="./references#CD008884-bbs2-0018" title="PryorKO , FaheyTJ3rd , LienCA , GoldsteinPA . Surgical site infection and the routine use of perioperative hyperoxia in a general surgical population: a randomized controlled trial. JAMA2004;291(1):79‐87. [PUBMED: 14709579] ">Pryor 2004</a>; <a href="./references#CD008884-bbs2-0021" title="SchietromaM , CeciliaEM , CarleiF , SistaF , DeSantisG , PiccioneF , et al. Prevention of anastomotic leakage after total gastrectomy with perioperative supplemental oxygen administration: a prospective randomized, double blind, controlled, single‐center trial. Annals of Surgical Oncology2013;20(5):584‐90. [DOI: 10.1245/s10434‐012‐2714‐7; PUBMED: 23099730] ">Schietroma 2013</a>), and one trial included exclusively patients for appendectomy (<a href="./references#CD008884-bbs2-0003" title="BickelA , GurevitsM , VamosR , IvryS , EitanA . Perioperative hyperoxygenation and wound site infection following surgery for acute appendicitis: a randomized, prospective, controlled trial. Archives of Surgery2011;146(4):464‐70. [PUBMED: 21502457] ">Bickel 2011</a>). Four trials included only women for caesarean section (<a href="./references#CD008884-bbs2-0004" title="DuggalN , PoddatooriV , NoroozkhaniS , CherryC , ParkT , CaugheyAB . Perioperative oxygen supplementation and surgical site infection after cesarean delivery. A randomized trial. Obstetrics &amp; Gynecology2013;122(1):79‐84. [DOI: 10.1097/AOG.0b013e318297ec6c] ">Duggal 2013</a>; <a href="./references#CD008884-bbs2-0006" title="GardellaC , GoltraLB , LaschanskyE , DroletteL , MagaretA , ChadwickHS , et al. High‐concentration supplemental perioperative oxygen to reduce the incidence of postcesarean surgical site infection: a randomized controlled trial. Obstetrics and Gynecology2008;112(3):545‐52. [PUBMED: 18757651] ">Gardella 2008</a>; <a href="./references#CD008884-bbs2-0022" title="ScifresCM , LeightonBL , FogerteyPJ , MaconesGA , StamilioDM . Supplemental oxygen for the prevention of postcesarean infectious morbidity: a randomized controlled trial. American Journal of Obstetrics and Gynecology2011;205(3):267.e1‐9. [PUBMED: 22071059] ">Scifres 2011</a>; <a href="./references#CD008884-bbs2-0027" title="WilliamsN , GloverM , CrispC , ActonA , McKennaD . Randomized controlled trial of the effect of 30% versus 80% fraction of inspired oxygen on caesarean delivery surgical site infection. American Journal of Perinatology2013;30(9):781‐6. [DOI: 10.1055/s‐0032‐1333405] ">Williams 2013</a>); one trial included only breast surgery patients (<a href="./references#CD008884-bbs2-0007" title="GolfamF . Effects of supplemental oxygen for prevention of wound infection after breast surgery. International Journal of Infectious Diseases2011;15(1):S55. [DOI: http://dx.doi.org/10.1016/S1201‐9712(11)60189‐6] ">Golfam 2011</a>); two trials only patients for orthopaedic surgery (<a href="./references#CD008884-bbs2-0012" title="KotaniN , HashimotoH , SesslerDI , MuraokaM , HashibaE , KubotaT , et al. Supplemental intraoperative oxygen augments antimicrobial and proinflammatory responses of alveolar macrophages. Anesthesiology2000;93(1):15‐25. [PUBMED: 10861141] ">Kotani 2000</a>; <a href="./references#CD008884-bbs2-0024" title="StallA , ParyaviE , GuptaR , ZadnikM , HuiE , O’TooleRV . Perioperative supplemental oxygen to reduce surgical site infection after open fixation of high‐risk fractures: a randomized controlled pilot trial. The Journal of Trauma and Acute Care Surgery2013;75(4):657‐63. [DOI: 10.1097/TA.0b0113e3182a1fe83] ">Stall 2013</a>); and four trials patients undergoing a variety of surgical procedures (<a href="./references#CD008884-bbs2-0017" title="MylesPS , LeslieK , ChanMT , ForbesA , PaechMJ , PeytonP , et al. ENIGMA Trial Group. Avoidance of nitrous oxide for patients undergoing major surgery: a randomized controlled trial. Anesthesiology2007;107(2):221‐31. [PUBMED: 17667565] ">Myles 2007</a>; <a href="./references#CD008884-bbs2-0013" title="MackintoshN , GertschMC , HopfHW , PaceNL , WhiteJ , MorrisR , et al. High intraoperative inspired oxygen does not increase postoperative supplemental oxygen requirements. Anesthesiology2012;117(2):271‐9. [MEDLINE: 22569132] ">Mackintosh 2012</a>; <a href="./references#CD008884-bbs2-0025" title="ThibonP , BorgeyF , BoutreuxS , HanouzJ‐L , LeCoutourX , ParientiJ‐J . Effect of perioperative oxygen supplementation on 30‐day surgical site infection rate in abdominal, gynecologic, and breast surgery. Anesthesiology2012;117:504–11. [MEDLINE: PMID: 22790961] ">Thibon 2012</a>; <a href="./references#CD008884-bbs2-0028" title="ZorembaM , DetteF , HuneckeT , BrauneckerS , WulfH . The influence of perioperative oxygen concentration on postoperative lung function in moderately obese adults. European Journal of Anaesthesiology2010;27(6):501‐7. [MEDLINE: 19550338] ">Zoremba 2010</a>). </p> </section> <section id="CD008884-sec-0051"> <h5 class="title">Experimental interventions</h5> <p>Of the 28 trials, 25 used an FIO<sub>2</sub> of 80% oxygen or greater in the group with a high FIO<sub>2</sub> during anaesthesia; two of these used more than 90% oxygen (<a href="./references#CD008884-bbs2-0012" title="KotaniN , HashimotoH , SesslerDI , MuraokaM , HashibaE , KubotaT , et al. Supplemental intraoperative oxygen augments antimicrobial and proinflammatory responses of alveolar macrophages. Anesthesiology2000;93(1):15‐25. [PUBMED: 10861141] ">Kotani 2000</a>; <a href="./references#CD008884-bbs2-0013" title="MackintoshN , GertschMC , HopfHW , PaceNL , WhiteJ , MorrisR , et al. High intraoperative inspired oxygen does not increase postoperative supplemental oxygen requirements. Anesthesiology2012;117(2):271‐9. [MEDLINE: 22569132] ">Mackintosh 2012</a>), and three used an FIO<sub>2</sub> of 60% to 80% (<a href="./references#CD008884-bbs2-0004" title="DuggalN , PoddatooriV , NoroozkhaniS , CherryC , ParkT , CaugheyAB . Perioperative oxygen supplementation and surgical site infection after cesarean delivery. A randomized trial. Obstetrics &amp; Gynecology2013;122(1):79‐84. [DOI: 10.1097/AOG.0b013e318297ec6c] ">Duggal 2013</a>; <a href="./references#CD008884-bbs2-0017" title="MylesPS , LeslieK , ChanMT , ForbesA , PaechMJ , PeytonP , et al. ENIGMA Trial Group. Avoidance of nitrous oxide for patients undergoing major surgery: a randomized controlled trial. Anesthesiology2007;107(2):221‐31. [PUBMED: 17667565] ">Myles 2007</a>; <a href="./references#CD008884-bbs2-0027" title="WilliamsN , GloverM , CrispC , ActonA , McKennaD . Randomized controlled trial of the effect of 30% versus 80% fraction of inspired oxygen on caesarean delivery surgical site infection. American Journal of Perinatology2013;30(9):781‐6. [DOI: 10.1055/s‐0032‐1333405] ">Williams 2013</a>). Fourteen trials also aimed for an FIO<sub>2</sub> of 80% or more in the high FIO<sub>2</sub> group during the recovery room period, and two trials used a high FIO<sub>2</sub> only during surgery. Thirteen trials used non‐rebreathing or tight/sealed masks with high flow, and three trials used ordinary face masks. Two trials used oxygen at the discretion of the attending physicians during the recovery room period. </p> </section> <section id="CD008884-sec-0052"> <h5 class="title">Comparator interventions</h5> <p>An FIO<sub>2</sub> of 30% to 40% during surgery was applied in all 28 trials in the control group. Of these, 17 trials aimed to achieve an FIO<sub>2</sub> of 30% to 40%, also during recovery room stay, and two trials used only supplemental oxygen during surgery. Fourteen trials used non‐rebreathing or tight masks with high flow, and three trials used a nasal catheter or cannula in the 30% to 40% oxygen group. Thirteen trials did not use nitrous oxide during surgery, and four trials used nitrous oxide with an FIO<sub>2</sub> of 30% to 40% during surgery in the control groups (<a href="./references#CD008884-bbs2-0003" title="BickelA , GurevitsM , VamosR , IvryS , EitanA . Perioperative hyperoxygenation and wound site infection following surgery for acute appendicitis: a randomized, prospective, controlled trial. Archives of Surgery2011;146(4):464‐70. [PUBMED: 21502457] ">Bickel 2011</a>; <a href="./references#CD008884-bbs2-0014" title="MayzlerO , WekslerN , DomchikS , KleinM , MizrahiS , GurmanGM . Does supplemental perioperative oxygen administration reduce the incidence of wound infection in elective colorectal surgery?. Minerva Anestesiology2005;71(1‐2):21‐5. [PUBMED: 15711503] ">Mayzler 2005</a>; <a href="./references#CD008884-bbs2-0017" title="MylesPS , LeslieK , ChanMT , ForbesA , PaechMJ , PeytonP , et al. ENIGMA Trial Group. Avoidance of nitrous oxide for patients undergoing major surgery: a randomized controlled trial. Anesthesiology2007;107(2):221‐31. [PUBMED: 17667565] ">Myles 2007</a>; <a href="./references#CD008884-bbs2-0018" title="PryorKO , FaheyTJ3rd , LienCA , GoldsteinPA . Surgical site infection and the routine use of perioperative hyperoxia in a general surgical population: a randomized controlled trial. JAMA2004;291(1):79‐87. [PUBMED: 14709579] ">Pryor 2004</a>). Use of nitrous oxide was not described in two trials (<a href="./references#CD008884-bbs2-0005" title="García‐BotelloSA , García‐GraneroE , LilloR , López‐MozosF , MillánM , LledóS . Randomized clinical trial to evaluate the effects of perioperative supplemental oxygen administration on the colorectal anastomosis. British Journal of Surgery2006;93(6):698‐706. [MEDLINE: 16703624] ">García‐Botello 2006</a>; <a href="./references#CD008884-bbs2-0007" title="GolfamF . Effects of supplemental oxygen for prevention of wound infection after breast surgery. International Journal of Infectious Diseases2011;15(1):S55. [DOI: http://dx.doi.org/10.1016/S1201‐9712(11)60189‐6] ">Golfam 2011</a>). </p> </section> <section id="CD008884-sec-0053"> <h5 class="title">Co‐interventions used in experimental and comparator intervention groups</h5> <p>An antibiotic was administered before surgical intervention to both intervention groups in 12 trials, whereas four trials with patients for caesarean section reported on antibiotics used after delivery at cord clamping in both intervention groups (<a href="./references#CD008884-bbs2-0004" title="DuggalN , PoddatooriV , NoroozkhaniS , CherryC , ParkT , CaugheyAB . Perioperative oxygen supplementation and surgical site infection after cesarean delivery. A randomized trial. Obstetrics &amp; Gynecology2013;122(1):79‐84. [DOI: 10.1097/AOG.0b013e318297ec6c] ">Duggal 2013</a>; <a href="./references#CD008884-bbs2-0006" title="GardellaC , GoltraLB , LaschanskyE , DroletteL , MagaretA , ChadwickHS , et al. High‐concentration supplemental perioperative oxygen to reduce the incidence of postcesarean surgical site infection: a randomized controlled trial. Obstetrics and Gynecology2008;112(3):545‐52. [PUBMED: 18757651] ">Gardella 2008</a>; <a href="./references#CD008884-bbs2-0022" title="ScifresCM , LeightonBL , FogerteyPJ , MaconesGA , StamilioDM . Supplemental oxygen for the prevention of postcesarean infectious morbidity: a randomized controlled trial. American Journal of Obstetrics and Gynecology2011;205(3):267.e1‐9. [PUBMED: 22071059] ">Scifres 2011</a>; <a href="./references#CD008884-bbs2-0027" title="WilliamsN , GloverM , CrispC , ActonA , McKennaD . Randomized controlled trial of the effect of 30% versus 80% fraction of inspired oxygen on caesarean delivery surgical site infection. American Journal of Perinatology2013;30(9):781‐6. [DOI: 10.1055/s‐0032‐1333405] ">Williams 2013</a>). The different regimens of antibiotic prophylaxis are described in <a href="./references#CD008884-sec-0148" title="">Characteristics of included studies</a>. Bowel preparation on the day before surgery was described in two trials (<a href="./references#CD008884-bbs2-0001" title="BeldaFJ , AguileraL , García de la AsunciónJ , AlbertiJ , VicenteR , FerrándizL , et al. Spanish Reduccion de la Tasa de Infeccion Quirurgica Group. Supplemental perioperative oxygen and the risk of surgical wound infection: a randomized controlled trial. JAMA2005;294(16):2035‐42. [PUBMED: 16249417] ">Belda 2005</a>; <a href="./references#CD008884-bbs2-0010" title="GreifR , AkçaO , HornEP , KurzA , SesslerDI , Outcomes Research Group. Supplemental perioperative oxygen to reduce the incidence of surgical‐wound infection. New England Journal of Medicine2000;342(3):161‐7. [PUBMED: 10639541] ">Greif 2000</a>). </p> </section> <section id="CD008884-sec-0054"> <h5 class="title">Ongoing studies</h5> <p>Two ongoing trials (<a href="./references#CD008884-bbs2-0055" title="Supplemental perioperative oxygen to reduce the incidence of post‐caesarean wound infection. Ongoing study2011. ">Osvaldo 2011</a>; <a href="./references#CD008884-bbs2-0056" title="Supplemental oxygen and risk of surgical site infection (PORSSI). Ongoing study2010. ">Santa Clara Valley Health</a>) identified at <a href="http://www.clinicaltrials.gov" target="_blank">www.clinicaltrials.gov</a> are seeking to include women for emergency caesarean section and elective caesarean section, respectively. The trial by <a href="./references#CD008884-bbs2-0055" title="Supplemental perioperative oxygen to reduce the incidence of post‐caesarean wound infection. Ongoing study2011. ">Osvaldo 2011</a> aimed for 382 participants and, according to www.clinicaltrials.gov, planned to start in 2011. The <a href="./references#CD008884-bbs2-0056" title="Supplemental oxygen and risk of surgical site infection (PORSSI). Ongoing study2010. ">Santa Clara Valley Health</a> trial did not mention the aim for a sample size and, according to <a href="http://www.clinicaltrials.gov" target="_blank">www.clinicaltrials.gov</a>, planned to start in 2006. See additional details at <a href="./references#CD008884-bbs1-0004" title="">Ongoing studies</a>. </p> </section> <section id="CD008884-sec-0055"> <h5 class="title">Awaiting classification</h5> <p>Two studies are awaiting classification (<a href="./references#CD008884-bbs2-0053" title="GinT , ChenY , LiuX , ChengC , ChanM . DNA damage and wound infection after use of nitrous oxide in anaesthesia for major surgery. EUROANAESTHESIA 2013. Barcelona: Lippincott Williams and Wilkins, 2013; Vol. 30:144. ">Gin 2013</a>; <a href="./references#CD008884-bbs2-0054" title="SchietromaM , CeciliaEM , SistaF , CarleiF , PessiaB , AmicucciG . High‐concentration supplemental perioperative oxygen and surgical site infection following elective colorectal surgery for rectal cancer: a prospective, randomized, double‐blind, controlled, single‐site trial. The Amercian Journal of Surgery2014;208(5):719‐26. [DOI: 10.1016/j.amjsurg.2014.04.002.] ">Schietroma 2014</a>). Please refer to <a href="./references#CD008884-sec-0150" title="">Characteristics of studies awaiting classification</a> for further details. </p> </section> </section> <section id="CD008884-sec-0056"> <h4 class="title">Excluded studies</h4> <p>We presented a detailed description of the characteristics of 24 excluded studies in <a href="./references#CD008884-sec-0149" title="">Characteristics of excluded studies</a>. We excluded seven articles for not reporting a randomized trial but instead a review or a meta‐analysis. We excluded seven articles because these trials used interventions outside the scope of this review. We excluded four articles because they were letters to the editor. We excluded three articles because of retractions for fraud and one article because the study included children only. </p> </section> </section> <section id="CD008884-sec-0057"> <h3 class="title">Risk of bias in included studies</h3> <p>Three trials had low risk of bias in all bias domains, including adequate outcome reporting on mortality (<a href="./references#CD008884-bbs2-0010" title="GreifR , AkçaO , HornEP , KurzA , SesslerDI , Outcomes Research Group. Supplemental perioperative oxygen to reduce the incidence of surgical‐wound infection. New England Journal of Medicine2000;342(3):161‐7. [PUBMED: 10639541] ">Greif 2000</a>; <a href="./references#CD008884-bbs2-0016" title="MeyhoffCS , WetterslevJ , JorgensenLN , HennebergSW , HøgdallC , LundvallL , et al. PROXI Trial Group. Effect of high perioperative oxygen fraction on surgical site infection and pulmonary complications after abdominal surgery: the PROXI randomized clinical trial. JAMA2009;302(14):1543‐50. [PUBMED: 19826023] ">Meyhoff 2009</a>; <a href="./references#CD008884-bbs2-0017" title="MylesPS , LeslieK , ChanMT , ForbesA , PaechMJ , PeytonP , et al. ENIGMA Trial Group. Avoidance of nitrous oxide for patients undergoing major surgery: a randomized controlled trial. Anesthesiology2007;107(2):221‐31. [PUBMED: 17667565] ">Myles 2007</a>). Five trials had low risk of bias in all bias domains, including adequate outcome reporting on surgical site infection (<a href="./references#CD008884-bbs2-0006" title="GardellaC , GoltraLB , LaschanskyE , DroletteL , MagaretA , ChadwickHS , et al. High‐concentration supplemental perioperative oxygen to reduce the incidence of postcesarean surgical site infection: a randomized controlled trial. Obstetrics and Gynecology2008;112(3):545‐52. [PUBMED: 18757651] ">Gardella 2008</a>; <a href="./references#CD008884-bbs2-0010" title="GreifR , AkçaO , HornEP , KurzA , SesslerDI , Outcomes Research Group. Supplemental perioperative oxygen to reduce the incidence of surgical‐wound infection. New England Journal of Medicine2000;342(3):161‐7. [PUBMED: 10639541] ">Greif 2000</a>; <a href="./references#CD008884-bbs2-0016" title="MeyhoffCS , WetterslevJ , JorgensenLN , HennebergSW , HøgdallC , LundvallL , et al. PROXI Trial Group. Effect of high perioperative oxygen fraction on surgical site infection and pulmonary complications after abdominal surgery: the PROXI randomized clinical trial. JAMA2009;302(14):1543‐50. [PUBMED: 19826023] ">Meyhoff 2009</a>; <a href="./references#CD008884-bbs2-0017" title="MylesPS , LeslieK , ChanMT , ForbesA , PaechMJ , PeytonP , et al. ENIGMA Trial Group. Avoidance of nitrous oxide for patients undergoing major surgery: a randomized controlled trial. Anesthesiology2007;107(2):221‐31. [PUBMED: 17667565] ">Myles 2007</a>; <a href="./references#CD008884-bbs2-0027" title="WilliamsN , GloverM , CrispC , ActonA , McKennaD . Randomized controlled trial of the effect of 30% versus 80% fraction of inspired oxygen on caesarean delivery surgical site infection. American Journal of Perinatology2013;30(9):781‐6. [DOI: 10.1055/s‐0032‐1333405] ">Williams 2013</a>). Six trials reported on mortality; three of these had overall low risk of bias (<a href="./references#CD008884-bbs2-0016" title="MeyhoffCS , WetterslevJ , JorgensenLN , HennebergSW , HøgdallC , LundvallL , et al. PROXI Trial Group. Effect of high perioperative oxygen fraction on surgical site infection and pulmonary complications after abdominal surgery: the PROXI randomized clinical trial. JAMA2009;302(14):1543‐50. [PUBMED: 19826023] ">Meyhoff 2009</a>; <a href="./references#CD008884-bbs2-0017" title="MylesPS , LeslieK , ChanMT , ForbesA , PaechMJ , PeytonP , et al. ENIGMA Trial Group. Avoidance of nitrous oxide for patients undergoing major surgery: a randomized controlled trial. Anesthesiology2007;107(2):221‐31. [PUBMED: 17667565] ">Myles 2007</a>; <a href="./references#CD008884-bbs2-0010" title="GreifR , AkçaO , HornEP , KurzA , SesslerDI , Outcomes Research Group. Supplemental perioperative oxygen to reduce the incidence of surgical‐wound infection. New England Journal of Medicine2000;342(3):161‐7. [PUBMED: 10639541] ">Greif 2000</a>), and four had high or unclear risk of bias in one or more bias domains other than outcome reporting bias (<a href="./references#CD008884-bbs2-0001" title="BeldaFJ , AguileraL , García de la AsunciónJ , AlbertiJ , VicenteR , FerrándizL , et al. Spanish Reduccion de la Tasa de Infeccion Quirurgica Group. Supplemental perioperative oxygen and the risk of surgical wound infection: a randomized controlled trial. JAMA2005;294(16):2035‐42. [PUBMED: 16249417] ">Belda 2005</a>; <a href="./references#CD008884-bbs2-0010" title="GreifR , AkçaO , HornEP , KurzA , SesslerDI , Outcomes Research Group. Supplemental perioperative oxygen to reduce the incidence of surgical‐wound infection. New England Journal of Medicine2000;342(3):161‐7. [PUBMED: 10639541] ">Greif 2000</a>; <a href="./references#CD008884-bbs2-0018" title="PryorKO , FaheyTJ3rd , LienCA , GoldsteinPA . Surgical site infection and the routine use of perioperative hyperoxia in a general surgical population: a randomized controlled trial. JAMA2004;291(1):79‐87. [PUBMED: 14709579] ">Pryor 2004</a>; <a href="./references#CD008884-bbs2-0021" title="SchietromaM , CeciliaEM , CarleiF , SistaF , DeSantisG , PiccioneF , et al. Prevention of anastomotic leakage after total gastrectomy with perioperative supplemental oxygen administration: a prospective randomized, double blind, controlled, single‐center trial. Annals of Surgical Oncology2013;20(5):584‐90. [DOI: 10.1245/s10434‐012‐2714‐7; PUBMED: 23099730] ">Schietroma 2013</a>) (<a href="#CD008884-fig-0005">Figure 5</a>). </p> <div class="figure" id="CD008884-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD008884-fig-0005" src="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/image_n/nCD008884-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <p>The funnel plot (<a href="./full#CD008884-fig-0001">Figure 1</a>) of all trials reporting surgical site infection showed slight asymmetry indicating bias;however, Egger's test was not statistically significant (P value = 0.63). As fewer than 10 trials were included in all other analyses. we did not construct a funnel plot for these outcomes. </p> <section id="CD008884-sec-0058"> <h4 class="title">Allocation</h4> <section id="CD008884-sec-0059"> <h5 class="title">Generation of the allocation sequence</h5> <p>Ten trials reporting on the primary outcome of surgical site infection described adequate generation of the allocation sequence (<a href="./references#CD008884-bbs2-0001" title="BeldaFJ , AguileraL , García de la AsunciónJ , AlbertiJ , VicenteR , FerrándizL , et al. Spanish Reduccion de la Tasa de Infeccion Quirurgica Group. Supplemental perioperative oxygen and the risk of surgical wound infection: a randomized controlled trial. JAMA2005;294(16):2035‐42. [PUBMED: 16249417] ">Belda 2005</a>; <a href="./references#CD008884-bbs2-0004" title="DuggalN , PoddatooriV , NoroozkhaniS , CherryC , ParkT , CaugheyAB . Perioperative oxygen supplementation and surgical site infection after cesarean delivery. A randomized trial. Obstetrics &amp; Gynecology2013;122(1):79‐84. [DOI: 10.1097/AOG.0b013e318297ec6c] ">Duggal 2013</a>; <a href="./references#CD008884-bbs2-0006" title="GardellaC , GoltraLB , LaschanskyE , DroletteL , MagaretA , ChadwickHS , et al. High‐concentration supplemental perioperative oxygen to reduce the incidence of postcesarean surgical site infection: a randomized controlled trial. Obstetrics and Gynecology2008;112(3):545‐52. [PUBMED: 18757651] ">Gardella 2008</a>; <a href="./references#CD008884-bbs2-0010" title="GreifR , AkçaO , HornEP , KurzA , SesslerDI , Outcomes Research Group. Supplemental perioperative oxygen to reduce the incidence of surgical‐wound infection. New England Journal of Medicine2000;342(3):161‐7. [PUBMED: 10639541] ">Greif 2000</a>; <a href="./references#CD008884-bbs2-0016" title="MeyhoffCS , WetterslevJ , JorgensenLN , HennebergSW , HøgdallC , LundvallL , et al. PROXI Trial Group. Effect of high perioperative oxygen fraction on surgical site infection and pulmonary complications after abdominal surgery: the PROXI randomized clinical trial. JAMA2009;302(14):1543‐50. [PUBMED: 19826023] ">Meyhoff 2009</a>; <a href="./references#CD008884-bbs2-0017" title="MylesPS , LeslieK , ChanMT , ForbesA , PaechMJ , PeytonP , et al. ENIGMA Trial Group. Avoidance of nitrous oxide for patients undergoing major surgery: a randomized controlled trial. Anesthesiology2007;107(2):221‐31. [PUBMED: 17667565] ">Myles 2007</a>; <a href="./references#CD008884-bbs2-0018" title="PryorKO , FaheyTJ3rd , LienCA , GoldsteinPA . Surgical site infection and the routine use of perioperative hyperoxia in a general surgical population: a randomized controlled trial. JAMA2004;291(1):79‐87. [PUBMED: 14709579] ">Pryor 2004</a>; <a href="./references#CD008884-bbs2-0024" title="StallA , ParyaviE , GuptaR , ZadnikM , HuiE , O’TooleRV . Perioperative supplemental oxygen to reduce surgical site infection after open fixation of high‐risk fractures: a randomized controlled pilot trial. The Journal of Trauma and Acute Care Surgery2013;75(4):657‐63. [DOI: 10.1097/TA.0b0113e3182a1fe83] ">Stall 2013</a>; <a href="./references#CD008884-bbs2-0025" title="ThibonP , BorgeyF , BoutreuxS , HanouzJ‐L , LeCoutourX , ParientiJ‐J . Effect of perioperative oxygen supplementation on 30‐day surgical site infection rate in abdominal, gynecologic, and breast surgery. Anesthesiology2012;117:504–11. [MEDLINE: PMID: 22790961] ">Thibon 2012</a>; <a href="./references#CD008884-bbs2-0027" title="WilliamsN , GloverM , CrispC , ActonA , McKennaD . Randomized controlled trial of the effect of 30% versus 80% fraction of inspired oxygen on caesarean delivery surgical site infection. American Journal of Perinatology2013;30(9):781‐6. [DOI: 10.1055/s‐0032‐1333405] ">Williams 2013</a>); four trials did not describe the method of sequence generation and were considered as having unclear risk of bias (<a href="./references#CD008884-bbs2-0003" title="BickelA , GurevitsM , VamosR , IvryS , EitanA . Perioperative hyperoxygenation and wound site infection following surgery for acute appendicitis: a randomized, prospective, controlled trial. Archives of Surgery2011;146(4):464‐70. [PUBMED: 21502457] ">Bickel 2011</a>; <a href="./references#CD008884-bbs2-0007" title="GolfamF . Effects of supplemental oxygen for prevention of wound infection after breast surgery. International Journal of Infectious Diseases2011;15(1):S55. [DOI: http://dx.doi.org/10.1016/S1201‐9712(11)60189‐6] ">Golfam 2011</a>; <a href="./references#CD008884-bbs2-0021" title="SchietromaM , CeciliaEM , CarleiF , SistaF , DeSantisG , PiccioneF , et al. Prevention of anastomotic leakage after total gastrectomy with perioperative supplemental oxygen administration: a prospective randomized, double blind, controlled, single‐center trial. Annals of Surgical Oncology2013;20(5):584‐90. [DOI: 10.1245/s10434‐012‐2714‐7; PUBMED: 23099730] ">Schietroma 2013</a>; <a href="./references#CD008884-bbs2-0022" title="ScifresCM , LeightonBL , FogerteyPJ , MaconesGA , StamilioDM . Supplemental oxygen for the prevention of postcesarean infectious morbidity: a randomized controlled trial. American Journal of Obstetrics and Gynecology2011;205(3):267.e1‐9. [PUBMED: 22071059] ">Scifres 2011</a>). One trial had high risk of bias, as investigators used tossing of envelopes for sequence generation (<a href="./references#CD008884-bbs2-0014" title="MayzlerO , WekslerN , DomchikS , KleinM , MizrahiS , GurmanGM . Does supplemental perioperative oxygen administration reduce the incidence of wound infection in elective colorectal surgery?. Minerva Anestesiology2005;71(1‐2):21‐5. [PUBMED: 15711503] ">Mayzler 2005</a>). </p> </section> <section id="CD008884-sec-0060"> <h5 class="title">Allocation concealment</h5> <p>Twelve trials reporting on the primary outcome of surgical site infection described adequate allocation concealment (<a href="./references#CD008884-bbs2-0001" title="BeldaFJ , AguileraL , García de la AsunciónJ , AlbertiJ , VicenteR , FerrándizL , et al. Spanish Reduccion de la Tasa de Infeccion Quirurgica Group. Supplemental perioperative oxygen and the risk of surgical wound infection: a randomized controlled trial. JAMA2005;294(16):2035‐42. [PUBMED: 16249417] ">Belda 2005</a>; <a href="./references#CD008884-bbs2-0003" title="BickelA , GurevitsM , VamosR , IvryS , EitanA . Perioperative hyperoxygenation and wound site infection following surgery for acute appendicitis: a randomized, prospective, controlled trial. Archives of Surgery2011;146(4):464‐70. [PUBMED: 21502457] ">Bickel 2011</a>; <a href="./references#CD008884-bbs2-0006" title="GardellaC , GoltraLB , LaschanskyE , DroletteL , MagaretA , ChadwickHS , et al. High‐concentration supplemental perioperative oxygen to reduce the incidence of postcesarean surgical site infection: a randomized controlled trial. Obstetrics and Gynecology2008;112(3):545‐52. [PUBMED: 18757651] ">Gardella 2008</a>; <a href="./references#CD008884-bbs2-0010" title="GreifR , AkçaO , HornEP , KurzA , SesslerDI , Outcomes Research Group. Supplemental perioperative oxygen to reduce the incidence of surgical‐wound infection. New England Journal of Medicine2000;342(3):161‐7. [PUBMED: 10639541] ">Greif 2000</a>; <a href="./references#CD008884-bbs2-0014" title="MayzlerO , WekslerN , DomchikS , KleinM , MizrahiS , GurmanGM . Does supplemental perioperative oxygen administration reduce the incidence of wound infection in elective colorectal surgery?. Minerva Anestesiology2005;71(1‐2):21‐5. [PUBMED: 15711503] ">Mayzler 2005</a>; <a href="./references#CD008884-bbs2-0016" title="MeyhoffCS , WetterslevJ , JorgensenLN , HennebergSW , HøgdallC , LundvallL , et al. PROXI Trial Group. Effect of high perioperative oxygen fraction on surgical site infection and pulmonary complications after abdominal surgery: the PROXI randomized clinical trial. JAMA2009;302(14):1543‐50. [PUBMED: 19826023] ">Meyhoff 2009</a>; <a href="./references#CD008884-bbs2-0017" title="MylesPS , LeslieK , ChanMT , ForbesA , PaechMJ , PeytonP , et al. ENIGMA Trial Group. Avoidance of nitrous oxide for patients undergoing major surgery: a randomized controlled trial. Anesthesiology2007;107(2):221‐31. [PUBMED: 17667565] ">Myles 2007</a>; <a href="./references#CD008884-bbs2-0018" title="PryorKO , FaheyTJ3rd , LienCA , GoldsteinPA . Surgical site infection and the routine use of perioperative hyperoxia in a general surgical population: a randomized controlled trial. JAMA2004;291(1):79‐87. [PUBMED: 14709579] ">Pryor 2004</a>; <a href="./references#CD008884-bbs2-0021" title="SchietromaM , CeciliaEM , CarleiF , SistaF , DeSantisG , PiccioneF , et al. Prevention of anastomotic leakage after total gastrectomy with perioperative supplemental oxygen administration: a prospective randomized, double blind, controlled, single‐center trial. Annals of Surgical Oncology2013;20(5):584‐90. [DOI: 10.1245/s10434‐012‐2714‐7; PUBMED: 23099730] ">Schietroma 2013</a>; <a href="./references#CD008884-bbs2-0022" title="ScifresCM , LeightonBL , FogerteyPJ , MaconesGA , StamilioDM . Supplemental oxygen for the prevention of postcesarean infectious morbidity: a randomized controlled trial. American Journal of Obstetrics and Gynecology2011;205(3):267.e1‐9. [PUBMED: 22071059] ">Scifres 2011</a>; <a href="./references#CD008884-bbs2-0024" title="StallA , ParyaviE , GuptaR , ZadnikM , HuiE , O’TooleRV . Perioperative supplemental oxygen to reduce surgical site infection after open fixation of high‐risk fractures: a randomized controlled pilot trial. The Journal of Trauma and Acute Care Surgery2013;75(4):657‐63. [DOI: 10.1097/TA.0b0113e3182a1fe83] ">Stall 2013</a>; <a href="./references#CD008884-bbs2-0027" title="WilliamsN , GloverM , CrispC , ActonA , McKennaD . Randomized controlled trial of the effect of 30% versus 80% fraction of inspired oxygen on caesarean delivery surgical site infection. American Journal of Perinatology2013;30(9):781‐6. [DOI: 10.1055/s‐0032‐1333405] ">Williams 2013</a>); three trials did not describe whether allocation concealment was adequate and thus were judged as having unclear risk of bias (<a href="./references#CD008884-bbs2-0004" title="DuggalN , PoddatooriV , NoroozkhaniS , CherryC , ParkT , CaugheyAB . Perioperative oxygen supplementation and surgical site infection after cesarean delivery. A randomized trial. Obstetrics &amp; Gynecology2013;122(1):79‐84. [DOI: 10.1097/AOG.0b013e318297ec6c] ">Duggal 2013</a>; <a href="./references#CD008884-bbs2-0005" title="García‐BotelloSA , García‐GraneroE , LilloR , López‐MozosF , MillánM , LledóS . Randomized clinical trial to evaluate the effects of perioperative supplemental oxygen administration on the colorectal anastomosis. British Journal of Surgery2006;93(6):698‐706. [MEDLINE: 16703624] ">García‐Botello 2006</a>; <a href="./references#CD008884-bbs2-0007" title="GolfamF . Effects of supplemental oxygen for prevention of wound infection after breast surgery. International Journal of Infectious Diseases2011;15(1):S55. [DOI: http://dx.doi.org/10.1016/S1201‐9712(11)60189‐6] ">Golfam 2011</a>). One trial did not adequately conceal allocation, as the anaesthesiologist enrolling participants to the trial had access to the allocation list (<a href="./references#CD008884-bbs2-0025" title="ThibonP , BorgeyF , BoutreuxS , HanouzJ‐L , LeCoutourX , ParientiJ‐J . Effect of perioperative oxygen supplementation on 30‐day surgical site infection rate in abdominal, gynecologic, and breast surgery. Anesthesiology2012;117:504–11. [MEDLINE: PMID: 22790961] ">Thibon 2012</a>). </p> </section> </section> <section id="CD008884-sec-0061"> <h4 class="title">Blinding</h4> <section id="CD008884-sec-0062"> <h5 class="title">Blinding of participants and personnel</h5> <p>Seven trials reporting on the primary outcome of surgical site infection described adequate blinding of participants and personnel (<a href="./references#CD008884-bbs2-0001" title="BeldaFJ , AguileraL , García de la AsunciónJ , AlbertiJ , VicenteR , FerrándizL , et al. Spanish Reduccion de la Tasa de Infeccion Quirurgica Group. Supplemental perioperative oxygen and the risk of surgical wound infection: a randomized controlled trial. JAMA2005;294(16):2035‐42. [PUBMED: 16249417] ">Belda 2005</a>; <a href="./references#CD008884-bbs2-0006" title="GardellaC , GoltraLB , LaschanskyE , DroletteL , MagaretA , ChadwickHS , et al. High‐concentration supplemental perioperative oxygen to reduce the incidence of postcesarean surgical site infection: a randomized controlled trial. Obstetrics and Gynecology2008;112(3):545‐52. [PUBMED: 18757651] ">Gardella 2008</a>; <a href="./references#CD008884-bbs2-0010" title="GreifR , AkçaO , HornEP , KurzA , SesslerDI , Outcomes Research Group. Supplemental perioperative oxygen to reduce the incidence of surgical‐wound infection. New England Journal of Medicine2000;342(3):161‐7. [PUBMED: 10639541] ">Greif 2000</a>; <a href="./references#CD008884-bbs2-0016" title="MeyhoffCS , WetterslevJ , JorgensenLN , HennebergSW , HøgdallC , LundvallL , et al. PROXI Trial Group. Effect of high perioperative oxygen fraction on surgical site infection and pulmonary complications after abdominal surgery: the PROXI randomized clinical trial. JAMA2009;302(14):1543‐50. [PUBMED: 19826023] ">Meyhoff 2009</a>; <a href="./references#CD008884-bbs2-0017" title="MylesPS , LeslieK , ChanMT , ForbesA , PaechMJ , PeytonP , et al. ENIGMA Trial Group. Avoidance of nitrous oxide for patients undergoing major surgery: a randomized controlled trial. Anesthesiology2007;107(2):221‐31. [PUBMED: 17667565] ">Myles 2007</a>; <a href="./references#CD008884-bbs2-0021" title="SchietromaM , CeciliaEM , CarleiF , SistaF , DeSantisG , PiccioneF , et al. Prevention of anastomotic leakage after total gastrectomy with perioperative supplemental oxygen administration: a prospective randomized, double blind, controlled, single‐center trial. Annals of Surgical Oncology2013;20(5):584‐90. [DOI: 10.1245/s10434‐012‐2714‐7; PUBMED: 23099730] ">Schietroma 2013</a>; <a href="./references#CD008884-bbs2-0027" title="WilliamsN , GloverM , CrispC , ActonA , McKennaD . Randomized controlled trial of the effect of 30% versus 80% fraction of inspired oxygen on caesarean delivery surgical site infection. American Journal of Perinatology2013;30(9):781‐6. [DOI: 10.1055/s‐0032‐1333405] ">Williams 2013</a>); five trials reported unclear blinding of participants and personnel (<a href="./references#CD008884-bbs2-0004" title="DuggalN , PoddatooriV , NoroozkhaniS , CherryC , ParkT , CaugheyAB . Perioperative oxygen supplementation and surgical site infection after cesarean delivery. A randomized trial. Obstetrics &amp; Gynecology2013;122(1):79‐84. [DOI: 10.1097/AOG.0b013e318297ec6c] ">Duggal 2013</a>; <a href="./references#CD008884-bbs2-0007" title="GolfamF . Effects of supplemental oxygen for prevention of wound infection after breast surgery. International Journal of Infectious Diseases2011;15(1):S55. [DOI: http://dx.doi.org/10.1016/S1201‐9712(11)60189‐6] ">Golfam 2011</a>; <a href="./references#CD008884-bbs2-0014" title="MayzlerO , WekslerN , DomchikS , KleinM , MizrahiS , GurmanGM . Does supplemental perioperative oxygen administration reduce the incidence of wound infection in elective colorectal surgery?. Minerva Anestesiology2005;71(1‐2):21‐5. [PUBMED: 15711503] ">Mayzler 2005</a>; <a href="./references#CD008884-bbs2-0024" title="StallA , ParyaviE , GuptaR , ZadnikM , HuiE , O’TooleRV . Perioperative supplemental oxygen to reduce surgical site infection after open fixation of high‐risk fractures: a randomized controlled pilot trial. The Journal of Trauma and Acute Care Surgery2013;75(4):657‐63. [DOI: 10.1097/TA.0b0113e3182a1fe83] ">Stall 2013</a>; <a href="./references#CD008884-bbs2-0025" title="ThibonP , BorgeyF , BoutreuxS , HanouzJ‐L , LeCoutourX , ParientiJ‐J . Effect of perioperative oxygen supplementation on 30‐day surgical site infection rate in abdominal, gynecologic, and breast surgery. Anesthesiology2012;117:504–11. [MEDLINE: PMID: 22790961] ">Thibon 2012</a>). Three trials were described as inadequately blinded for participants and personnel and thus were considered at high risk of bias (<a href="./references#CD008884-bbs2-0003" title="BickelA , GurevitsM , VamosR , IvryS , EitanA . Perioperative hyperoxygenation and wound site infection following surgery for acute appendicitis: a randomized, prospective, controlled trial. Archives of Surgery2011;146(4):464‐70. [PUBMED: 21502457] ">Bickel 2011</a>; <a href="./references#CD008884-bbs2-0018" title="PryorKO , FaheyTJ3rd , LienCA , GoldsteinPA . Surgical site infection and the routine use of perioperative hyperoxia in a general surgical population: a randomized controlled trial. JAMA2004;291(1):79‐87. [PUBMED: 14709579] ">Pryor 2004</a>; <a href="./references#CD008884-bbs2-0022" title="ScifresCM , LeightonBL , FogerteyPJ , MaconesGA , StamilioDM . Supplemental oxygen for the prevention of postcesarean infectious morbidity: a randomized controlled trial. American Journal of Obstetrics and Gynecology2011;205(3):267.e1‐9. [PUBMED: 22071059] ">Scifres 2011</a>). </p> </section> <section id="CD008884-sec-0063"> <h5 class="title">Blinding of outcome assessors</h5> <p>Twelve trials reporting on the primary outcome of surgical site infection described adequate blinding of outcome assessors (<a href="./references#CD008884-bbs2-0001" title="BeldaFJ , AguileraL , García de la AsunciónJ , AlbertiJ , VicenteR , FerrándizL , et al. Spanish Reduccion de la Tasa de Infeccion Quirurgica Group. Supplemental perioperative oxygen and the risk of surgical wound infection: a randomized controlled trial. JAMA2005;294(16):2035‐42. [PUBMED: 16249417] ">Belda 2005</a>; <a href="./references#CD008884-bbs2-0003" title="BickelA , GurevitsM , VamosR , IvryS , EitanA . Perioperative hyperoxygenation and wound site infection following surgery for acute appendicitis: a randomized, prospective, controlled trial. Archives of Surgery2011;146(4):464‐70. [PUBMED: 21502457] ">Bickel 2011</a>; <a href="./references#CD008884-bbs2-0004" title="DuggalN , PoddatooriV , NoroozkhaniS , CherryC , ParkT , CaugheyAB . Perioperative oxygen supplementation and surgical site infection after cesarean delivery. A randomized trial. Obstetrics &amp; Gynecology2013;122(1):79‐84. [DOI: 10.1097/AOG.0b013e318297ec6c] ">Duggal 2013</a>; <a href="./references#CD008884-bbs2-0006" title="GardellaC , GoltraLB , LaschanskyE , DroletteL , MagaretA , ChadwickHS , et al. High‐concentration supplemental perioperative oxygen to reduce the incidence of postcesarean surgical site infection: a randomized controlled trial. Obstetrics and Gynecology2008;112(3):545‐52. [PUBMED: 18757651] ">Gardella 2008</a>; <a href="./references#CD008884-bbs2-0010" title="GreifR , AkçaO , HornEP , KurzA , SesslerDI , Outcomes Research Group. Supplemental perioperative oxygen to reduce the incidence of surgical‐wound infection. New England Journal of Medicine2000;342(3):161‐7. [PUBMED: 10639541] ">Greif 2000</a>; <a href="./references#CD008884-bbs2-0014" title="MayzlerO , WekslerN , DomchikS , KleinM , MizrahiS , GurmanGM . Does supplemental perioperative oxygen administration reduce the incidence of wound infection in elective colorectal surgery?. Minerva Anestesiology2005;71(1‐2):21‐5. [PUBMED: 15711503] ">Mayzler 2005</a>; <a href="./references#CD008884-bbs2-0016" title="MeyhoffCS , WetterslevJ , JorgensenLN , HennebergSW , HøgdallC , LundvallL , et al. PROXI Trial Group. Effect of high perioperative oxygen fraction on surgical site infection and pulmonary complications after abdominal surgery: the PROXI randomized clinical trial. JAMA2009;302(14):1543‐50. [PUBMED: 19826023] ">Meyhoff 2009</a>; <a href="./references#CD008884-bbs2-0017" title="MylesPS , LeslieK , ChanMT , ForbesA , PaechMJ , PeytonP , et al. ENIGMA Trial Group. Avoidance of nitrous oxide for patients undergoing major surgery: a randomized controlled trial. Anesthesiology2007;107(2):221‐31. [PUBMED: 17667565] ">Myles 2007</a>; <a href="./references#CD008884-bbs2-0021" title="SchietromaM , CeciliaEM , CarleiF , SistaF , DeSantisG , PiccioneF , et al. Prevention of anastomotic leakage after total gastrectomy with perioperative supplemental oxygen administration: a prospective randomized, double blind, controlled, single‐center trial. Annals of Surgical Oncology2013;20(5):584‐90. [DOI: 10.1245/s10434‐012‐2714‐7; PUBMED: 23099730] ">Schietroma 2013</a>; <a href="./references#CD008884-bbs2-0024" title="StallA , ParyaviE , GuptaR , ZadnikM , HuiE , O’TooleRV . Perioperative supplemental oxygen to reduce surgical site infection after open fixation of high‐risk fractures: a randomized controlled pilot trial. The Journal of Trauma and Acute Care Surgery2013;75(4):657‐63. [DOI: 10.1097/TA.0b0113e3182a1fe83] ">Stall 2013</a>; <a href="./references#CD008884-bbs2-0025" title="ThibonP , BorgeyF , BoutreuxS , HanouzJ‐L , LeCoutourX , ParientiJ‐J . Effect of perioperative oxygen supplementation on 30‐day surgical site infection rate in abdominal, gynecologic, and breast surgery. Anesthesiology2012;117:504–11. [MEDLINE: PMID: 22790961] ">Thibon 2012</a>; <a href="./references#CD008884-bbs2-0027" title="WilliamsN , GloverM , CrispC , ActonA , McKennaD . Randomized controlled trial of the effect of 30% versus 80% fraction of inspired oxygen on caesarean delivery surgical site infection. American Journal of Perinatology2013;30(9):781‐6. [DOI: 10.1055/s‐0032‐1333405] ">Williams 2013</a>); two trials did not describe this bias risk and thus were considered as having unclear risk of bias (<a href="./references#CD008884-bbs2-0007" title="GolfamF . Effects of supplemental oxygen for prevention of wound infection after breast surgery. International Journal of Infectious Diseases2011;15(1):S55. [DOI: http://dx.doi.org/10.1016/S1201‐9712(11)60189‐6] ">Golfam 2011</a>; <a href="./references#CD008884-bbs2-0022" title="ScifresCM , LeightonBL , FogerteyPJ , MaconesGA , StamilioDM . Supplemental oxygen for the prevention of postcesarean infectious morbidity: a randomized controlled trial. American Journal of Obstetrics and Gynecology2011;205(3):267.e1‐9. [PUBMED: 22071059] ">Scifres 2011</a>). One trial had high risk of bias, as perioperative FIO<sub>2</sub> could be assessed during the postoperative period and at wound evaluation, and as data on FIO<sub>2</sub> or gas flow used during anaesthesia were available in the participant file (<a href="./references#CD008884-bbs2-0018" title="PryorKO , FaheyTJ3rd , LienCA , GoldsteinPA . Surgical site infection and the routine use of perioperative hyperoxia in a general surgical population: a randomized controlled trial. JAMA2004;291(1):79‐87. [PUBMED: 14709579] ">Pryor 2004</a>). </p> </section> </section> <section id="CD008884-sec-0064"> <h4 class="title">Incomplete outcome data</h4> <p>Eleven trials reporting on the primary outcome of surgical site infection provided numbers and reasons for dropouts and withdrawals in the intervention groups, or described no dropouts or withdrawals (<a href="./references#CD008884-bbs2-0001" title="BeldaFJ , AguileraL , García de la AsunciónJ , AlbertiJ , VicenteR , FerrándizL , et al. Spanish Reduccion de la Tasa de Infeccion Quirurgica Group. Supplemental perioperative oxygen and the risk of surgical wound infection: a randomized controlled trial. JAMA2005;294(16):2035‐42. [PUBMED: 16249417] ">Belda 2005</a>; <a href="./references#CD008884-bbs2-0003" title="BickelA , GurevitsM , VamosR , IvryS , EitanA . Perioperative hyperoxygenation and wound site infection following surgery for acute appendicitis: a randomized, prospective, controlled trial. Archives of Surgery2011;146(4):464‐70. [PUBMED: 21502457] ">Bickel 2011</a>; <a href="./references#CD008884-bbs2-0004" title="DuggalN , PoddatooriV , NoroozkhaniS , CherryC , ParkT , CaugheyAB . Perioperative oxygen supplementation and surgical site infection after cesarean delivery. A randomized trial. Obstetrics &amp; Gynecology2013;122(1):79‐84. [DOI: 10.1097/AOG.0b013e318297ec6c] ">Duggal 2013</a>; <a href="./references#CD008884-bbs2-0006" title="GardellaC , GoltraLB , LaschanskyE , DroletteL , MagaretA , ChadwickHS , et al. High‐concentration supplemental perioperative oxygen to reduce the incidence of postcesarean surgical site infection: a randomized controlled trial. Obstetrics and Gynecology2008;112(3):545‐52. [PUBMED: 18757651] ">Gardella 2008</a>; <a href="./references#CD008884-bbs2-0014" title="MayzlerO , WekslerN , DomchikS , KleinM , MizrahiS , GurmanGM . Does supplemental perioperative oxygen administration reduce the incidence of wound infection in elective colorectal surgery?. Minerva Anestesiology2005;71(1‐2):21‐5. [PUBMED: 15711503] ">Mayzler 2005</a>; <a href="./references#CD008884-bbs2-0016" title="MeyhoffCS , WetterslevJ , JorgensenLN , HennebergSW , HøgdallC , LundvallL , et al. PROXI Trial Group. Effect of high perioperative oxygen fraction on surgical site infection and pulmonary complications after abdominal surgery: the PROXI randomized clinical trial. JAMA2009;302(14):1543‐50. [PUBMED: 19826023] ">Meyhoff 2009</a>; <a href="./references#CD008884-bbs2-0017" title="MylesPS , LeslieK , ChanMT , ForbesA , PaechMJ , PeytonP , et al. ENIGMA Trial Group. Avoidance of nitrous oxide for patients undergoing major surgery: a randomized controlled trial. Anesthesiology2007;107(2):221‐31. [PUBMED: 17667565] ">Myles 2007</a>; <a href="./references#CD008884-bbs2-0018" title="PryorKO , FaheyTJ3rd , LienCA , GoldsteinPA . Surgical site infection and the routine use of perioperative hyperoxia in a general surgical population: a randomized controlled trial. JAMA2004;291(1):79‐87. [PUBMED: 14709579] ">Pryor 2004</a>; <a href="./references#CD008884-bbs2-0021" title="SchietromaM , CeciliaEM , CarleiF , SistaF , DeSantisG , PiccioneF , et al. Prevention of anastomotic leakage after total gastrectomy with perioperative supplemental oxygen administration: a prospective randomized, double blind, controlled, single‐center trial. Annals of Surgical Oncology2013;20(5):584‐90. [DOI: 10.1245/s10434‐012‐2714‐7; PUBMED: 23099730] ">Schietroma 2013</a>; <a href="./references#CD008884-bbs2-0025" title="ThibonP , BorgeyF , BoutreuxS , HanouzJ‐L , LeCoutourX , ParientiJ‐J . Effect of perioperative oxygen supplementation on 30‐day surgical site infection rate in abdominal, gynecologic, and breast surgery. Anesthesiology2012;117:504–11. [MEDLINE: PMID: 22790961] ">Thibon 2012</a>; <a href="./references#CD008884-bbs2-0027" title="WilliamsN , GloverM , CrispC , ActonA , McKennaD . Randomized controlled trial of the effect of 30% versus 80% fraction of inspired oxygen on caesarean delivery surgical site infection. American Journal of Perinatology2013;30(9):781‐6. [DOI: 10.1055/s‐0032‐1333405] ">Williams 2013</a>). We judged four trials as having unclear risk of bias, as they did not consistently report on dropouts or withdrawals (<a href="./references#CD008884-bbs2-0007" title="GolfamF . Effects of supplemental oxygen for prevention of wound infection after breast surgery. International Journal of Infectious Diseases2011;15(1):S55. [DOI: http://dx.doi.org/10.1016/S1201‐9712(11)60189‐6] ">Golfam 2011</a>; <a href="./references#CD008884-bbs2-0010" title="GreifR , AkçaO , HornEP , KurzA , SesslerDI , Outcomes Research Group. Supplemental perioperative oxygen to reduce the incidence of surgical‐wound infection. New England Journal of Medicine2000;342(3):161‐7. [PUBMED: 10639541] ">Greif 2000</a>; <a href="./references#CD008884-bbs2-0022" title="ScifresCM , LeightonBL , FogerteyPJ , MaconesGA , StamilioDM . Supplemental oxygen for the prevention of postcesarean infectious morbidity: a randomized controlled trial. American Journal of Obstetrics and Gynecology2011;205(3):267.e1‐9. [PUBMED: 22071059] ">Scifres 2011</a>; <a href="./references#CD008884-bbs2-0024" title="StallA , ParyaviE , GuptaR , ZadnikM , HuiE , O’TooleRV . Perioperative supplemental oxygen to reduce surgical site infection after open fixation of high‐risk fractures: a randomized controlled pilot trial. The Journal of Trauma and Acute Care Surgery2013;75(4):657‐63. [DOI: 10.1097/TA.0b0113e3182a1fe83] ">Stall 2013</a>). </p> </section> <section id="CD008884-sec-0065"> <h4 class="title">Selective reporting</h4> <p>Fourteen trials reported adequately on surgical site infection, and one trial reported exclusively on anastomosis leakage ‐ not on all types of surgical site infection (<a href="./references#CD008884-bbs2-0005" title="García‐BotelloSA , García‐GraneroE , LilloR , López‐MozosF , MillánM , LledóS . Randomized clinical trial to evaluate the effects of perioperative supplemental oxygen administration on the colorectal anastomosis. British Journal of Surgery2006;93(6):698‐706. [MEDLINE: 16703624] ">García‐Botello 2006</a>). Three trials did not report surgical site infection at all (<a href="./references#CD008884-bbs2-0013" title="MackintoshN , GertschMC , HopfHW , PaceNL , WhiteJ , MorrisR , et al. High intraoperative inspired oxygen does not increase postoperative supplemental oxygen requirements. Anesthesiology2012;117(2):271‐9. [MEDLINE: 22569132] ">Mackintosh 2012</a>; <a href="./references#CD008884-bbs2-0014" title="MayzlerO , WekslerN , DomchikS , KleinM , MizrahiS , GurmanGM . Does supplemental perioperative oxygen administration reduce the incidence of wound infection in elective colorectal surgery?. Minerva Anestesiology2005;71(1‐2):21‐5. [PUBMED: 15711503] ">Mayzler 2005</a>; <a href="./references#CD008884-bbs2-0028" title="ZorembaM , DetteF , HuneckeT , BrauneckerS , WulfH . The influence of perioperative oxygen concentration on postoperative lung function in moderately obese adults. European Journal of Anaesthesiology2010;27(6):501‐7. [MEDLINE: 19550338] ">Zoremba 2010</a>). </p> <p>Six trials reported on mortality within 14 to 30 days after randomization (<a href="./references#CD008884-bbs2-0001" title="BeldaFJ , AguileraL , García de la AsunciónJ , AlbertiJ , VicenteR , FerrándizL , et al. Spanish Reduccion de la Tasa de Infeccion Quirurgica Group. Supplemental perioperative oxygen and the risk of surgical wound infection: a randomized controlled trial. JAMA2005;294(16):2035‐42. [PUBMED: 16249417] ">Belda 2005</a>; <a href="./references#CD008884-bbs2-0010" title="GreifR , AkçaO , HornEP , KurzA , SesslerDI , Outcomes Research Group. Supplemental perioperative oxygen to reduce the incidence of surgical‐wound infection. New England Journal of Medicine2000;342(3):161‐7. [PUBMED: 10639541] ">Greif 2000</a>; <a href="./references#CD008884-bbs2-0016" title="MeyhoffCS , WetterslevJ , JorgensenLN , HennebergSW , HøgdallC , LundvallL , et al. PROXI Trial Group. Effect of high perioperative oxygen fraction on surgical site infection and pulmonary complications after abdominal surgery: the PROXI randomized clinical trial. JAMA2009;302(14):1543‐50. [PUBMED: 19826023] ">Meyhoff 2009</a>; <a href="./references#CD008884-bbs2-0017" title="MylesPS , LeslieK , ChanMT , ForbesA , PaechMJ , PeytonP , et al. ENIGMA Trial Group. Avoidance of nitrous oxide for patients undergoing major surgery: a randomized controlled trial. Anesthesiology2007;107(2):221‐31. [PUBMED: 17667565] ">Myles 2007</a>; <a href="./references#CD008884-bbs2-0018" title="PryorKO , FaheyTJ3rd , LienCA , GoldsteinPA . Surgical site infection and the routine use of perioperative hyperoxia in a general surgical population: a randomized controlled trial. JAMA2004;291(1):79‐87. [PUBMED: 14709579] ">Pryor 2004</a>; <a href="./references#CD008884-bbs2-0021" title="SchietromaM , CeciliaEM , CarleiF , SistaF , DeSantisG , PiccioneF , et al. Prevention of anastomotic leakage after total gastrectomy with perioperative supplemental oxygen administration: a prospective randomized, double blind, controlled, single‐center trial. Annals of Surgical Oncology2013;20(5):584‐90. [DOI: 10.1245/s10434‐012‐2714‐7; PUBMED: 23099730] ">Schietroma 2013</a>). Two trials described long‐term mortality within a median of 3.9 years and 3.5 years, respectively (<a href="./references#CD008884-bbs2-0016" title="MeyhoffCS , WetterslevJ , JorgensenLN , HennebergSW , HøgdallC , LundvallL , et al. PROXI Trial Group. Effect of high perioperative oxygen fraction on surgical site infection and pulmonary complications after abdominal surgery: the PROXI randomized clinical trial. JAMA2009;302(14):1543‐50. [PUBMED: 19826023] ">Meyhoff 2009</a>; <a href="./references#CD008884-bbs2-0017" title="MylesPS , LeslieK , ChanMT , ForbesA , PaechMJ , PeytonP , et al. ENIGMA Trial Group. Avoidance of nitrous oxide for patients undergoing major surgery: a randomized controlled trial. Anesthesiology2007;107(2):221‐31. [PUBMED: 17667565] ">Myles 2007</a>). </p> <p>Three trials reported on SAEs (<a href="./references#CD008884-bbs2-0016" title="MeyhoffCS , WetterslevJ , JorgensenLN , HennebergSW , HøgdallC , LundvallL , et al. PROXI Trial Group. Effect of high perioperative oxygen fraction on surgical site infection and pulmonary complications after abdominal surgery: the PROXI randomized clinical trial. JAMA2009;302(14):1543‐50. [PUBMED: 19826023] ">Meyhoff 2009</a>; <a href="./references#CD008884-bbs2-0017" title="MylesPS , LeslieK , ChanMT , ForbesA , PaechMJ , PeytonP , et al. ENIGMA Trial Group. Avoidance of nitrous oxide for patients undergoing major surgery: a randomized controlled trial. Anesthesiology2007;107(2):221‐31. [PUBMED: 17667565] ">Myles 2007</a>; <a href="./references#CD008884-bbs2-0018" title="PryorKO , FaheyTJ3rd , LienCA , GoldsteinPA . Surgical site infection and the routine use of perioperative hyperoxia in a general surgical population: a randomized controlled trial. JAMA2004;291(1):79‐87. [PUBMED: 14709579] ">Pryor 2004</a>) ‐ two trials on respiratory insufficiency (<a href="./references#CD008884-bbs2-0016" title="MeyhoffCS , WetterslevJ , JorgensenLN , HennebergSW , HøgdallC , LundvallL , et al. PROXI Trial Group. Effect of high perioperative oxygen fraction on surgical site infection and pulmonary complications after abdominal surgery: the PROXI randomized clinical trial. JAMA2009;302(14):1543‐50. [PUBMED: 19826023] ">Meyhoff 2009</a>; <a href="./references#CD008884-bbs2-0017" title="MylesPS , LeslieK , ChanMT , ForbesA , PaechMJ , PeytonP , et al. ENIGMA Trial Group. Avoidance of nitrous oxide for patients undergoing major surgery: a randomized controlled trial. Anesthesiology2007;107(2):221‐31. [PUBMED: 17667565] ">Myles 2007</a>) and one trial on postoperative pulse oximetry monitored desaturation (<a href="./references#CD008884-bbs2-0028" title="ZorembaM , DetteF , HuneckeT , BrauneckerS , WulfH . The influence of perioperative oxygen concentration on postoperative lung function in moderately obese adults. European Journal of Anaesthesiology2010;27(6):501‐7. [MEDLINE: 19550338] ">Zoremba 2010</a>). </p> <p>Nine trials reported on length of stay (LOS) (<a href="./references#CD008884-bbs2-0001" title="BeldaFJ , AguileraL , García de la AsunciónJ , AlbertiJ , VicenteR , FerrándizL , et al. Spanish Reduccion de la Tasa de Infeccion Quirurgica Group. Supplemental perioperative oxygen and the risk of surgical wound infection: a randomized controlled trial. JAMA2005;294(16):2035‐42. [PUBMED: 16249417] ">Belda 2005</a>; <a href="./references#CD008884-bbs2-0003" title="BickelA , GurevitsM , VamosR , IvryS , EitanA . Perioperative hyperoxygenation and wound site infection following surgery for acute appendicitis: a randomized, prospective, controlled trial. Archives of Surgery2011;146(4):464‐70. [PUBMED: 21502457] ">Bickel 2011</a>; <a href="./references#CD008884-bbs2-0006" title="GardellaC , GoltraLB , LaschanskyE , DroletteL , MagaretA , ChadwickHS , et al. High‐concentration supplemental perioperative oxygen to reduce the incidence of postcesarean surgical site infection: a randomized controlled trial. Obstetrics and Gynecology2008;112(3):545‐52. [PUBMED: 18757651] ">Gardella 2008</a>; <a href="./references#CD008884-bbs2-0010" title="GreifR , AkçaO , HornEP , KurzA , SesslerDI , Outcomes Research Group. Supplemental perioperative oxygen to reduce the incidence of surgical‐wound infection. New England Journal of Medicine2000;342(3):161‐7. [PUBMED: 10639541] ">Greif 2000</a>; <a href="./references#CD008884-bbs2-0014" title="MayzlerO , WekslerN , DomchikS , KleinM , MizrahiS , GurmanGM . Does supplemental perioperative oxygen administration reduce the incidence of wound infection in elective colorectal surgery?. Minerva Anestesiology2005;71(1‐2):21‐5. [PUBMED: 15711503] ">Mayzler 2005</a>; <a href="./references#CD008884-bbs2-0016" title="MeyhoffCS , WetterslevJ , JorgensenLN , HennebergSW , HøgdallC , LundvallL , et al. PROXI Trial Group. Effect of high perioperative oxygen fraction on surgical site infection and pulmonary complications after abdominal surgery: the PROXI randomized clinical trial. JAMA2009;302(14):1543‐50. [PUBMED: 19826023] ">Meyhoff 2009</a>; <a href="./references#CD008884-bbs2-0017" title="MylesPS , LeslieK , ChanMT , ForbesA , PaechMJ , PeytonP , et al. ENIGMA Trial Group. Avoidance of nitrous oxide for patients undergoing major surgery: a randomized controlled trial. Anesthesiology2007;107(2):221‐31. [PUBMED: 17667565] ">Myles 2007</a>; <a href="./references#CD008884-bbs2-0018" title="PryorKO , FaheyTJ3rd , LienCA , GoldsteinPA . Surgical site infection and the routine use of perioperative hyperoxia in a general surgical population: a randomized controlled trial. JAMA2004;291(1):79‐87. [PUBMED: 14709579] ">Pryor 2004</a>; <a href="./references#CD008884-bbs2-0021" title="SchietromaM , CeciliaEM , CarleiF , SistaF , DeSantisG , PiccioneF , et al. Prevention of anastomotic leakage after total gastrectomy with perioperative supplemental oxygen administration: a prospective randomized, double blind, controlled, single‐center trial. Annals of Surgical Oncology2013;20(5):584‐90. [DOI: 10.1245/s10434‐012‐2714‐7; PUBMED: 23099730] ">Schietroma 2013</a>). </p> <p>One trial reported on quality of life (<a href="./references#CD008884-bbs2-0009" title="GreifR , LacinyS , RapfB , HickleRS , SesslerDI . Supplemental oxygen reduces the incidence of postoperative nausea and vomiting. Anesthesiology1999;91(5):1246‐52. ">Greif 1999</a>). </p> <p>Therefore we determined that 20 studies had low risk of reporting bias, and eight studies had unclear risk (<a href="./references#CD008884-bbs2-0005" title="García‐BotelloSA , García‐GraneroE , LilloR , López‐MozosF , MillánM , LledóS . Randomized clinical trial to evaluate the effects of perioperative supplemental oxygen administration on the colorectal anastomosis. British Journal of Surgery2006;93(6):698‐706. [MEDLINE: 16703624] ">García‐Botello 2006</a>; <a href="./references#CD008884-bbs2-0006" title="GardellaC , GoltraLB , LaschanskyE , DroletteL , MagaretA , ChadwickHS , et al. High‐concentration supplemental perioperative oxygen to reduce the incidence of postcesarean surgical site infection: a randomized controlled trial. Obstetrics and Gynecology2008;112(3):545‐52. [PUBMED: 18757651] ">Gardella 2008</a>; <a href="./references#CD008884-bbs2-0012" title="KotaniN , HashimotoH , SesslerDI , MuraokaM , HashibaE , KubotaT , et al. Supplemental intraoperative oxygen augments antimicrobial and proinflammatory responses of alveolar macrophages. Anesthesiology2000;93(1):15‐25. [PUBMED: 10861141] ">Kotani 2000</a>; <a href="./references#CD008884-bbs2-0013" title="MackintoshN , GertschMC , HopfHW , PaceNL , WhiteJ , MorrisR , et al. High intraoperative inspired oxygen does not increase postoperative supplemental oxygen requirements. Anesthesiology2012;117(2):271‐9. [MEDLINE: 22569132] ">Mackintosh 2012</a>; <a href="./references#CD008884-bbs2-0014" title="MayzlerO , WekslerN , DomchikS , KleinM , MizrahiS , GurmanGM . Does supplemental perioperative oxygen administration reduce the incidence of wound infection in elective colorectal surgery?. Minerva Anestesiology2005;71(1‐2):21‐5. [PUBMED: 15711503] ">Mayzler 2005</a>; <a href="./references#CD008884-bbs2-0020" title="PurhonenS , NiskanenM , WüstefeldM , HirvonenE , HynynenM . Supplemental 80% oxygen does not attenuate post‐operative nausea and vomiting after breast surgery. Acta Anaesthesiologica Scandinavica2006;50(1):26‐31. [PUBMED: 16451147] ">Purhonen 2006</a>; <a href="./references#CD008884-bbs2-0026" title="TuranA , ApfelCC , KumpchM , DanzeisenO , EberhartLH , ForstH , et al. Does the efficacy of supplemental oxygen for the prevention of postoperative nausea and vomiting depend on the measured outcome, observational period or site of surgery. Anaesthesia2006;61(7):628‐33. [PUBMED: 16792606] ">Turan 2006</a>; <a href="./references#CD008884-bbs2-0028" title="ZorembaM , DetteF , HuneckeT , BrauneckerS , WulfH . The influence of perioperative oxygen concentration on postoperative lung function in moderately obese adults. European Journal of Anaesthesiology2010;27(6):501‐7. [MEDLINE: 19550338] ">Zoremba 2010</a>) as they did not present adequate information for assessment of selective reporting. </p> </section> <section id="CD008884-sec-0066"> <h4 class="title">Other potential sources of bias</h4> <p>Two trials had unclear risk of industry bias, as a company was involved in planning and design of the trials (<a href="./references#CD008884-bbs2-0001" title="BeldaFJ , AguileraL , García de la AsunciónJ , AlbertiJ , VicenteR , FerrándizL , et al. Spanish Reduccion de la Tasa de Infeccion Quirurgica Group. Supplemental perioperative oxygen and the risk of surgical wound infection: a randomized controlled trial. JAMA2005;294(16):2035‐42. [PUBMED: 16249417] ">Belda 2005</a>; <a href="./references#CD008884-bbs2-0025" title="ThibonP , BorgeyF , BoutreuxS , HanouzJ‐L , LeCoutourX , ParientiJ‐J . Effect of perioperative oxygen supplementation on 30‐day surgical site infection rate in abdominal, gynecologic, and breast surgery. Anesthesiology2012;117:504–11. [MEDLINE: PMID: 22790961] ">Thibon 2012</a>). </p> <p>Seventeen trials reporting on outcomes included in this review had low risk of financial bias (<a href="./references#CD008884-bbs2-0003" title="BickelA , GurevitsM , VamosR , IvryS , EitanA . Perioperative hyperoxygenation and wound site infection following surgery for acute appendicitis: a randomized, prospective, controlled trial. Archives of Surgery2011;146(4):464‐70. [PUBMED: 21502457] ">Bickel 2011</a>; <a href="./references#CD008884-bbs2-0004" title="DuggalN , PoddatooriV , NoroozkhaniS , CherryC , ParkT , CaugheyAB . Perioperative oxygen supplementation and surgical site infection after cesarean delivery. A randomized trial. Obstetrics &amp; Gynecology2013;122(1):79‐84. [DOI: 10.1097/AOG.0b013e318297ec6c] ">Duggal 2013</a>; <a href="./references#CD008884-bbs2-0005" title="García‐BotelloSA , García‐GraneroE , LilloR , López‐MozosF , MillánM , LledóS . Randomized clinical trial to evaluate the effects of perioperative supplemental oxygen administration on the colorectal anastomosis. British Journal of Surgery2006;93(6):698‐706. [MEDLINE: 16703624] ">García‐Botello 2006</a>; <a href="./references#CD008884-bbs2-0006" title="GardellaC , GoltraLB , LaschanskyE , DroletteL , MagaretA , ChadwickHS , et al. High‐concentration supplemental perioperative oxygen to reduce the incidence of postcesarean surgical site infection: a randomized controlled trial. Obstetrics and Gynecology2008;112(3):545‐52. [PUBMED: 18757651] ">Gardella 2008</a>; <a href="./references#CD008884-bbs2-0007" title="GolfamF . Effects of supplemental oxygen for prevention of wound infection after breast surgery. International Journal of Infectious Diseases2011;15(1):S55. [DOI: http://dx.doi.org/10.1016/S1201‐9712(11)60189‐6] ">Golfam 2011</a>; <a href="./references#CD008884-bbs2-0009" title="GreifR , LacinyS , RapfB , HickleRS , SesslerDI . Supplemental oxygen reduces the incidence of postoperative nausea and vomiting. Anesthesiology1999;91(5):1246‐52. ">Greif 1999</a>; <a href="./references#CD008884-bbs2-0010" title="GreifR , AkçaO , HornEP , KurzA , SesslerDI , Outcomes Research Group. Supplemental perioperative oxygen to reduce the incidence of surgical‐wound infection. New England Journal of Medicine2000;342(3):161‐7. [PUBMED: 10639541] ">Greif 2000</a>; <a href="./references#CD008884-bbs2-0013" title="MackintoshN , GertschMC , HopfHW , PaceNL , WhiteJ , MorrisR , et al. High intraoperative inspired oxygen does not increase postoperative supplemental oxygen requirements. Anesthesiology2012;117(2):271‐9. [MEDLINE: 22569132] ">Mackintosh 2012</a>; <a href="./references#CD008884-bbs2-0014" title="MayzlerO , WekslerN , DomchikS , KleinM , MizrahiS , GurmanGM . Does supplemental perioperative oxygen administration reduce the incidence of wound infection in elective colorectal surgery?. Minerva Anestesiology2005;71(1‐2):21‐5. [PUBMED: 15711503] ">Mayzler 2005</a>; <a href="./references#CD008884-bbs2-0016" title="MeyhoffCS , WetterslevJ , JorgensenLN , HennebergSW , HøgdallC , LundvallL , et al. PROXI Trial Group. Effect of high perioperative oxygen fraction on surgical site infection and pulmonary complications after abdominal surgery: the PROXI randomized clinical trial. JAMA2009;302(14):1543‐50. [PUBMED: 19826023] ">Meyhoff 2009</a>; <a href="./references#CD008884-bbs2-0017" title="MylesPS , LeslieK , ChanMT , ForbesA , PaechMJ , PeytonP , et al. ENIGMA Trial Group. Avoidance of nitrous oxide for patients undergoing major surgery: a randomized controlled trial. Anesthesiology2007;107(2):221‐31. [PUBMED: 17667565] ">Myles 2007</a>; <a href="./references#CD008884-bbs2-0018" title="PryorKO , FaheyTJ3rd , LienCA , GoldsteinPA . Surgical site infection and the routine use of perioperative hyperoxia in a general surgical population: a randomized controlled trial. JAMA2004;291(1):79‐87. [PUBMED: 14709579] ">Pryor 2004</a>; <a href="./references#CD008884-bbs2-0022" title="ScifresCM , LeightonBL , FogerteyPJ , MaconesGA , StamilioDM . Supplemental oxygen for the prevention of postcesarean infectious morbidity: a randomized controlled trial. American Journal of Obstetrics and Gynecology2011;205(3):267.e1‐9. [PUBMED: 22071059] ">Scifres 2011</a>; <a href="./references#CD008884-bbs2-0027" title="WilliamsN , GloverM , CrispC , ActonA , McKennaD . Randomized controlled trial of the effect of 30% versus 80% fraction of inspired oxygen on caesarean delivery surgical site infection. American Journal of Perinatology2013;30(9):781‐6. [DOI: 10.1055/s‐0032‐1333405] ">Williams 2013</a>; <a href="./references#CD008884-bbs2-0028" title="ZorembaM , DetteF , HuneckeT , BrauneckerS , WulfH . The influence of perioperative oxygen concentration on postoperative lung function in moderately obese adults. European Journal of Anaesthesiology2010;27(6):501‐7. [MEDLINE: 19550338] ">Zoremba 2010</a>; <a href="./references#CD008884-bbs2-0021" title="SchietromaM , CeciliaEM , CarleiF , SistaF , DeSantisG , PiccioneF , et al. Prevention of anastomotic leakage after total gastrectomy with perioperative supplemental oxygen administration: a prospective randomized, double blind, controlled, single‐center trial. Annals of Surgical Oncology2013;20(5):584‐90. [DOI: 10.1245/s10434‐012‐2714‐7; PUBMED: 23099730] ">Schietroma 2013</a>; <a href="./references#CD008884-bbs2-0024" title="StallA , ParyaviE , GuptaR , ZadnikM , HuiE , O’TooleRV . Perioperative supplemental oxygen to reduce surgical site infection after open fixation of high‐risk fractures: a randomized controlled pilot trial. The Journal of Trauma and Acute Care Surgery2013;75(4):657‐63. [DOI: 10.1097/TA.0b0113e3182a1fe83] ">Stall 2013</a>). </p> </section> </section> <section id="CD008884-sec-0067"> <h3 class="title" id="CD008884-sec-0067">Effects of interventions</h3> <p>See: <a href="./full#CD008884-tbl-0001"><b>Summary of findings for the main comparison</b> Summary of findings in randomized clinical trials with overall low risk of bias and in all trials</a> </p> <section id="CD008884-sec-0068"> <h4 class="title">Primary outcomes</h4> <section id="CD008884-sec-0069"> <h5 class="title">1. All‐cause mortality in all trials according to the longest follow‐up period for each trial. </h5> <p>Eight trials with 4229 participants provided data on all‐cause mortality (<a href="./references#CD008884-bbs2-0001" title="BeldaFJ , AguileraL , García de la AsunciónJ , AlbertiJ , VicenteR , FerrándizL , et al. Spanish Reduccion de la Tasa de Infeccion Quirurgica Group. Supplemental perioperative oxygen and the risk of surgical wound infection: a randomized controlled trial. JAMA2005;294(16):2035‐42. [PUBMED: 16249417] ">Belda 2005</a>; <a href="./references#CD008884-bbs2-0010" title="GreifR , AkçaO , HornEP , KurzA , SesslerDI , Outcomes Research Group. Supplemental perioperative oxygen to reduce the incidence of surgical‐wound infection. New England Journal of Medicine2000;342(3):161‐7. [PUBMED: 10639541] ">Greif 2000</a>; <a href="./references#CD008884-bbs2-0111" title="MeyhoffCS , JorgensenLN , WetterslevJ , ChristensenKB , RasmussenLS , PROXI Trial Group. Increased long‐term mortality after a high perioperative inspiratory oxygen fraction during abdominal surgery: follow‐up of a randomized clinical trial. Anesthesia and Analgesia2012;115(4):849‐54. [PUBMED: 22798533] ">Meyhoff 2012</a>; <a href="./references#CD008884-bbs2-0017" title="MylesPS , LeslieK , ChanMT , ForbesA , PaechMJ , PeytonP , et al. ENIGMA Trial Group. Avoidance of nitrous oxide for patients undergoing major surgery: a randomized controlled trial. Anesthesiology2007;107(2):221‐31. [PUBMED: 17667565] ">Myles 2007</a>; <a href="./references#CD008884-bbs2-0018" title="PryorKO , FaheyTJ3rd , LienCA , GoldsteinPA . Surgical site infection and the routine use of perioperative hyperoxia in a general surgical population: a randomized controlled trial. JAMA2004;291(1):79‐87. [PUBMED: 14709579] ">Pryor 2004</a>; <a href="./references#CD008884-bbs2-0021" title="SchietromaM , CeciliaEM , CarleiF , SistaF , DeSantisG , PiccioneF , et al. Prevention of anastomotic leakage after total gastrectomy with perioperative supplemental oxygen administration: a prospective randomized, double blind, controlled, single‐center trial. Annals of Surgical Oncology2013;20(5):584‐90. [DOI: 10.1245/s10434‐012‐2714‐7; PUBMED: 23099730] ">Schietroma 2013</a>; <a href="./references#CD008884-bbs2-0024" title="StallA , ParyaviE , GuptaR , ZadnikM , HuiE , O’TooleRV . Perioperative supplemental oxygen to reduce surgical site infection after open fixation of high‐risk fractures: a randomized controlled pilot trial. The Journal of Trauma and Acute Care Surgery2013;75(4):657‐63. [DOI: 10.1097/TA.0b0113e3182a1fe83] ">Stall 2013</a>; <a href="./references#CD008884-bbs2-0027" title="WilliamsN , GloverM , CrispC , ActonA , McKennaD . Randomized controlled trial of the effect of 30% versus 80% fraction of inspired oxygen on caesarean delivery surgical site infection. American Journal of Perinatology2013;30(9):781‐6. [DOI: 10.1055/s‐0032‐1333405] ">Williams 2013</a>). Two trials reported long‐term mortality with a median follow‐up of 3.9 years in 83% of randomly assigned participants and 3.5 years in 99% of participants, respectively (<a href="./references#CD008884-bbs2-0017" title="MylesPS , LeslieK , ChanMT , ForbesA , PaechMJ , PeytonP , et al. ENIGMA Trial Group. Avoidance of nitrous oxide for patients undergoing major surgery: a randomized controlled trial. Anesthesiology2007;107(2):221‐31. [PUBMED: 17667565] ">Myles 2007</a>; <a href="./references#CD008884-bbs2-0016" title="MeyhoffCS , WetterslevJ , JorgensenLN , HennebergSW , HøgdallC , LundvallL , et al. PROXI Trial Group. Effect of high perioperative oxygen fraction on surgical site infection and pulmonary complications after abdominal surgery: the PROXI randomized clinical trial. JAMA2009;302(14):1543‐50. [PUBMED: 19826023] ">Meyhoff 2009</a>). Four trials reported mortality only within 30 days (<a href="./references#CD008884-bbs2-0001" title="BeldaFJ , AguileraL , García de la AsunciónJ , AlbertiJ , VicenteR , FerrándizL , et al. Spanish Reduccion de la Tasa de Infeccion Quirurgica Group. Supplemental perioperative oxygen and the risk of surgical wound infection: a randomized controlled trial. JAMA2005;294(16):2035‐42. [PUBMED: 16249417] ">Belda 2005</a>; <a href="./references#CD008884-bbs2-0010" title="GreifR , AkçaO , HornEP , KurzA , SesslerDI , Outcomes Research Group. Supplemental perioperative oxygen to reduce the incidence of surgical‐wound infection. New England Journal of Medicine2000;342(3):161‐7. [PUBMED: 10639541] ">Greif 2000</a>; <a href="./references#CD008884-bbs2-0018" title="PryorKO , FaheyTJ3rd , LienCA , GoldsteinPA . Surgical site infection and the routine use of perioperative hyperoxia in a general surgical population: a randomized controlled trial. JAMA2004;291(1):79‐87. [PUBMED: 14709579] ">Pryor 2004</a>; <a href="./references#CD008884-bbs2-0021" title="SchietromaM , CeciliaEM , CarleiF , SistaF , DeSantisG , PiccioneF , et al. Prevention of anastomotic leakage after total gastrectomy with perioperative supplemental oxygen administration: a prospective randomized, double blind, controlled, single‐center trial. Annals of Surgical Oncology2013;20(5):584‐90. [DOI: 10.1245/s10434‐012‐2714‐7; PUBMED: 23099730] ">Schietroma 2013</a>). Overall, in all trials a high fraction of inspired oxygen with an FIO<sub>2</sub> of 60% to 90% compared with 30% to 40% oxygen used during anaesthesia and surgery was not associated with all‐cause mortality within the longest follow‐up in a random‐effects model (RR 1.07, 95% CI 0.87 to 1.33; participants = 4918; trials = 8; I<sup>2</sup> = 30%; <a href="./references#CD008884-fig-0007" title="">Analysis 1.1</a>; nor in a fixed‐effect model (RR 1.10, 95% CI 0.97 to 1.25; participants = 4918; trials = 8; I<sup>2</sup> = 30%; <a href="./references#CD008884-fig-0007" title="">Analysis 1.1</a>). </p> <section id="CD008884-sec-0070"> <h6 class="title">All‐cause mortality according to overall risk of bias in the included trials</h6> <section id="CD008884-sec-0071"> <p><b>Within longest follow‐up</b></p> <p>In trials with overall low risk of bias (<a href="./references#CD008884-bbs2-0016" title="MeyhoffCS , WetterslevJ , JorgensenLN , HennebergSW , HøgdallC , LundvallL , et al. PROXI Trial Group. Effect of high perioperative oxygen fraction on surgical site infection and pulmonary complications after abdominal surgery: the PROXI randomized clinical trial. JAMA2009;302(14):1543‐50. [PUBMED: 19826023] ">Meyhoff 2009</a>; <a href="./references#CD008884-bbs2-0017" title="MylesPS , LeslieK , ChanMT , ForbesA , PaechMJ , PeytonP , et al. ENIGMA Trial Group. Avoidance of nitrous oxide for patients undergoing major surgery: a randomized controlled trial. Anesthesiology2007;107(2):221‐31. [PUBMED: 17667565] ">Myles 2007</a>; <a href="./references#CD008884-bbs2-0010" title="GreifR , AkçaO , HornEP , KurzA , SesslerDI , Outcomes Research Group. Supplemental perioperative oxygen to reduce the incidence of surgical‐wound infection. New England Journal of Medicine2000;342(3):161‐7. [PUBMED: 10639541] ">Greif 2000</a>; <a href="./references#CD008884-bbs2-0027" title="WilliamsN , GloverM , CrispC , ActonA , McKennaD . Randomized controlled trial of the effect of 30% versus 80% fraction of inspired oxygen on caesarean delivery surgical site infection. American Journal of Perinatology2013;30(9):781‐6. [DOI: 10.1055/s‐0032‐1333405] ">Williams 2013</a>), an FIO<sub>2</sub> of 60% to 90% compared with 30% to 40% oxygen used during anaesthesia and surgery was not associated with mortality within the longest follow‐up in a random‐effects model (RR 1.12, 95% CI 0.93 to 1.36; P value = 0.23; I<sup>2</sup> = 41; <a href="./references#CD008884-fig-0007" title="">Analysis 1.1</a>). In trials with overall high or unclear risk of bias (<a href="./references#CD008884-bbs2-0001" title="BeldaFJ , AguileraL , García de la AsunciónJ , AlbertiJ , VicenteR , FerrándizL , et al. Spanish Reduccion de la Tasa de Infeccion Quirurgica Group. Supplemental perioperative oxygen and the risk of surgical wound infection: a randomized controlled trial. JAMA2005;294(16):2035‐42. [PUBMED: 16249417] ">Belda 2005</a>; <a href="./references#CD008884-bbs2-0018" title="PryorKO , FaheyTJ3rd , LienCA , GoldsteinPA . Surgical site infection and the routine use of perioperative hyperoxia in a general surgical population: a randomized controlled trial. JAMA2004;291(1):79‐87. [PUBMED: 14709579] ">Pryor 2004</a>; <a href="./references#CD008884-bbs2-0021" title="SchietromaM , CeciliaEM , CarleiF , SistaF , DeSantisG , PiccioneF , et al. Prevention of anastomotic leakage after total gastrectomy with perioperative supplemental oxygen administration: a prospective randomized, double blind, controlled, single‐center trial. Annals of Surgical Oncology2013;20(5):584‐90. [DOI: 10.1245/s10434‐012‐2714‐7; PUBMED: 23099730] ">Schietroma 2013</a>; <a href="./references#CD008884-bbs2-0024" title="StallA , ParyaviE , GuptaR , ZadnikM , HuiE , O’TooleRV . Perioperative supplemental oxygen to reduce surgical site infection after open fixation of high‐risk fractures: a randomized controlled pilot trial. The Journal of Trauma and Acute Care Surgery2013;75(4):657‐63. [DOI: 10.1097/TA.0b0113e3182a1fe83] ">Stall 2013</a>), a high fraction of oxygen during anaesthesia and surgery was not associated with all‐cause mortality within the longest follow‐up in a random‐effects model (RR 0.43, 95% CI 0.15 to 1.20; P value = 0.11; I<sup>2</sup> = 0; <a href="./references#CD008884-fig-0007" title="">Analysis 1.1</a>). The test of interaction for a subgroup difference was not statistically significant (P value = 0.07; I<sup>2</sup> = 69.5%). </p> </section> </section> <section id="CD008884-sec-0072"> <h6 class="title">All‐cause mortality in best/worst and worst/best case scenarios of participants lost to follow‐up </h6> <p>In a best/worst case scenario (<a href="./references#CD008884-fig-0008" title="">Analysis 1.2</a>): Assuming that all participants lost to follow‐up in the group randomly assigned to a high fraction of inspired oxygen did survive, and that all participants lost to follow‐up in the group randomly assigned to a 30% to 40% fraction of inspired oxygen died, 60% to 90% oxygen was not associated with all‐cause mortality in a random‐effects model (RR 0.56, 95% CI 0.25 to 1.25). </p> <p>In a worst/best case scenario (<a href="./references#CD008884-fig-0009" title="">Analysis 1.3</a>): Assuming that all participants lost to follow‐up in the group randomly assigned to a high fraction of inspired oxygen died, and that all participants lost to follow‐up in the group randomly assigned to 30% to 40% inspiratory oxygen survived, 60% to 90% oxygen was associated with an increase in all‐cause mortality in a random‐effects model (RR 1.50, 95% CI 1.04 to 2.15; P value = 0.03; I<sup>2</sup> = 66%). </p> </section> <section id="CD008884-sec-0073"> <h6 class="title">Trial sequential analysis on all‐cause mortality</h6> <p>TSA (<a href="./full#CD008884-fig-0002">Figure 2</a>) of the four trials (<a href="./references#CD008884-bbs2-0010" title="GreifR , AkçaO , HornEP , KurzA , SesslerDI , Outcomes Research Group. Supplemental perioperative oxygen to reduce the incidence of surgical‐wound infection. New England Journal of Medicine2000;342(3):161‐7. [PUBMED: 10639541] ">Greif 2000</a>; <a href="./references#CD008884-bbs2-0016" title="MeyhoffCS , WetterslevJ , JorgensenLN , HennebergSW , HøgdallC , LundvallL , et al. PROXI Trial Group. Effect of high perioperative oxygen fraction on surgical site infection and pulmonary complications after abdominal surgery: the PROXI randomized clinical trial. JAMA2009;302(14):1543‐50. [PUBMED: 19826023] ">Meyhoff 2009</a>; <a href="./references#CD008884-bbs2-0017" title="MylesPS , LeslieK , ChanMT , ForbesA , PaechMJ , PeytonP , et al. ENIGMA Trial Group. Avoidance of nitrous oxide for patients undergoing major surgery: a randomized controlled trial. Anesthesiology2007;107(2):221‐31. [PUBMED: 17667565] ">Myles 2007</a>; <a href="./references#CD008884-bbs2-0027" title="WilliamsN , GloverM , CrispC , ActonA , McKennaD . Randomized controlled trial of the effect of 30% versus 80% fraction of inspired oxygen on caesarean delivery surgical site infection. American Journal of Perinatology2013;30(9):781‐6. [DOI: 10.1055/s‐0032‐1333405] ">Williams 2013</a>) with overall low risk of bias reporting all‐cause mortality showed that with an anticipated RRI of 20%, mortality in the control group of 15.7% and a type 1 error of 5% and a type 2 error of 20%, and diversity (D<sup>2</sup>) of 57%, the required information size was 10,736 participants. The cumulative Z‐curve did not cross any boundaries for benefit and harm nor TSMB for futility, indicating that evidence was insufficient to refute a 20% RRI or a 20% RRR for benefit or harm of a high fraction of inspired oxygen of 60% to 90%, in the light of sparse data and repetitive testing. The TSA adjusted confidence interval for the intervention effect measured in the three trials with low risk of bias was RR 1.12 with TSA adjusted CI 0.80 to 1.59. </p> <p>TSA (<a href="./full#CD008884-fig-0003">Figure 3</a>) of all eight trials (<a href="./references#CD008884-bbs2-0001" title="BeldaFJ , AguileraL , García de la AsunciónJ , AlbertiJ , VicenteR , FerrándizL , et al. Spanish Reduccion de la Tasa de Infeccion Quirurgica Group. Supplemental perioperative oxygen and the risk of surgical wound infection: a randomized controlled trial. JAMA2005;294(16):2035‐42. [PUBMED: 16249417] ">Belda 2005</a>; <a href="./references#CD008884-bbs2-0009" title="GreifR , LacinyS , RapfB , HickleRS , SesslerDI . Supplemental oxygen reduces the incidence of postoperative nausea and vomiting. Anesthesiology1999;91(5):1246‐52. ">Greif 1999</a>; <a href="./references#CD008884-bbs2-0016" title="MeyhoffCS , WetterslevJ , JorgensenLN , HennebergSW , HøgdallC , LundvallL , et al. PROXI Trial Group. Effect of high perioperative oxygen fraction on surgical site infection and pulmonary complications after abdominal surgery: the PROXI randomized clinical trial. JAMA2009;302(14):1543‐50. [PUBMED: 19826023] ">Meyhoff 2009</a>; <a href="./references#CD008884-bbs2-0017" title="MylesPS , LeslieK , ChanMT , ForbesA , PaechMJ , PeytonP , et al. ENIGMA Trial Group. Avoidance of nitrous oxide for patients undergoing major surgery: a randomized controlled trial. Anesthesiology2007;107(2):221‐31. [PUBMED: 17667565] ">Myles 2007</a>; <a href="./references#CD008884-bbs2-0018" title="PryorKO , FaheyTJ3rd , LienCA , GoldsteinPA . Surgical site infection and the routine use of perioperative hyperoxia in a general surgical population: a randomized controlled trial. JAMA2004;291(1):79‐87. [PUBMED: 14709579] ">Pryor 2004</a>; <a href="./references#CD008884-bbs2-0021" title="SchietromaM , CeciliaEM , CarleiF , SistaF , DeSantisG , PiccioneF , et al. Prevention of anastomotic leakage after total gastrectomy with perioperative supplemental oxygen administration: a prospective randomized, double blind, controlled, single‐center trial. Annals of Surgical Oncology2013;20(5):584‐90. [DOI: 10.1245/s10434‐012‐2714‐7; PUBMED: 23099730] ">Schietroma 2013</a>; <a href="./references#CD008884-bbs2-0024" title="StallA , ParyaviE , GuptaR , ZadnikM , HuiE , O’TooleRV . Perioperative supplemental oxygen to reduce surgical site infection after open fixation of high‐risk fractures: a randomized controlled pilot trial. The Journal of Trauma and Acute Care Surgery2013;75(4):657‐63. [DOI: 10.1097/TA.0b0113e3182a1fe83] ">Stall 2013</a>; <a href="./references#CD008884-bbs2-0027" title="WilliamsN , GloverM , CrispC , ActonA , McKennaD . Randomized controlled trial of the effect of 30% versus 80% fraction of inspired oxygen on caesarean delivery surgical site infection. American Journal of Perinatology2013;30(9):781‐6. [DOI: 10.1055/s‐0032‐1333405] ">Williams 2013</a>) of the effect of a high fraction of inspired oxygen on all‐cause mortality within the longest follow‐up showed that with an anticipated RRI of 20%, mortality in the control group of 15.7% and a type 1 error of 5% and a type 2 error of 20%, and diversity (D<sup>2</sup>) of 67%, the required information size was 13,264 participants. The cumulative Z‐curve did not cross the conventional boundary (P value &lt; 0.05) nor the TSMB for harm. Neither did the cumulative Z‐curve reach the futility area. Therefore evidence was insufficient for an effect on all‐cause mortality based on all trials disregarding risk of bias and time to follow‐up. We could not exclude a 20% RRI nor a 20% RRR for lack of data. The TSA adjusted </p> <p> confidence interval for the intervention effect measured in all trials was RR 1.07, with TSA adjusted CI 0.73 to 1.60. </p> <p>Using a fixed‐effect model for all trials reporting all‐cause mortality did not change the results noticeably, as the cumulative Z‐curve did not enter the futility area for a 20% RRI or RRR. </p> </section> </section> <section id="CD008884-sec-0074"> <h5 class="title">2. Surgical site infection within 14 to 30 days of follow‐up after surgery</h5> <p>Fifteen trials with 7219 participants provided data on surgical site infection. Overall, in all trials a high fraction of inspired oxygen of 60% to 90% compared with 30% to 40% oxygen used during anaesthesia and surgery was not associated with a change in the risk of surgical site infection in a random‐effects model (RR 0.87, 95% CI 0.71 to 1.07; P value = 0.18; I<sup>2</sup> = 48%; <a href="./references#CD008884-fig-0011" title="">Analysis 1.5</a>). However, in the fixed‐effect model, an FIO<sub>2</sub> of 60% to 90% compared with 30% to 40% oxygen used during anaesthesia and surgery was associated with a reduction in the risk of surgical site infection (RR 0.87, 95% CI 0.77 to 0.99; <a href="./references#CD008884-fig-0012" title="">Analysis 1.6</a>). </p> <section id="CD008884-sec-0075"> <h6 class="title">Surgical site infection according to overall risk of bias</h6> <p>In trials with overall low risk of bias (<a href="./references#CD008884-bbs2-0006" title="GardellaC , GoltraLB , LaschanskyE , DroletteL , MagaretA , ChadwickHS , et al. High‐concentration supplemental perioperative oxygen to reduce the incidence of postcesarean surgical site infection: a randomized controlled trial. Obstetrics and Gynecology2008;112(3):545‐52. [PUBMED: 18757651] ">Gardella 2008</a>; <a href="./references#CD008884-bbs2-0010" title="GreifR , AkçaO , HornEP , KurzA , SesslerDI , Outcomes Research Group. Supplemental perioperative oxygen to reduce the incidence of surgical‐wound infection. New England Journal of Medicine2000;342(3):161‐7. [PUBMED: 10639541] ">Greif 2000</a>; <a href="./references#CD008884-bbs2-0016" title="MeyhoffCS , WetterslevJ , JorgensenLN , HennebergSW , HøgdallC , LundvallL , et al. PROXI Trial Group. Effect of high perioperative oxygen fraction on surgical site infection and pulmonary complications after abdominal surgery: the PROXI randomized clinical trial. JAMA2009;302(14):1543‐50. [PUBMED: 19826023] ">Meyhoff 2009</a>; <a href="./references#CD008884-bbs2-0017" title="MylesPS , LeslieK , ChanMT , ForbesA , PaechMJ , PeytonP , et al. ENIGMA Trial Group. Avoidance of nitrous oxide for patients undergoing major surgery: a randomized controlled trial. Anesthesiology2007;107(2):221‐31. [PUBMED: 17667565] ">Myles 2007</a>; <a href="./references#CD008884-bbs2-0027" title="WilliamsN , GloverM , CrispC , ActonA , McKennaD . Randomized controlled trial of the effect of 30% versus 80% fraction of inspired oxygen on caesarean delivery surgical site infection. American Journal of Perinatology2013;30(9):781‐6. [DOI: 10.1055/s‐0032‐1333405] ">Williams 2013</a>), an FIO<sub>2</sub> of 60% to 90% compared with 30% to 40% oxygen used during anaesthesia and surgery was not associated with risk of surgical site infection in a random‐effects model (RR 0.86, 95% CI 0.63 to 1.17; participants = 4201; studies = 5; I<sup>2</sup> = 60%; <a href="./references#CD008884-fig-0011" title="">Analysis 1.5</a>) and in the fixed‐effect model (RR 0.86, 95% CI 0.73 to 1.00; participants = 4201; studies = 5; I<sup>2</sup> = 60%; <a href="./references#CD008884-fig-0012" title="">Analysis 1.6</a>). In trials with overall high or unclear risk of bias (<a href="./references#CD008884-bbs2-0001" title="BeldaFJ , AguileraL , García de la AsunciónJ , AlbertiJ , VicenteR , FerrándizL , et al. Spanish Reduccion de la Tasa de Infeccion Quirurgica Group. Supplemental perioperative oxygen and the risk of surgical wound infection: a randomized controlled trial. JAMA2005;294(16):2035‐42. [PUBMED: 16249417] ">Belda 2005</a>; <a href="./references#CD008884-bbs2-0003" title="BickelA , GurevitsM , VamosR , IvryS , EitanA . Perioperative hyperoxygenation and wound site infection following surgery for acute appendicitis: a randomized, prospective, controlled trial. Archives of Surgery2011;146(4):464‐70. [PUBMED: 21502457] ">Bickel 2011</a>; <a href="./references#CD008884-bbs2-0004" title="DuggalN , PoddatooriV , NoroozkhaniS , CherryC , ParkT , CaugheyAB . Perioperative oxygen supplementation and surgical site infection after cesarean delivery. A randomized trial. Obstetrics &amp; Gynecology2013;122(1):79‐84. [DOI: 10.1097/AOG.0b013e318297ec6c] ">Duggal 2013</a>; <a href="./references#CD008884-bbs2-0007" title="GolfamF . Effects of supplemental oxygen for prevention of wound infection after breast surgery. International Journal of Infectious Diseases2011;15(1):S55. [DOI: http://dx.doi.org/10.1016/S1201‐9712(11)60189‐6] ">Golfam 2011</a>; <a href="./references#CD008884-bbs2-0014" title="MayzlerO , WekslerN , DomchikS , KleinM , MizrahiS , GurmanGM . Does supplemental perioperative oxygen administration reduce the incidence of wound infection in elective colorectal surgery?. Minerva Anestesiology2005;71(1‐2):21‐5. [PUBMED: 15711503] ">Mayzler 2005</a>; <a href="./references#CD008884-bbs2-0018" title="PryorKO , FaheyTJ3rd , LienCA , GoldsteinPA . Surgical site infection and the routine use of perioperative hyperoxia in a general surgical population: a randomized controlled trial. JAMA2004;291(1):79‐87. [PUBMED: 14709579] ">Pryor 2004</a>; <a href="./references#CD008884-bbs2-0021" title="SchietromaM , CeciliaEM , CarleiF , SistaF , DeSantisG , PiccioneF , et al. Prevention of anastomotic leakage after total gastrectomy with perioperative supplemental oxygen administration: a prospective randomized, double blind, controlled, single‐center trial. Annals of Surgical Oncology2013;20(5):584‐90. [DOI: 10.1245/s10434‐012‐2714‐7; PUBMED: 23099730] ">Schietroma 2013</a>; <a href="./references#CD008884-bbs2-0022" title="ScifresCM , LeightonBL , FogerteyPJ , MaconesGA , StamilioDM . Supplemental oxygen for the prevention of postcesarean infectious morbidity: a randomized controlled trial. American Journal of Obstetrics and Gynecology2011;205(3):267.e1‐9. [PUBMED: 22071059] ">Scifres 2011</a>; <a href="./references#CD008884-bbs2-0024" title="StallA , ParyaviE , GuptaR , ZadnikM , HuiE , O’TooleRV . Perioperative supplemental oxygen to reduce surgical site infection after open fixation of high‐risk fractures: a randomized controlled pilot trial. The Journal of Trauma and Acute Care Surgery2013;75(4):657‐63. [DOI: 10.1097/TA.0b0113e3182a1fe83] ">Stall 2013</a>; <a href="./references#CD008884-bbs2-0025" title="ThibonP , BorgeyF , BoutreuxS , HanouzJ‐L , LeCoutourX , ParientiJ‐J . Effect of perioperative oxygen supplementation on 30‐day surgical site infection rate in abdominal, gynecologic, and breast surgery. Anesthesiology2012;117:504–11. [MEDLINE: PMID: 22790961] ">Thibon 2012</a>) in one or more bias domains, a high fraction of inspired oxygen during anaesthesia and surgery was not associated with risk of surgical site infection in a random‐effects model (RR 0.87, 95% CI 0.64 to 1.18; participants = 3018; studies = 10; I<sup>2</sup> = 47%; <a href="./references#CD008884-fig-0011" title="">Analysis 1.5</a>) and in the fixed‐effect model (RR 0.91, 95% CI 0.74 to 1.11; <a href="./references#CD008884-fig-0012" title="">Analysis 1.6</a>). The test of interaction for a subgroup difference in effect between trials with low risk of bias and those with unclear or high risk of bias was not significant (P value = 0.96; <a href="./references#CD008884-fig-0011" title="">Analysis 1.5</a>). </p> </section> <section id="CD008884-sec-0076"> <h6 class="title">Trial sequential analysis on surgical site infection</h6> <p>In the TSA of a high fraction of inspired oxygen of 60% to 90% versus 30% to 40% on surgical site infection within 14 to 30 days of follow‐up in trials with low risk of bias (RR 0.86, 95% CI 0.63 to 1.17; participants = 4201; studies = 5; I<sup>2</sup> = 60%; <a href="./references#CD008884-fig-0011" title="">Analysis 1.5</a>), the required information size to detect or reject an a priori anticipated intervention effect of 20% RRR in a random‐effects model was estimated to be 18,399 participants using a control event proportion of 12.9% and the diversity of 74% found among included trials (I<sup>2</sup> = 60%; 95% CI 34% to 75%; P value = 0.04). Five trials with 4211 participants provided data on surgical site infection. The conventional boundary for statistical significance was not crossed (P value = 0.33), and the TSMB for benefit was not crossed (RR 0.86, TSA adjusted CI 0.42 to 1.75), suggesting that a high fraction of inspired oxygen was not associated with risk of surgical site infection. </p> <p>TSA (<a href="#CD008884-fig-0006">Figure 6</a>) of a high fraction of inspired oxygen of 60% to 90% versus 30% to 40% oxygen on surgical site infection in all trials of surgical patients within 14 to 30 days of follow‐up shows that the required information size to detect or reject a 20% RRR in a random‐effects model was 13,189 participants using a control event proportion of 12.9% and the 63% diversity found among the included trials (I<sup>2</sup> = 48%; 95% CI 30% to 62%; P value = 0.02). The conventional boundary for statistical significance was not crossed (P value = 0.18), nor was the TSMB for benefit (RR 0.87, 95% CI 0.65 to 1.17). However, in a fixed‐effect model (RR 0.87, TSA adjusted CI 0.77 to 0.998; P value = 0.033), the TSMB for benefit was crossed, suggesting that a high fraction of inspired oxygen may be associated with surgical site infection. </p> <div class="figure" id="CD008884-fig-0006"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 6</div> </div> <hr class="top"/><img alt="Trial sequential analysis (TSA) of high inspiratory supplemental oxygen fraction 60% to 90% vs 30% to 40% in surgical site infection for all trials of surgical participants within 14 to 30 days of follow‐up. The required information size to detect or reject a 20% relative risk reduction in a random‐effects model was estimated at 13,189 participants, using a control event proportion of 12.9% and diversity of 63% among included trials (I2 = 48%; 95% CI 30% to 62%; P value = 0.02). Fifteen trials with 7219 participants provided data on surgical site infection. The conventional boundary for statistical significance was not crossed (P value = 0.18) and the trial sequential monitoring boundary for benefit was not crossed, as the TSA adjusted CI for the risk ratio was as follows: RR 0.87, 95% CI 0.65 to 1.17)." data-id="CD008884-fig-0006" src="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/image_n/nCD008884-AFig-FIG06.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Trial sequential analysis (TSA) of high inspiratory supplemental oxygen fraction 60% to 90% vs 30% to 40% in surgical site infection for all trials of surgical participants within 14 to 30 days of follow‐up. The required information size to detect or reject a 20% relative risk reduction in a random‐effects model was estimated at 13,189 participants, using a control event proportion of 12.9% and diversity of 63% among included trials (I<sup>2</sup> = 48%; 95% CI 30% to 62%; P value = 0.02). Fifteen trials with 7219 participants provided data on surgical site infection. The conventional boundary for statistical significance was not crossed (P value = 0.18) and the trial sequential monitoring boundary for benefit was not crossed, as the TSA adjusted CI for the risk ratio was as follows: RR 0.87, 95% CI 0.65 to 1.17). </p> </div> </div> </div> <p>The information size required to detect or reject an intervention effect suggested by the point estimate of 13% RRR in the random‐effects model of all trials was 34,890. No boundaries were crossed. </p> <p>In the fixed‐effect model (RR 0.87, 95% CI 0.77 to 0.99), assuming absence of heterogeneity, the required information size of 4840 was surpassed and the high inspired oxygen fraction may be associated with a reduction in surgical site infection (RR 0.87, TSA adjusted CI 0.77 to 1.00; participants = 7219; studies = 15; D<sup>2</sup> = 63%). </p> </section> <section id="CD008884-sec-0077"> <h6 class="title">Surgical site infection according to use or no use of nitrous oxide in the control group </h6> <p>In trials with no use of nitrous oxide in the control group, a high fraction of inspired oxygen of 60% to 90% compared with 30% to 40% oxygen used during anaesthesia and surgery was not associated with a change in the risk of surgical site infection (RR 0.88, 95% CI 0.71 to 1.11; <a href="./references#CD008884-fig-0013" title="">Analysis 1.7</a>); in trials with use of nitrous oxide in the control group, supplemental oxygen during anaesthesia and surgery was not associated with a change in the risk of surgical site infection (RR 0.85, 95% CI 0.45 to 1.61; <a href="./references#CD008884-fig-0013" title="">Analysis 1.7</a>) and the test of interaction was not significant (P value = 0.91). Results when a fixed‐effect model was used were not noticeably different. </p> </section> <section id="CD008884-sec-0078"> <h6 class="title">Surgical site infection according to FIO<sub>2</sub> of 80% or higher in the experimental intervention </h6> <p>In trials that used an FIO<sub>2</sub> of 80% or higher in the experimental group compared with 30% to 40% oxygen during anaesthesia and surgery, a high fraction of inspired oxygen was not associated with risk of surgical site infection in a random‐effects model (RR 0.87, 95% CI 0.66 to 1.15; <a href="./references#CD008884-fig-0014" title="">Analysis 1.8</a>). Likewise, in trials that used an FIO<sub>2</sub> between 60% and 80% in the experimental intervention during anaesthesia and surgery, the high fraction of inspired oxygen was not associated with risk of surgical site infection in a random‐effects model (RR 0.81, 95% CI 0.65 to 1.02; <a href="./references#CD008884-fig-0014" title="">Analysis 1.8</a>), and the test of interaction was not significant (P value = 0.71). Results when a fixed‐effect model was used were not noticeably different. </p> </section> <section id="CD008884-sec-0079"> <h6 class="title">Surgical site infection according to use of high FIO<sub>2</sub> during the postoperative recovery period in the experimental intervention group </h6> <p>In trials that used a high FIO<sub>2</sub> during postoperative recovery compared with 30% to 40% oxygen during anaesthesia, surgery and recovery, a high fraction of inspired oxygen was not associated with risk of surgical site infection in a random‐effects model (RR 0.87, 95% CI 0.70 to 1.09; <a href="./references#CD008884-fig-0015" title="">Analysis 1.9</a>). However, in a fixed‐effect model, a high fraction of inspired oxygen during both surgery and postoperative recovery was associated with lower risk of surgical site infection (RR 0.87, 95% CI 0.77 to 0.99). In trials reporting use of a high fraction of inspired oxygen only during surgery, the high fraction of inspired oxygen was not associated with risk of surgical site infection in a random‐effects model (RR 0.88, 95% CI 0.45 to 1.73; <a href="./references#CD008884-fig-0015" title="">Analysis 1.9</a>) nor in a fixed‐effect model (RR 0.87, 95% CI 0.44 to 1.70). However, the test for subgroup differences was not statistically significant (P value = 0.91). </p> </section> <section id="CD008884-sec-0080"> <h6 class="title">Surgical site infection according to type of surgery</h6> <p>In trials including colorectal and abdominal surgical patients, a high FIO<sub>2</sub> compared with 30% to 40% oxygen during anaesthesia and surgery was not associated with risk of surgical site infection (RR 0.74, 95% CI 0.50 to 1.09; <a href="./references#CD008884-fig-0016" title="">Analysis 1.10</a>), but in the fixed‐effect model, a high fraction of inspired oxygen was associated with lower risk of surgical site infection (RR 0.84, 95% CI 0.70 to 0.99). In trials including only patients for caesarean section, a high FIO<sub>2</sub> during anaesthesia and surgery was not associated with risk of surgical site infection in a random‐effects model (RR 1.21, 95% CI 0.91 to 1.60; <a href="./references#CD008884-fig-0016" title="">Analysis 1.10</a>), and the result did not change noticeably in the fixed‐effect model. In trials including only patients for orthopaedic surgery, a high FIO<sub>2</sub> during anaesthesia and surgery was not associated with risk of surgical site infection (RR 0.71, 95% CI 0.37 to 1.34; <a href="./references#CD008884-fig-0016" title="">Analysis 1.10</a>), and the result did not change noticeably in a fixed‐effect model. In the trial including only patients for breast surgery, a high FIO<sub>2</sub> during anaesthesia and surgery was not associated with a change in the risk of surgical site infection (RR 0.33, 95% CI 0.01 to 7.87; <a href="./references#CD008884-fig-0016" title="">Analysis 1.10</a>). Among patients undergoing various types of surgical procedures, use of a high FIO<sub>2</sub> during anaesthesia and surgery was associated with a decrease in the risk of surgical site infection (RR 0.76, 95% CI 0.59 to 0.99; <a href="./references#CD008884-fig-0016" title="">Analysis 1.10</a>), but the test of interaction for a subgroup difference in effect was not statistically significant (P value = 0.10). </p> </section> <section id="CD008884-sec-0081"> <h6 class="title">Surgical site infection according to follow‐up longer or shorter than 14 days</h6> <p>In trials with follow‐up longer than 14 days, a high FIO<sub>2</sub> during postoperative recovery compared with 30% to 40% oxygen used during anaesthesia and surgery was not associated with risk of surgical site infection (RR 0.87, 95% CI 0.72 to 1.05; <a href="./references#CD008884-fig-0017" title="">Analysis 1.11</a>); this association also was not seen in trials with follow‐up of 14 or fewer days (RR 0.84, 95% CI 0.48 to 1.47; <a href="./references#CD008884-fig-0017" title="">Analysis 1.11</a>). The test for a subgroup difference was not statistically significant (P value = 0.91). Use of a fixed‐effect model did not change the results noticeably. </p> </section> <section id="CD008884-sec-0082"> <h6 class="title">Surgical site infection according to preoperative use of antibiotics</h6> <p>In trials with preoperative use of antibiotics, a high FIO<sub>2</sub> compared with 30% to 40% oxygen used during anaesthesia and surgery was associated with risk of surgical site infection in a random‐effects model (RR 0.76, 95% CI 0.60 to 0.97; P value = 0.04; I<sup>2</sup> = 49%; <a href="./references#CD008884-fig-0018" title="">Analysis 1.12</a>), but this association was lacking in trials not reporting or not using preoperative antibiotics (RR 1.20, 95% CI 0.91 to 1.58; P value = 0.21; I<sup>2</sup> = 0; <a href="./references#CD008884-fig-0018" title="">Analysis 1.12</a>). The test for a subgroup difference was statistically significant (P value = 0.02; I<sup>2</sup> = 82.6%). Use of a fixed‐effect model did not change the results noticeably. </p> </section> <section id="CD008884-sec-0083"> <h6 class="title">Surgical site infection according to low risk of bias compared with unclear or high risk of bias of specific bias components </h6> <section id="CD008884-sec-0084"> <p><b>Surgical site infection according to adequate allocation sequence generation</b></p> <p>In trials with adequate allocation sequence generation, an FIO<sub>2</sub> of 60% to 90% compared with 30% to 40% oxygen used during anaesthesia and surgery was not associated with surgical site infection in a random‐effects model (RR 0.89, 95% CI 0.71 to 1.11; <a href="./references#CD008884-fig-0019" title="">Analysis 1.13</a>) nor in trials with unclear or inadequate allocation sequence generation (RR 0.69, 95% CI 0.36 to 1.31; <a href="./references#CD008884-fig-0019" title="">Analysis 1.13</a>). The test for a subgroup difference was not statistically significant (P value = 0.46; I<sup>2</sup> = 0). </p> </section> <section id="CD008884-sec-0085"> <p><b>Surgical site infection according to adequate allocation concealment</b></p> <p>In trials with adequate allocation concealment, an FIO<sub>2</sub> of 60% to 90% compared with 30% to 40% oxygen used during anaesthesia and surgery was not associated with risk of surgical site infection in a random‐effects model (RR 0.85, 95% CI 0.67 to 1.08; <a href="./references#CD008884-fig-0020" title="">Analysis 1.14</a>) nor in trials with unclear or inadequate allocation concealment (RR 0.96, 95% CI 0.66 to 1.40; <a href="./references#CD008884-fig-0020" title="">Analysis 1.14</a>). The test for a subgroup difference was not statistically significant (P value = 0.60; I<sup>2</sup> = 45%). </p> </section> <section id="CD008884-sec-0086"> <p><b>Surgical site infection according to blinding of participants and personnel</b></p> <p>In trials with adequate blinding of participants and personnel, an FIO<sub>2</sub> of 60% to 90% compared with 30% to 40% oxygen used during anaesthesia and surgery was not associated with risk of surgical site infection in a random‐effects model (RR 0.79, 95% CI 0.61 to 1.03; <a href="./references#CD008884-fig-0021" title="">Analysis 1.15</a>) nor in trials with unclear or inadequate blinding of participants and personnel (RR 0.98, 95% CI 0.70 to 1.37; <a href="./references#CD008884-fig-0021" title="">Analysis 1.15</a>). The test for a subgroup difference was not statistically significant (P value = 0.33; I<sup>2</sup> = 0). </p> </section> <section id="CD008884-sec-0087"> <p><b>Surgical site infection according to blinding of outcome assessors</b></p> <p>In trials with adequate blinding of outcome assessors, an FiO<sub>2</sub> of 60% to 90% compared with 30% to 40% oxygen used during anaesthesia and surgery was associated with a decrease in risk of surgical site infection in a random‐effects model (RR 0.79, 95% CI 0.66 to 0.96; <a href="./references#CD008884-fig-0022" title="">Analysis 1.16</a>), but in trials with unclear or inadequate blinding of outcome assessors, a high oxygen fraction was associated with an increase in the risk of surgical site infection (RR 1.57, 95% CI 1.04 to 2.37; <a href="./references#CD008884-fig-0022" title="">Analysis 1.16</a>). The test for a subgroup difference was statistically significant (P value = 0.003; I<sup>2</sup> = 48%). </p> </section> <section id="CD008884-sec-0088"> <p><b>Surgical site infection according to completeness of outcome data</b></p> <p>In trials with adequate completeness of outcome data, an FIO<sub>2</sub> of 60% to 90% compared with 30% to 40% oxygen used during anaesthesia and surgery was not associated with risk of surgical site infection in a random‐effects model (RR 0.89, 95% CI 0.71 to 1.11; <a href="./references#CD008884-fig-0023" title="">Analysis 1.17</a>) nor in trials with unclear or inadequate completeness of outcome data (RR 0.77, 95% CI 0.41 to 1.43; <a href="./references#CD008884-fig-0023" title="">Analysis 1.17</a>). The test for subgroup differences was not statistically significant (P value = 0.67; I<sup>2</sup> = 0). </p> </section> <section id="CD008884-sec-0089"> <p><b>Surgical site infection according to adequate outcome reporting</b></p> <p>Six trials (<a href="./references#CD008884-bbs2-0001" title="BeldaFJ , AguileraL , García de la AsunciónJ , AlbertiJ , VicenteR , FerrándizL , et al. Spanish Reduccion de la Tasa de Infeccion Quirurgica Group. Supplemental perioperative oxygen and the risk of surgical wound infection: a randomized controlled trial. JAMA2005;294(16):2035‐42. [PUBMED: 16249417] ">Belda 2005</a>; <a href="./references#CD008884-bbs2-0010" title="GreifR , AkçaO , HornEP , KurzA , SesslerDI , Outcomes Research Group. Supplemental perioperative oxygen to reduce the incidence of surgical‐wound infection. New England Journal of Medicine2000;342(3):161‐7. [PUBMED: 10639541] ">Greif 2000</a>; <a href="./references#CD008884-bbs2-0016" title="MeyhoffCS , WetterslevJ , JorgensenLN , HennebergSW , HøgdallC , LundvallL , et al. PROXI Trial Group. Effect of high perioperative oxygen fraction on surgical site infection and pulmonary complications after abdominal surgery: the PROXI randomized clinical trial. JAMA2009;302(14):1543‐50. [PUBMED: 19826023] ">Meyhoff 2009</a>; <a href="./references#CD008884-bbs2-0017" title="MylesPS , LeslieK , ChanMT , ForbesA , PaechMJ , PeytonP , et al. ENIGMA Trial Group. Avoidance of nitrous oxide for patients undergoing major surgery: a randomized controlled trial. Anesthesiology2007;107(2):221‐31. [PUBMED: 17667565] ">Myles 2007</a>; <a href="./references#CD008884-bbs2-0018" title="PryorKO , FaheyTJ3rd , LienCA , GoldsteinPA . Surgical site infection and the routine use of perioperative hyperoxia in a general surgical population: a randomized controlled trial. JAMA2004;291(1):79‐87. [PUBMED: 14709579] ">Pryor 2004</a>; <a href="./references#CD008884-bbs2-0021" title="SchietromaM , CeciliaEM , CarleiF , SistaF , DeSantisG , PiccioneF , et al. Prevention of anastomotic leakage after total gastrectomy with perioperative supplemental oxygen administration: a prospective randomized, double blind, controlled, single‐center trial. Annals of Surgical Oncology2013;20(5):584‐90. [DOI: 10.1245/s10434‐012‐2714‐7; PUBMED: 23099730] ">Schietroma 2013</a>) reported adequately on all‐cause mortality within a follow‐up ranging from 14 days to a median of 3.9 years. Sixteen trials reported adequately on their predefined outcome of surgical site infection (RR 0.87, 95% CI 0.71 to 1.07; participants = 7264; studies = 16; I<sup>2</sup> = 48%; <a href="./references#CD008884-fig-0024" title="">Analysis 1.18</a>), whereas one trial (<a href="./references#CD008884-bbs2-0005" title="García‐BotelloSA , García‐GraneroE , LilloR , López‐MozosF , MillánM , LledóS . Randomized clinical trial to evaluate the effects of perioperative supplemental oxygen administration on the colorectal anastomosis. British Journal of Surgery2006;93(6):698‐706. [MEDLINE: 16703624] ">García‐Botello 2006</a>) reported only on pH<sub>i</sub>, CO<sub>2</sub> and anastomotic dehiscence within seven days ‐ not on surgical site infections. Nine trials (<a href="./references#CD008884-bbs2-0002" title="BhatnagarS , MishraS , GuptaM , SinghalAK , MandalAS . Effects of different concentrations of intraoperative supplemental oxygen on post‐operative nausea and vomiting (PONV) in patients undergoing modified radical mastectomy. Internet Journal of Anesthesiology2005;9(12):1‐6. ">Bhatnagar 2005</a>; <a href="./references#CD008884-bbs2-0011" title="JorisJL , PothNJ , DjamadarAM , SesslerDI , HamoirEE , DefêchereuxTR , et al. Supplemental oxygen does not reduce postoperative nausea and vomiting after thyroidectomy. British Journal of Anaesthesia2003;91(6):857‐61. [PUBMED: 14633758 ] ">Joris 2003</a>; <a href="./references#CD008884-bbs2-0012" title="KotaniN , HashimotoH , SesslerDI , MuraokaM , HashibaE , KubotaT , et al. Supplemental intraoperative oxygen augments antimicrobial and proinflammatory responses of alveolar macrophages. Anesthesiology2000;93(1):15‐25. [PUBMED: 10861141] ">Kotani 2000</a>; <a href="./references#CD008884-bbs2-0013" title="MackintoshN , GertschMC , HopfHW , PaceNL , WhiteJ , MorrisR , et al. High intraoperative inspired oxygen does not increase postoperative supplemental oxygen requirements. Anesthesiology2012;117(2):271‐9. [MEDLINE: 22569132] ">Mackintosh 2012</a>; <a href="./references#CD008884-bbs2-0015" title="McKeenDM , ArellanoR , O'ConnellC . Supplemental oxygen does not prevent postoperative nausea and vomiting after gynecological laparoscopy. Canadian Journal of Anaesthesia2009;56(9):651‐7. [DOI: 10.1007/s12630‐009‐9136‐4] ">McKeen 2009</a>; <a href="./references#CD008884-bbs2-0019" title="PurhonenS , TurunenM , RuohoahoUM , NiskanenM , HynynenM . Supplemental oxygen does not reduce the incidence of postoperative nausea and vomiting after ambulatory gynecologic laparoscopy. Anesthesia and Analgesia2003;96(1):91‐6. [PUBMED: 12505931] ">Purhonen 2003</a>; <a href="./references#CD008884-bbs2-0020" title="PurhonenS , NiskanenM , WüstefeldM , HirvonenE , HynynenM . Supplemental 80% oxygen does not attenuate post‐operative nausea and vomiting after breast surgery. Acta Anaesthesiologica Scandinavica2006;50(1):26‐31. [PUBMED: 16451147] ">Purhonen 2006</a>; <a href="./references#CD008884-bbs2-0023" title="ŠimurinaT , MraovićB , MikulandraS , SonickiZ , SulenN , DukićB , et al. Effects of high intraoperative inspired oxygen on postoperative nausea and vomiting in gynecologic laparoscopic surgery. Journal of Clinical Anesthesia2010;22(7):492‐8. [DOI: 10.1016/j.jclinane.2009.10.013] ">Simurina 2010</a>; <a href="./references#CD008884-bbs2-0028" title="ZorembaM , DetteF , HuneckeT , BrauneckerS , WulfH . The influence of perioperative oxygen concentration on postoperative lung function in moderately obese adults. European Journal of Anaesthesiology2010;27(6):501‐7. [MEDLINE: 19550338] ">Zoremba 2010</a>) did not report any of the outcomes chosen for this review. </p> </section> <section id="CD008884-sec-0090"> <p><b>Surgical site infection according to the presence of other bias</b></p> <p>In trials with no presence of other bias risk, an FIO<sub>2</sub> of 60% to 90% compared with 30 to 40% oxygen used during anaesthesia and surgery was not associated with risk of surgical site infection in a random‐effects model (RR 0.89, 95% CI 0.71 to 1.13; <a href="./references#CD008884-fig-0025" title="">Analysis 1.19</a> ), nor in trials with the presence of unclear or other bias (RR 0.72, 95% CI 0.48 to 1.07; <a href="./references#CD008884-fig-0025" title="">Analysis 1.19</a>). The test for subgroup differences was not statistically significant (P value = 0.36; I<sup>2</sup> = 48%). </p> </section> </section> <section id="CD008884-sec-0091"> <h6 class="title">Surgical site infection in best/worst compared with worst/best case scenarios of participants lost to follow‐up </h6> <p>The best/worst case scenario (<a href="./references#CD008884-fig-0026" title="">Analysis 1.20</a>): Assuming that all participants lost to follow‐up in the group randomly assigned to a high fraction of inspired oxygen did not develop a surgical site infection, and that all participants lost to follow‐up in the group randomly assigned to 30% to 40% inspired oxygen developed a surgical site infection, the intervention effect was as follows: RR 0.71, 95% CI 0.54 to 0.93. </p> <p>The worst/best case scenario (<a href="./references#CD008884-fig-0027" title="">Analysis 1.21</a>): Assuming that all participants lost to follow‐up in the group randomly assigned to a high fraction of inspired oxygen developed a surgical site infection, and that all participants lost to follow‐up in the group randomly assigned to 30% to 40% oxygen did not develop a surgical site infection, the intervention effect was as follows: RR 1.05, 95% CI 0.78 to 1.42. </p> </section> </section> <section id="CD008884-sec-0092"> <h5 class="title">Sensitivity analyses</h5> <p>Assessment of the benefits and harms of high FIO<sub>2</sub> performed by conducting a continuity adjustment of trials with zero events did not change the results, as very few of the trials included in meta‐analyses had a zero event. </p> <p>Excluding the largest trial did change the point estimate of all‐cause mortality (RR 0.61, 95% CI 0.26 to 1.41) but was not associated with a statistically significant intervention effect and did not change the effect on surgical site infection (RR 0.89, 95% CI 0.70 to 1.12). </p> <p>Excluding the smallest trial did not change our results substantially regarding all‐cause mortality (RR 1.07, 95% CI 0.86 to 1.35) nor surgical site infection (RR 0.88, 95% CI 0.71 to 1.08). </p> <p>Excluding data from trials published only as abstracts and from trials with commercial involvement did not change the results for all‐cause mortality (RR 1.07, 95% CI 0.87, 1.33) and surgical site infection (RR 0.89, 95% CI 0.71 to 1.13). </p> </section> </section> <section id="CD008884-sec-0093"> <h4 class="title">Secondary outcomes</h4> <section id="CD008884-sec-0094"> <h5 class="title">1. All‐cause mortality within 30 days of follow‐up</h5> <p>Overall, in all trials a high fraction of inspired oxygen of 60% to 90% compared with 30% to 40% oxygen used during anaesthesia and surgery was not associated with all‐cause mortality within 30 days of follow‐up in a model using the Peto odds ratio (POR 0.83, 95% CI 0.54 to 1.29; P value = 0.41; I<sup>2</sup> = 60%; 4229 participants; six trials; <a href="./references#CD008884-fig-0010" title="">Analysis 1.4</a>). </p> <section id="CD008884-sec-0095"> <h6 class="title">All‐cause mortality within 30 days of follow‐up according to overall risk of bias in the included trials </h6> <p>Within 30 days of follow‐upIn trials with overall low risk of bias (<a href="./references#CD008884-bbs2-0010" title="GreifR , AkçaO , HornEP , KurzA , SesslerDI , Outcomes Research Group. Supplemental perioperative oxygen to reduce the incidence of surgical‐wound infection. New England Journal of Medicine2000;342(3):161‐7. [PUBMED: 10639541] ">Greif 2000</a>; <a href="./references#CD008884-bbs2-0016" title="MeyhoffCS , WetterslevJ , JorgensenLN , HennebergSW , HøgdallC , LundvallL , et al. PROXI Trial Group. Effect of high perioperative oxygen fraction on surgical site infection and pulmonary complications after abdominal surgery: the PROXI randomized clinical trial. JAMA2009;302(14):1543‐50. [PUBMED: 19826023] ">Meyhoff 2009</a>; <a href="./references#CD008884-bbs2-0017" title="MylesPS , LeslieK , ChanMT , ForbesA , PaechMJ , PeytonP , et al. ENIGMA Trial Group. Avoidance of nitrous oxide for patients undergoing major surgery: a randomized controlled trial. Anesthesiology2007;107(2):221‐31. [PUBMED: 17667565] ">Myles 2007</a>; <a href="./references#CD008884-bbs2-0027" title="WilliamsN , GloverM , CrispC , ActonA , McKennaD . Randomized controlled trial of the effect of 30% versus 80% fraction of inspired oxygen on caesarean delivery surgical site infection. American Journal of Perinatology2013;30(9):781‐6. [DOI: 10.1055/s‐0032‐1333405] ">Williams 2013</a>), an FIO<sub>2</sub> of 60% to 90% compared with 30% to 40% oxygen used during anaesthesia and surgery was not associated with mortality within 30 days of follow‐up (POR 0.99, 95% CI 0.61 to 1.60; participants = 4058; trials = 4; I<sup>2</sup> = 77%; <a href="./references#CD008884-fig-0010" title="">Analysis 1.4</a>). In trials with overall high or unclear risk of bias (<a href="./references#CD008884-bbs2-0001" title="BeldaFJ , AguileraL , García de la AsunciónJ , AlbertiJ , VicenteR , FerrándizL , et al. Spanish Reduccion de la Tasa de Infeccion Quirurgica Group. Supplemental perioperative oxygen and the risk of surgical wound infection: a randomized controlled trial. JAMA2005;294(16):2035‐42. [PUBMED: 16249417] ">Belda 2005</a>; <a href="./references#CD008884-bbs2-0018" title="PryorKO , FaheyTJ3rd , LienCA , GoldsteinPA . Surgical site infection and the routine use of perioperative hyperoxia in a general surgical population: a randomized controlled trial. JAMA2004;291(1):79‐87. [PUBMED: 14709579] ">Pryor 2004</a>; <a href="./references#CD008884-bbs2-0021" title="SchietromaM , CeciliaEM , CarleiF , SistaF , DeSantisG , PiccioneF , et al. Prevention of anastomotic leakage after total gastrectomy with perioperative supplemental oxygen administration: a prospective randomized, double blind, controlled, single‐center trial. Annals of Surgical Oncology2013;20(5):584‐90. [DOI: 10.1245/s10434‐012‐2714‐7; PUBMED: 23099730] ">Schietroma 2013</a>; <a href="./references#CD008884-bbs2-0024" title="StallA , ParyaviE , GuptaR , ZadnikM , HuiE , O’TooleRV . Perioperative supplemental oxygen to reduce surgical site infection after open fixation of high‐risk fractures: a randomized controlled pilot trial. The Journal of Trauma and Acute Care Surgery2013;75(4):657‐63. [DOI: 10.1097/TA.0b0113e3182a1fe83] ">Stall 2013</a>), a high fraction of oxygen during anaesthesia and surgery was not associated with all‐cause mortality within 30 days of follow‐up in a random‐effects model (POR 0.37, 95% CI 0.13 to 1.05; participants = 860; trials = 4; I<sup>2</sup> = 0%; <a href="./references#CD008884-fig-0010" title="">Analysis 1.4</a> ). The test of interaction for a subgroup difference was not statistically significant (P value = 0.09; I<sup>2</sup> = 64.7%). </p> </section> </section> <section id="CD008884-sec-0096"> <h5 class="title">2. Respiratory insufficiency</h5> <p>Respiratory insufficiency, defined as the need for respiratory assistance through ventilator therapy or non‐invasive ventilation within the longest follow‐up period, was explicitly reported in only three trials (<a href="./references#CD008884-bbs2-0012" title="KotaniN , HashimotoH , SesslerDI , MuraokaM , HashibaE , KubotaT , et al. Supplemental intraoperative oxygen augments antimicrobial and proinflammatory responses of alveolar macrophages. Anesthesiology2000;93(1):15‐25. [PUBMED: 10861141] ">Kotani 2000</a>; <a href="./references#CD008884-bbs2-0016" title="MeyhoffCS , WetterslevJ , JorgensenLN , HennebergSW , HøgdallC , LundvallL , et al. PROXI Trial Group. Effect of high perioperative oxygen fraction on surgical site infection and pulmonary complications after abdominal surgery: the PROXI randomized clinical trial. JAMA2009;302(14):1543‐50. [PUBMED: 19826023] ">Meyhoff 2009</a>; <a href="./references#CD008884-bbs2-0028" title="ZorembaM , DetteF , HuneckeT , BrauneckerS , WulfH . The influence of perioperative oxygen concentration on postoperative lung function in moderately obese adults. European Journal of Anaesthesiology2010;27(6):501‐7. [MEDLINE: 19550338] ">Zoremba 2010</a>) and could not be meta‐analysed, as two trials (<a href="./references#CD008884-bbs2-0012" title="KotaniN , HashimotoH , SesslerDI , MuraokaM , HashibaE , KubotaT , et al. Supplemental intraoperative oxygen augments antimicrobial and proinflammatory responses of alveolar macrophages. Anesthesiology2000;93(1):15‐25. [PUBMED: 10861141] ">Kotani 2000</a>; <a href="./references#CD008884-bbs2-0028" title="ZorembaM , DetteF , HuneckeT , BrauneckerS , WulfH . The influence of perioperative oxygen concentration on postoperative lung function in moderately obese adults. European Journal of Anaesthesiology2010;27(6):501‐7. [MEDLINE: 19550338] ">Zoremba 2010</a>) reported no events during 24 hours of observation; however, in the other trial (<a href="./references#CD008884-bbs2-0016" title="MeyhoffCS , WetterslevJ , JorgensenLN , HennebergSW , HøgdallC , LundvallL , et al. PROXI Trial Group. Effect of high perioperative oxygen fraction on surgical site infection and pulmonary complications after abdominal surgery: the PROXI randomized clinical trial. JAMA2009;302(14):1543‐50. [PUBMED: 19826023] ">Meyhoff 2009</a>), a high fraction of inspired FIO<sub>2</sub> was not statistically significantly associated with respiratory insufficiency (RR 1.25, 95% CI 0.79 to 1.99; <a href="./references#CD008884-fig-0028" title="">Analysis 1.22</a>). </p> </section> <section id="CD008884-sec-0097"> <h5 class="title">3. Serious adverse events (SAEs)</h5> <p>An SAE, defined (<a href="./references#CD008884-bbs2-0077" title="European Parliament and the Council of the European Union. Directive 2001/20/EC of the European Parliament and of the Council of 4 April 2001 on the approximation of the laws, regulations and administrative provisions of the Member States relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use. Official Journal of the European Union http://eur‐lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2001:121:0034:0044:EN:PDF2001; Vol. L 121:34‐44. ">Directive 2001</a>) as "any event that led to death, was life‐threatening, required in‐patient hospitalisation or prolongation of existing hospitalisation, resulted in persistent or significant disability, and any important medical event which might jeopardise the patient or required intervention to prevent it", was reported in only three trials (<a href="./references#CD008884-bbs2-0016" title="MeyhoffCS , WetterslevJ , JorgensenLN , HennebergSW , HøgdallC , LundvallL , et al. PROXI Trial Group. Effect of high perioperative oxygen fraction on surgical site infection and pulmonary complications after abdominal surgery: the PROXI randomized clinical trial. JAMA2009;302(14):1543‐50. [PUBMED: 19826023] ">Meyhoff 2009</a>; <a href="./references#CD008884-bbs2-0017" title="MylesPS , LeslieK , ChanMT , ForbesA , PaechMJ , PeytonP , et al. ENIGMA Trial Group. Avoidance of nitrous oxide for patients undergoing major surgery: a randomized controlled trial. Anesthesiology2007;107(2):221‐31. [PUBMED: 17667565] ">Myles 2007</a>; <a href="./references#CD008884-bbs2-0018" title="PryorKO , FaheyTJ3rd , LienCA , GoldsteinPA . Surgical site infection and the routine use of perioperative hyperoxia in a general surgical population: a randomized controlled trial. JAMA2004;291(1):79‐87. [PUBMED: 14709579] ">Pryor 2004</a>). A high FIO<sub>2</sub> compared with 30% to 40% oxygen used during anaesthesia and surgery was not associated with the proportion of SAEs in a random‐effects model (RR 0.96, 95% CI 0.65 to 1.43; <a href="./references#CD008884-fig-0029" title="">Analysis 1.23</a>). In trials with overall low risk of bias, a high FIO<sub>2</sub> compared with 30% to 40% oxygen used during anaesthesia and surgery was not associated with risk of an SAE in a random‐effects model (RR 0.91, 95% CI 0.63 to 1.31; <a href="./references#CD008884-fig-0029" title="">Analysis 1.23</a>) nor in trials with high risk of bias in a random‐effects model (RR 5.00, 95% CI 0.60 to 41.85; <a href="./references#CD008884-fig-0029" title="">Analysis 1.23</a>), and the test for subgroup differences was not statistically significant (P value = 0.12). </p> </section> <section id="CD008884-sec-0098"> <h5 class="title">4. Duration of postoperative hospitalizations</h5> <p>Overall, in all trials, supplemental oxygen with an FIO<sub>2</sub> 60% to 90% compared with 30% to 40% oxygen used during anaesthesia and surgery was not associated with LOS in days in a random‐effects model (MD ‐0.06, 95% CI ‐0.44 to 0.32; P value = 0.77; I<sup>2</sup> = 62%; 4702 participants; nine trials; <a href="./references#CD008884-fig-0030" title="">Analysis 1.24</a>). </p> </section> <section id="CD008884-sec-0099"> <h5 class="title">Duration of postoperative hospitalization according to overall risk of bias</h5> <p>In trials with an overall low risk of bias, an FIO<sub>2</sub> of 60% to 90% compared with 30% to 40% oxygen used during anaesthesia and surgery was not associated with LOS in a random‐effects model (MD ‐0.13 days, 95% CI ‐0.49 to 0.24; participants = 4041; studies = 4; I<sup>2</sup> = 41%; <a href="./references#CD008884-fig-0030" title="">Analysis 1.24</a>) nor in trials with overall high or unclear risk of bias (MD 0.69 days, 95% CI ‐0.82 to 2.20; participants = 661; studies = 5; I<sup>2</sup> = 80%; <a href="./references#CD008884-fig-0030" title="">Analysis 1.24</a>). The test for subgroup differences was not significant (P value = 0.30; I<sup>2</sup> = 6.6%). </p> </section> <section id="CD008884-sec-0100"> <h5 class="title">5. Quality of life</h5> <p>Quality of life was not reported in any of the articles reporting trial results. However, we obtained data on Short Form (SF)‐36 from the Grief et al trial (<a href="./references#CD008884-bbs2-0009" title="GreifR , LacinyS , RapfB , HickleRS , SesslerDI . Supplemental oxygen reduces the incidence of postoperative nausea and vomiting. Anesthesiology1999;91(5):1246‐52. ">Greif 1999</a>) through Daniel Sessler, who was a co‐author of this trial report. Accordingly, no meta‐analysis could be performed for this outcome, but the trial reporting this outcome did not show an association between a high fraction of inspired oxygen and 30% to 40% oxygen and quality of life, as SF‐36 scores on the various domains were as follows. </p> <p> <div class="table" id="CD008884-tblf-0001"> <table> <div class="table-heading"><span class="table-title"></span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>SF‐36 domain</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>80% oxygen</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>30% oxygen</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Physical functioning</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>61 ± 31</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>67 ± 29</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Role physical</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>78 ± 34</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>79 ± 37</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Role emotional</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>84 ± 32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>84 ± 33</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Vitality</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>60 ± 16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>61 ± 20</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Bodily pain</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>72 ± 27</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>74 ± 29</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>General health</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>72 ± 20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>79 ± 31</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Social functioning</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>84 ± 21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>80 ± 25</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mental health</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>72 ± 18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>70 ± 20</p> </td> </tr> </tbody> </table> </div> </p> </section> <section id="CD008884-sec-0101"> <h5 class="title">Meta‐regression</h5> <p>Univariate meta‐regression did not show an association between the intervention effect, Log(RR), of a high inspired fraction of oxygen and the mean age of included trial populations (MD ‐0.007 years, 95% CI ‐0.016 to 0.0023 years; P value = 0.14). However, meta‐regression of characteristics on the trial level may reveal both false‐positive and false‐negative results, and may not be applicable for the inference of the impact of age on the effect of a high inspired fraction of oxygen on outcomes at the patient level. </p> <p>As information was lacking for most trials, we were not able to perform meta‐regression analyses of the intervention effect of a high inspired fraction of oxygen on mean BMI of the trial population at baseline; the fraction of diabetic patients in the trial population at baseline; the fraction of smokers in the trial population at baseline; and the fraction of patients with a contaminated or dirty infected surgical field during surgery. </p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD008884-sec-0102" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD008884-sec-0102"></div> <section id="CD008884-sec-0103"> <h3 class="title" id="CD008884-sec-0103">Summary of main results</h3> <p>Our systematic review reveals several important findings. Analysis of the eight trials reporting on mortality suggests that no statistically significant association can be found between postoperative mortality and a high fraction of inspired oxygen (FIO<sub>2</sub>) during anaesthesia, surgery and recovery when we disregard risks of bias. Meta‐analysis of the four trials with low risk of bias in all bias domains (<a href="./references#CD008884-fig-0007" title="">Analysis 1.1</a>) did not show a statistically significant association between a high inspired fraction of oxygen and mortality (risk ratio (RR) 1.12, 95% confidence interval (CI) 0.93 to 1.36). Follow‐up was within 30 days in the trial of Greif et al (<a href="./references#CD008884-bbs2-0010" title="GreifR , AkçaO , HornEP , KurzA , SesslerDI , Outcomes Research Group. Supplemental perioperative oxygen to reduce the incidence of surgical‐wound infection. New England Journal of Medicine2000;342(3):161‐7. [PUBMED: 10639541] ">Greif 2000</a>), and median time of follow‐up was longer than three years in two trials (<a href="./references#CD008884-bbs2-0111" title="MeyhoffCS , JorgensenLN , WetterslevJ , ChristensenKB , RasmussenLS , PROXI Trial Group. Increased long‐term mortality after a high perioperative inspiratory oxygen fraction during abdominal surgery: follow‐up of a randomized clinical trial. Anesthesia and Analgesia2012;115(4):849‐54. [PUBMED: 22798533] ">Meyhoff 2012</a>; <a href="./references#CD008884-bbs2-0017" title="MylesPS , LeslieK , ChanMT , ForbesA , PaechMJ , PeytonP , et al. ENIGMA Trial Group. Avoidance of nitrous oxide for patients undergoing major surgery: a randomized controlled trial. Anesthesiology2007;107(2):221‐31. [PUBMED: 17667565] ">Myles 2007</a>). <a href="./references#CD008884-bbs2-0016" title="MeyhoffCS , WetterslevJ , JorgensenLN , HennebergSW , HøgdallC , LundvallL , et al. PROXI Trial Group. Effect of high perioperative oxygen fraction on surgical site infection and pulmonary complications after abdominal surgery: the PROXI randomized clinical trial. JAMA2009;302(14):1543‐50. [PUBMED: 19826023] ">Meyhoff 2009</a> reported a statistically significant increase in all‐cause mortality in the high inspiratory oxygen group within one year and within long‐term follow‐up with a median of 3.9 years (<a href="./references#CD008884-bbs2-0112" title="MeyhoffCS , JorgensenLN , WetterslevJ , SiersmaVD , RasmussenLS , PROXI Trial Group. Risk of new or recurrent cancer after a high perioperative inspiratory oxygen fraction during abdominal surgery. British Journal of Anaesthesia2014;2:1‐8. [PUBMED: 24860156] ">Meyhoff 2014</a>). During long‐term follow‐up of the <a href="./references#CD008884-bbs2-0017" title="MylesPS , LeslieK , ChanMT , ForbesA , PaechMJ , PeytonP , et al. ENIGMA Trial Group. Avoidance of nitrous oxide for patients undergoing major surgery: a randomized controlled trial. Anesthesiology2007;107(2):221‐31. [PUBMED: 17667565] ">Myles 2007</a> trial, Leslie et al (<a href="./references#CD008884-bbs2-0108" title="LeslieK , MylesPS , ChanMTV , ForbesA , PaechMJ , PeytonP , et al. Nitrous oxide and long‐term morbidity and mortality in the ENIGMA trial. Anesthesia and Analgesia2011;112(2):387–93. [PUBMED: 20861416] ">Leslie 2011</a>) reported no statistically significant differences in all‐cause mortality within a median follow‐up of 3.5 years. However, <a href="./references#CD008884-bbs2-0016" title="MeyhoffCS , WetterslevJ , JorgensenLN , HennebergSW , HøgdallC , LundvallL , et al. PROXI Trial Group. Effect of high perioperative oxygen fraction on surgical site infection and pulmonary complications after abdominal surgery: the PROXI randomized clinical trial. JAMA2009;302(14):1543‐50. [PUBMED: 19826023] ">Meyhoff 2009</a> and <a href="./references#CD008884-bbs2-0010" title="GreifR , AkçaO , HornEP , KurzA , SesslerDI , Outcomes Research Group. Supplemental perioperative oxygen to reduce the incidence of surgical‐wound infection. New England Journal of Medicine2000;342(3):161‐7. [PUBMED: 10639541] ">Greif 2000</a> did not use nitrous oxide in the control group, and these trials were specifically designed to investigate the effects of 80% oxygen versus 30% oxygen during surgery and recovery; <a href="./references#CD008884-bbs2-0017" title="MylesPS , LeslieK , ChanMT , ForbesA , PaechMJ , PeytonP , et al. ENIGMA Trial Group. Avoidance of nitrous oxide for patients undergoing major surgery: a randomized controlled trial. Anesthesiology2007;107(2):221‐31. [PUBMED: 17667565] ">Myles 2007</a> used nitrous oxide in the control group and the trial was actually designed to investigate the effects of nitrous oxide versus oxygen on mortality, surgical site infection and adverse events. In the group of trials with unclear or high risk of bias, which reported only mortality within 30 days of follow‐up (RR 0.43, 95% CI 0.15 to 1.20), no association was found between a high inspired fraction of oxygen and mortality in a random‐effects model, and the test for subgroup differences between trials with low and high or unclear risk of bias was not statistically significant (P value = 0.07; I<sup>2</sup> = 69.5%). A fixed‐effect meta‐analysis does not noticeably change the results. The required information size to detect or reject a relative risk increase (RRI) of 35% is surpassed, and we can refute such an intervention effect. However, trial sequential analysis (TSA) (<a href="./full#CD008884-fig-0002">Figure 2</a>; <a href="./full#CD008884-fig-0003">Figure 3</a>) showed that only 36% of the diversity‐adjusted required information size has been accrued to detect or reject an RRI of 20% in a random‐effects model. The effect of a high fraction of inspiratory oxygen during surgical and recovery periods of 20% RRI or relative risk reduction (RRR) on mortality may be noted when further data arrive. The TSA of the four trials with low risk of bias (<a href="./full#CD008884-fig-0001">Figure 1</a>) indicates that an RRI or RRR of 20% cannot be refuted in the light of sparse data and repetitive updating of the cumulative meta‐analysis. However, the estimate of the intervention effect is likely to change when future trial data become available and are added to the cumulative meta‐analysis. A post hoc analysis (POR 0.83, 95% CI 0.54 to 1.29; <a href="./references#CD008884-fig-0010" title="">Analysis 1.4</a>) showed that the effect of a high fraction of inspired oxygen versus routine use of oxygen was not statistically significantly associated with all‐cause mortality within 30 days of follow‐up; however, the required information size was far from reached, and effect as well as lack of effect cannot be excluded. </p> <p>Overall, in 15 trials, an FIO<sub>2</sub> of 60% to 90% compared with 30% to 40% oxygen used during anaesthesia and surgery was not associated with risk of surgical site infection in a random‐effects model (RR 0.87, 95% CI 0.71 to 1.07; <a href="./references#CD008884-fig-0011" title="">Analysis 1.5</a>), but in a fixed‐effect model (RR 0.87, 95% CI 0.77 to 0.99; <a href="./references#CD008884-fig-0012" title="">Analysis 1.6</a>), a high FIO<sub>2</sub> compared with routine use of oxygen seemed to be associated with reduced risk of surgical site infection. Given the substantial clinical and statistical heterogeneity among all trials with I<sup>2</sup> of 60%, and among trials with low risk of bias with I<sup>2</sup> of 47%, a fixed‐effect model seems to lack robustness. Even though the point estimate (RR 0.87) of the intervention effect is the same in both models, a considerably wider confidence interval is seen in the random‐effects model compared with the fixed‐effect model. In the subgroup analysis of trials with overall low risk of bias compared with trials with unclear or high risk of bias, the intervention with high inspiratory oxygen was not associated with surgical site infection in any of the groups, and the test for subgroup differences was not statistically significant (P value = 0.96); however, heterogeneity was substantial in both groups. TSA (<a href="./full#CD008884-fig-0003">Figure 3</a>), using a random‐effects model, showed that only 55% of the required information size of 13,189 randomly assigned participants has been reached so far, and neither the conventional boundary (P value = 0.05) nor the trial sequential monitoring boundaries for benefit, harm and futility have been crossed. </p> <p>In the subgroup analysis of trials using adequate blinding of outcome assessment, use of a high FIO<sub>2</sub> compared with routine use of oxygen during anaesthesia and surgery was associated with risk of surgical site infection in both fixed‐effect and random‐effects models, and the test for subgroup differences between trials with adequate blinding of outcome assessment and trials with unclear or inadequate blinding of outcome assessment was statistically significant (P value = 0.003). However, many of the trials using adequate blinding in outcome assessment had other types of unclear or high risk of bias, and the estimate of the intervention effect is likely to change if further trials with adequate blinding are included. The information size required to detect or reject an intervention effect of 20% on surgical site infection has not been reached. </p> <p>In the subgroup of eight trials with colorectal or abdominal surgery, use of a high FIO<sub>2</sub> compared with routine use of oxygen during anaesthesia and surgery was not associated with risk of surgical site infection in a random‐effects model, and the test for subgroup differences was not statistically significant (P value = 0.10). In a fixed‐effect model, the high inspiratory oxygen fraction was associated with a decrease in surgical site infection (P value = 0.04), but the fixed‐effect model seems inappropriate in the light of substantial clinical and statistical heterogeneity between trials included in this analysis (I² = 64%; P value = 0.010). Further, several trials had unclear or high risk of bias, and the information size required to detect or reject an RRR of 20% is far from being reached. </p> <p>In the subgroup of trials including various types of surgery (<a href="./references#CD008884-bbs2-0017" title="MylesPS , LeslieK , ChanMT , ForbesA , PaechMJ , PeytonP , et al. ENIGMA Trial Group. Avoidance of nitrous oxide for patients undergoing major surgery: a randomized controlled trial. Anesthesiology2007;107(2):221‐31. [PUBMED: 17667565] ">Myles 2007</a>; <a href="./references#CD008884-bbs2-0025" title="ThibonP , BorgeyF , BoutreuxS , HanouzJ‐L , LeCoutourX , ParientiJ‐J . Effect of perioperative oxygen supplementation on 30‐day surgical site infection rate in abdominal, gynecologic, and breast surgery. Anesthesiology2012;117:504–11. [MEDLINE: PMID: 22790961] ">Thibon 2012</a>), use of a high FIO<sub>2</sub> compared with routine use of oxygen was associated with risk of surgical site infection in both fixed‐effect and random‐effects models, but the test for subgroup differences was not statistically significant (P value = 0.10). </p> <p>In the post hoc subgroup analysis of trials using antibiotics administered before surgery commenced, use of a high FIO<sub>2</sub> compared with routine use of oxygen was associated with risk of surgical site infection in both fixed‐effect and random‐effects models, and the test for subgroup differences between trials with preoperative use of antibiotics and trials not using preoperative antibiotics (or lack of reporting) was statistically significant (P value = 0.03). However, only two of the trials using preoperative antibiotics had overall low risk of bias in all bias domains, and in these trials a high FIO<sub>2</sub> compared with routine use of oxygen was not associated with a change in the risk of surgical site infection. </p> <p>We were not able to exclude a 20% excess in all‐cause mortality of a high FIO<sub>2</sub> compared with routine use of oxygen in trials with overall low risk of bias (RR 1.12, TSA adjusted CI 0.80 to 1.59) nor in all trials (RR 1.07, TSA adjusted CI 0.73 to 1.60) because the cumulative Z‐curve in the TSA did not reach the futility area. Further, best/worst and worst/best case analyses show that the results are highly sensitive to the loss to follow‐up noted during long‐term follow‐up, especially in the ENIGMA trial (<a href="./references#CD008884-bbs2-0108" title="LeslieK , MylesPS , ChanMTV , ForbesA , PaechMJ , PeytonP , et al. Nitrous oxide and long‐term morbidity and mortality in the ENIGMA trial. Anesthesia and Analgesia2011;112(2):387–93. [PUBMED: 20861416] ">Leslie 2011</a>; <a href="./references#CD008884-bbs2-0017" title="MylesPS , LeslieK , ChanMT , ForbesA , PaechMJ , PeytonP , et al. ENIGMA Trial Group. Avoidance of nitrous oxide for patients undergoing major surgery: a randomized controlled trial. Anesthesiology2007;107(2):221‐31. [PUBMED: 17667565] ">Myles 2007</a>), as the effect in these analyses is estimated to be RR 0.56, with 95% CI 0.25 to 1.25, and RR 1.50, with 95% CI 1.04 to 2.15, respectively. We did not find consistent evidence that a high FIO<sub>2</sub> compared with routine use of oxygen is associated with risk of surgical site infection, respiratory insufficiency, serious adverse events (SAEs) or length of stay during the index admission. The effect on quality of life was reported in only one trial (<a href="./references#CD008884-bbs2-0009" title="GreifR , LacinyS , RapfB , HickleRS , SesslerDI . Supplemental oxygen reduces the incidence of postoperative nausea and vomiting. Anesthesiology1999;91(5):1246‐52. ">Greif 1999</a>) and accordingly could not be meta‐analysed, but the trial did not report an association between a high fraction of inspired oxygen and quality of life as measured by Short Form (SF)‐36 score. Some of the subgroup analyses performed in both fixed‐effect and random‐effects models indicate that a high FIO<sub>2</sub> compared with routine use of oxygen was associated with a reduction in surgical site infection in trials of various types of surgical procedures; using preoperative antibiotics; and using adequate blinding of the outcome assessment. However, the evidence is sparse in all of these analyses, not reaching the required information size, and all subgroup analyses have considerable drawbacks according to other types of confounders and bias risks;analysis of trials using antibiotics was a post hoc defined analysis, performed after the protocol had been published. </p> </section> <section id="CD008884-sec-0104"> <h3 class="title" id="CD008884-sec-0104">Overall completeness and applicability of evidence</h3> <p>The plan to analyse the effects of a high FIO<sub>2</sub> compared with routine use of oxygen during anaesthesia and surgery followed our published protocol to a great extent. We included all eligible randomized clinical trials (RCTs) up to February 2014. All trials were conducted in high‐income countries. Both sexes were included (63% women, 37% men). Most participants were patients undergoing colorectal or abdominal surgery under general anaesthesia; the second largest group of participants consisted of women undergoing caesarean section, mainly under regional anaesthesia. All participants came from primary prevention trials. Moderate to substantial heterogeneity was found in all of our analyses, which unfortunately was not explained by our subgroup analyses. Although more than half of the participants were randomly assigned in trials considered to have overall low risk of bias, our analyses revealed that lack of outcome reporting could influence the effect of the estimate of the intervention on surgical site infection. Accordingly, our 'best/worst case' and 'worst/best case' analyses revealed that results were compatible with no association and a harmful association with mortality and a beneficial effect, as well as with no association with surgical site infection of a high FIO<sub>2</sub> compared with routine use of oxygen. Although these extreme sensitivity analyses represent unlikely results, they reveal how few participants lost to follow‐up should have died to change our lack of findings into a potentially harmful effect. On the contrary, these sensitivity analyses also reveal how few participants lost to follow‐up should have developed surgical site infection to change our lack of finding an effect on surgical site infections into a potentially beneficial effect. </p> <p>Two trials were stopped early for benefit (meta‐analytical estimate of effect: 65% RRR for surgical site infection) (<a href="./references#CD008884-bbs2-0003" title="BickelA , GurevitsM , VamosR , IvryS , EitanA . Perioperative hyperoxygenation and wound site infection following surgery for acute appendicitis: a randomized, prospective, controlled trial. Archives of Surgery2011;146(4):464‐70. [PUBMED: 21502457] ">Bickel 2011</a>; <a href="./references#CD008884-bbs2-0009" title="GreifR , LacinyS , RapfB , HickleRS , SesslerDI . Supplemental oxygen reduces the incidence of postoperative nausea and vomiting. Anesthesiology1999;91(5):1246‐52. ">Greif 1999</a>), one trial was stopped early for harm (estimate of effect: 100% RRI for surgical site infection) (<a href="./references#CD008884-bbs2-0018" title="PryorKO , FaheyTJ3rd , LienCA , GoldsteinPA . Surgical site infection and the routine use of perioperative hyperoxia in a general surgical population: a randomized controlled trial. JAMA2004;291(1):79‐87. [PUBMED: 14709579] ">Pryor 2004</a>) and three trials were stopped early for futility (meta‐analytical estimate of effect: 16% RRI) (<a href="./references#CD008884-bbs2-0006" title="GardellaC , GoltraLB , LaschanskyE , DroletteL , MagaretA , ChadwickHS , et al. High‐concentration supplemental perioperative oxygen to reduce the incidence of postcesarean surgical site infection: a randomized controlled trial. Obstetrics and Gynecology2008;112(3):545‐52. [PUBMED: 18757651] ">Gardella 2008</a>; <a href="./references#CD008884-bbs2-0025" title="ThibonP , BorgeyF , BoutreuxS , HanouzJ‐L , LeCoutourX , ParientiJ‐J . Effect of perioperative oxygen supplementation on 30‐day surgical site infection rate in abdominal, gynecologic, and breast surgery. Anesthesiology2012;117:504–11. [MEDLINE: PMID: 22790961] ">Thibon 2012</a>, <a href="./references#CD008884-bbs2-0027" title="WilliamsN , GloverM , CrispC , ActonA , McKennaD . Randomized controlled trial of the effect of 30% versus 80% fraction of inspired oxygen on caesarean delivery surgical site infection. American Journal of Perinatology2013;30(9):781‐6. [DOI: 10.1055/s‐0032‐1333405] ">Williams 2013</a>). Three trials did not report a sample size estimation (meta‐analytical estimate of effect: 46% RRR) (<a href="./references#CD008884-bbs2-0012" title="KotaniN , HashimotoH , SesslerDI , MuraokaM , HashibaE , KubotaT , et al. Supplemental intraoperative oxygen augments antimicrobial and proinflammatory responses of alveolar macrophages. Anesthesiology2000;93(1):15‐25. [PUBMED: 10861141] ">Kotani 2000</a>; <a href="./references#CD008884-bbs2-0014" title="MayzlerO , WekslerN , DomchikS , KleinM , MizrahiS , GurmanGM . Does supplemental perioperative oxygen administration reduce the incidence of wound infection in elective colorectal surgery?. Minerva Anestesiology2005;71(1‐2):21‐5. [PUBMED: 15711503] ">Mayzler 2005</a>; <a href="./references#CD008884-bbs2-0021" title="SchietromaM , CeciliaEM , CarleiF , SistaF , DeSantisG , PiccioneF , et al. Prevention of anastomotic leakage after total gastrectomy with perioperative supplemental oxygen administration: a prospective randomized, double blind, controlled, single‐center trial. Annals of Surgical Oncology2013;20(5):584‐90. [DOI: 10.1245/s10434‐012‐2714‐7; PUBMED: 23099730] ">Schietroma 2013</a>). All of these trials were stopped early on invalid stopping criteria (one‐sided P values, P &lt; 0.05) and on criteria not accepted by the Food and Drug Administration (FDA) or the European Medicines Agency (EMA), increasing the risk of random errors, that is, the risk of finding a difference that is not true and the risk of overlooking a difference that actually is true (<a href="./references#CD008884-bbs2-0132" title="TikkinenKAO , Garcia‐AlaminoJM , DevereauxPJ , GuyattGH , Alonso‐CoelloP . Questionable early stopping: case study of supplemental perioperative oxygen and the incidence of surgical site infection. Poster presentation at the 19th Cochrane Colloquium; 2011 Oct 19‐22; Madrid, Spain [abstract]. Cochrane Database of Systematic Reviews,2011; Vol. Suppl:142‐3. [CMR‐16789] ">Tikkinen 2011</a>). </p> <p>All of our meta‐analyses fall short of the required information size of 13,264 participants (<a href="./references#CD008884-bbs2-0131" title="ThorlundK , ImbergerG , WalshM , ChuR , GluudC , WetterslevJ , et al. The number of patients and events required to limit the risk of overestimation of intervention effects in meta‐analysis—a simulation study. PloS One2011;6(10):e25491. ">Thorlund 2011a</a>) to detect or reject a 20% RRI or RRR for mortality and surgical site infection. In this respect, they are merely interim analyses performed to reach or not reach conclusive evidence of a 20% effect. When evaluating benefits and harms, we used trial sequential analysis to control for random errors, and we applied congruence (i.e. we requested the same thresholds for beneficial and harmful effects). This may not be ethically defensible in the case of harms, as we usually require more solid evidence for benefits than for harms. Moreover, many interventions that may offer benefits have been withdrawn from the market because some patients have died in association with the intervention. Accordingly, societies and regulatory agencies do not have congruent requirements for evidence on benefits and harms. Therefore, we may have been too stringent when dealing with risks of harm. </p> </section> <section id="CD008884-sec-0105"> <h3 class="title" id="CD008884-sec-0105">Quality of the evidence</h3> <p>A total of eight trials including 4918 participants reported on mortality. Fifteen trials with 7219 participants reported on surgical site infection. </p> <p>A major drawback of some of the included trials is the proportion of participants lost to follow‐up. This opens up the potential for attrition bias, and our 'best/worst' and 'worst/best' intention‐to‐treat analyses demonstrate that the intervention effect of a high FIO<sub>2</sub> compared with routine use of oxygen during anaesthesia and surgery may be either beneficial or harmful. This observation calls for more comprehensive meta‐analyses of individual participant data plus further large RCTs. We have abstained from conducting 'uncertainty' analyses (<a href="./references#CD008884-bbs2-0082" title="GambleC , HollisS . Uncertainty method improved on best‐worst case analysis in a binary meta‐analysis. Journal of Clinical Epidemiology2005;58(6):579‐88. [PUBMED: 15878471] ">Gamble 2005</a>), which accept the point estimate from the complete participant analysis, while assuming that the distribution of surgical site infections among participants lost to follow‐up is equal to the distribution of deaths among all participants. Actually, the distribution of surgical site infections among participants lost to follow‐up may indeed be different from the distribution of participants actually followed through the whole observation period, making the 'uncertainty' analyses themselves uncertain. </p> <p>We conducted various subgroup analyses. We observed no statistically significantly differences in the intervention effect of a high FIO<sub>2</sub> compared with routine use of oxygen on mortality and surgical site infections in subgroup analyses of trials with overall low risk of bias compared with trials with overall unclear or high risk of bias; nor of trials using nitrogen compared with no nitrous oxide in the control group; trials using a high inspiratory oxygen fraction in the recovery period compared with trials using the intervention only during surgery; trials using a supplemental inspiratory oxygen fraction equal to or greater than 80% during the intervention compared with trials using 60% to 80% oxygen during the intervention; trials using a follow‐up period shorter than 14 days compared with trials using follow‐up of 30 days or longer; and trials in colorectal and abdominal surgical patients compared with trials in other types of surgery. However, in a post hoc analysis of trials using preoperative antibiotics compared with trials not using or not reporting use of preoperative antibiotics, we observed subgroup differences in effects of the intervention. Furthermore, it may be worthwhile to analyse whether the effects of a high FIO<sub>2</sub> compared with routine use of oxygen depend on the type of anaesthesia (general or regional anaesthesia) used during surgery. We did not plan such an analysis, and analysis may be complicated by the fact that some trials used both types of anaesthesia. </p> <p>In addition to the six trials reporting mortality, nine trials reported on surgical site infection but not on mortality. Most of these trials were RCTs conducted to assess the effects of high FIO<sub>2</sub> compared with routine use of oxygen on surgical site infection; two trials reported exclusively on surrogate outcomes. A high FIO<sub>2</sub> compared with routine use of oxygen decreased surgical site infection on the fixed‐effect model meta‐analysis, but heterogeneity was substantial. The random‐effects model did not reveal a statistically significant effect of a high FIO<sub>2</sub> compared with routine use of oxygen on surgical site infection. Accordingly, the decrease in the proportion of surgical site infections in a fixed‐effect model may be due to an assumption that the intervention effect is equal across included trials ‐ an assumption that probably is not valid because the incidence of surgical site infection and the bacteria involved differ substantially (e.g. in abdominal surgery vs other types of surgery). </p> <p>We present our main results on all investigated outcomes in a summary of findings table (<a href="./full#CD008884-tbl-0001">summary of findings Table for the main comparison</a>) and have graded the quality of the evidence, including imprecision, according to Grades of Recommendation, Assessment, Development and Evaluation (GRADE) (<a href="./references#CD008884-bbs2-0086" title="GuyattGH , OxmanAD , KunzR , BrozekJ , Alonso‐CoelloP , RindD , et al. GRADE guidelines 6. Rating the quality of evidence‐imprecision. Journal of Clinical Epidemiology2011;64(12):1283‐93. [DOI: 10.1016/j.jclinepi.2011.01.012] ">Guyatt 2011</a>; <a href="./references#CD008884-bbs2-0087" title="GuyattGH , OxmanAD , SantessoN , HelfandM , VistG , KunzR , et al. GRADE guidelines: 12. Preparing summary of findings tables‐binary outcomes. Journal of Clinical Epidemiology2013;66(2):158‐72. [DOI: 10.1016/j.jclinepi.2012.01.012] ">Guyatt 2013</a>), stressing that results of meta‐analyses reflect data derived from trials of low or very low quality. </p> <p>The finding of a lack of significant association between a high FIO<sub>2</sub> of 60% to 90% and 30% to 40% oxygen and mortality and surgical site infection may be due to a type 2 error ‐ a false‐negative finding. This is exemplified by the fact that the cumulative Z‐curve did not cross the trial sequential monitoring boundaries for futility nor for benefit or harm nor for the boundaries of futility for an anticipated effect of 20% RRR. However, such an analysis cannot remove risks of bias ‐ detected or undetected. One should discuss, however, how much evidence one would require when dealing with potential benefit or harm. On the one hand, estimated beneficial or harmful effects can occur as the result of random errors. Therefore, sufficient information needs to be assessed to demonstrate benefit or harm beyond reasonable doubt. In this review, the TSA performed was based on anticipation of rather big intervention effects, undoubtedly clinically relevant but possibly not realistic. To detect or reject even smaller intervention effects, much larger information sizes are required. </p> </section> <section id="CD008884-sec-0106"> <h3 class="title" id="CD008884-sec-0106">Potential biases in the review process</h3> <p>We repeatedly searched several databases and contacted authors of trials investigating a high fraction of inspired oxygen of 60% to 90% compared with 30% to 40% oxygen used during anaesthesia and surgery. Therefore, we assume that we have not overlooked important RCTs. On the other hand, in general only about every second trial is reported (<a href="./references#CD008884-bbs2-0083" title="GluudC , HildenJ . Povl Heiberg’s 1897 methodological study on the statistical method as an aid in therapeutic trials. JLL Bulletin: commentaries on the history of treatment evaluation 2008; accessed 23rd June 2015:http://www.jameslindlibrary.org/articles/povl‐heibergs‐1897‐methodological‐study‐on‐the‐statistical‐method‐as‐an‐aid‐in‐therapeutic‐trials/. ">Gluud 2008</a>), so we cannot exclude reporting biases, and inspecting our funnel plot for the effect of high supplemental oxygen on surgical site infection may suggest small trial bias. On the positive side, we managed to obtain more information on several trials than was revealed by any previously conducted reviews and meta‐analyses. However, this does not detract from the fact that we did not have access to individual participant data. Accordingly, we have no chance of analysing the effect of an FIO<sub>2</sub> of 60% to 90% compared with 30% to 40% oxygen used during anaesthesia and surgery in patients receiving epidural analgesia, in patients kept normothermic during anaesthesia and surgery and in those with adequate fluid balance postoperatively. We selected all trials and extracted all data in duplicate, and we reached a high level of agreement. We did not conduct quality assessments nor data extractions while blinded to study authors and bias risks, and four of the authors of this review have been involved in one of the included trials (<a href="./references#CD008884-bbs2-0016" title="MeyhoffCS , WetterslevJ , JorgensenLN , HennebergSW , HøgdallC , LundvallL , et al. PROXI Trial Group. Effect of high perioperative oxygen fraction on surgical site infection and pulmonary complications after abdominal surgery: the PROXI randomized clinical trial. JAMA2009;302(14):1543‐50. [PUBMED: 19826023] ">Meyhoff 2009</a>). In this review, we present a conservative and, we believe, a more correct interpretation of findings compared with interpretations given in some other reviews and meta‐analyses previously published outside The Cochrane Collaboration. </p> </section> <section id="CD008884-sec-0107"> <h3 class="title" id="CD008884-sec-0107">Agreements and disagreements with other studies or reviews</h3> <p>Previous meta‐analyses of preventive trials of a high fraction of inspired oxygen with FIO<sub>2</sub> 60% to 90% compared with 30% to 40% oxygen have provided substantially less information and have not examined the separate influence of different ways of using the intervention (<a href="./references#CD008884-bbs2-0066" title="BrarMS , BrarSS , DixonE . Perioperaive supplemental oxygen in colorectal patients: a meta‐analysis. Journal of Surgical Research2011;166:227‐35. [DOI: 10.1016/j.jss.2009.06.007] ">Brar 2009</a>; <a href="./references#CD008884-bbs2-0032" title="BrarMS , BrarSS , DixonE . Perioperative supplemental oxygen in colorectal patients: a meta‐analysis. Journal of Surgical Research2011;166(2):227‐35. [MEDLINE: 19922947] ">Brar 2011</a>; <a href="./references#CD008884-bbs2-0034" title="ChuraJC , BoydA , ArgentaPA . Surgical site infections and supplemental perioperative oxygen in colorectal surgery patients: a systematic review. Surgical Infection2007;8(4):455‐61. [PUBMED: 17883362] ">Chura 2007</a>; <a href="./references#CD008884-bbs2-0035" title="FakhrySM , MontgomerySC . Peri‐operative oxygen and the risk of surgical infection. Surgical Infections2012;13(4):228‐33. [MEDLINE: 22913336] ">Fakhry 2012</a>; <a href="./references#CD008884-bbs2-0096" title="HovaguimianF , LysakowskiC , EliaN , TramèrMR . Effect of intraoperative high inspired oxygen fraction on surgical site infection, postoperative nausea and vomiting, and pulmonary function: systematic review and meta‐analysis of randomized controlled trials.. Anesthesiology2013;119(2):303‐16. [DOI: 10.1097/ALN.0b013e31829aaff4] ">Hovaguimian 2013</a>; <a href="./references#CD008884-bbs2-0101" title="KaoLS1 , MillasSG , PedrozaC , TysonJE , LallyKP . Should perioperative supplemental oxygen be routinely recommended for surgery patients? A Bayesian meta‐analysis. Annals of Surgery2012;256(6):894‐901. [DOI: 10.1097/SLA.0b013e31826cc8da] ">Kao 2012</a>; <a href="./references#CD008884-bbs2-0105" title="KlingelML , PatelSV . A meta‐analysis of the effect of inspired oxygen concentration on the incidence of surgical site infection following cesarean section. International Journal of Obstetric Anesthesia2013;22(2):104‐12. [DOI: 10.1016/j.ijoa.2013.01.001] ">Klingel 2013</a>; <a href="./references#CD008884-bbs2-0117" title="PatelSV1 , CoughlinSC , MalthanerRA . High‐concentration oxygen and surgical site infections in abdominal surgery: a meta‐analysis. Canadian Journal of Surgery2013;56(4):E82‐90. ">Patel 2012</a>; <a href="./references#CD008884-bbs2-0043" title="QadanM , AkçaO , MahidSS , HornungCA , PolkHCJr . Perioperative supplemental oxygen therapy and surgical site infection: a meta‐analysis of randomized controlled trials. Archives of Surgery2009;144(4):359‐66. [MEDLINE: 19380650] ">Qadan 2009</a>; <a href="./references#CD008884-bbs2-0133" title="TogiokaB1 , GalvagnoS , SumidaS , MurphyJ , OuanesJP , WuC . The role of perioperative high inspired oxygen therapy in reducing surgical site infection: a meta‐analysis. Anesthesia and Analgesia2012;114(2):334‐42. [DOI: 10.1213/ANE.0b013e31823fada8] ">Togioka 2012</a>). None of these meta‐analyses or systematic reviews conducted a proper bias assessment according to the Cochrane method, investigated the effect of bias in the seven domains as recommended by The Cochrane Collaboration or conducted analyses of possible subgroup differences in the effects of a high fraction of inspired oxygen between trials with overall low risk of bias and trials with one or more domains having high or unclear risk of bias. We conducted a thorough review in accordance with The Cochrane Collaboration methodology (<a href="./references#CD008884-bbs2-0092" title="HigginsJPT , GreenS , editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1. [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane‐handbook.org. ">Higgins 2011</a>), implementing findings of methodological studies (<a href="./references#CD008884-bbs2-0104" title="KjaergardLL , VillumsenJ , GluudC . Reported methodologic quality and discrepancies between large and small randomized trials in meta‐analyses. Annals of Internal Medicine2001;135(11):982‐9. ">Kjaergard 2001</a>; <a href="./references#CD008884-bbs2-0109" title="LundhA , SismondoS , LexchinJ , BusuiocOA , BeroL . Industry sponsorship and research outcome. Cochrane Database of Systematic Reviews2012, Issue 12. [DOI: 10.1002/14651858.MR000033.pub2] ">Lundh 2012</a>; <a href="./references#CD008884-bbs2-0114" title="MoherD , PhamB , JonesA , CookDJ , JadadA , MoherM , et al. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta‐analysis. Lancet1998;352(9128):609‐13. ">Moher 1998</a>; <a href="./references#CD008884-bbs2-0123" title="SavovićJ , JonesH , AltmanD , HarrisR , JűniP , PildalJ , et al. Influence of reported study design characteristics on intervention effect estimates from randomised controlled trials: combined analysis of meta‐epidemiological studies. Health Technology Assessment2012;16(35):1‐82. ">Savović 2012</a>; <a href="./references#CD008884-bbs2-0124" title="SchulzKF , ChalmersI , HayesRJ , AltmanDG . Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA1995;273(5):408‐12. ">Schulz 1995</a>; <a href="./references#CD008884-bbs2-0139" title="WoodL , EggerM , GluudLL , SchulzKF , JüniP , AltmanDG , et al. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta‐epidemiological study. BMJ2008;336(7644):601‐5. ">Wood 2008</a>). Between‐trial heterogeneity was moderate to substantial in all of our meta‐analyses. This may emphasize the inconsistency of our findings but also the diversity of the populations and settings included in the different trials, making results more generalizable (<a href="./references#CD008884-bbs2-0099" title="IoannidisJP , TrikalinosTA , ZintzarasE . Extreme between‐study homogeneity in meta‐analyses could offer useful insights. Journal of Clinical Epidemiology2006;59(10):1023‐32. ">Ioannidis 2006</a>). Furthermore, all‐cause mortality generally should be connected with unbiased estimates (<a href="./references#CD008884-bbs2-0123" title="SavovićJ , JonesH , AltmanD , HarrisR , JűniP , PildalJ , et al. Influence of reported study design characteristics on intervention effect estimates from randomised controlled trials: combined analysis of meta‐epidemiological studies. Health Technology Assessment2012;16(35):1‐82. ">Savović 2012</a>; <a href="./references#CD008884-bbs2-0139" title="WoodL , EggerM , GluudLL , SchulzKF , JüniP , AltmanDG , et al. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta‐epidemiological study. BMJ2008;336(7644):601‐5. ">Wood 2008</a>). We also performed trial sequential analyses to control the risk of random errors in a cumulative meta‐analysis and to prevent premature statements of superiority of a high fraction of inspired oxygen compared with routine use of oxygen (<a href="./references#CD008884-bbs2-0068" title="BrokJ , ThorlundK , GluudC , WetterslevJ . Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta‐analyses. Journal of Clinical Epidemiology2008;61(8):763‐9. [PUBMED: 18411040] ">Brok 2008</a>; <a href="./references#CD008884-bbs2-0069" title="BrokJ , ThorlundK , WetterslevJ , GluudC . Apparently conclusive meta‐analyses may be inconclusive ‐ Trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta‐analyses. International Journal of Epidemiology2009;38(1):287‐98. [PUBMED: 18824466] ">Brok 2009</a>; <a href="./references#CD008884-bbs2-0129" title="ThorlundK , DevereauxPJ , WetterslevJ , GuyattG , IoannidisJP , ThabaneL , et al. Can trial sequential monitoring boundaries reduce spurious inferences from meta‐analyses?. International Journal of Epidemiology2009;38(1):276‐86. [PUBMED: 18824467] ">Thorlund 2009</a>; <a href="./references#CD008884-bbs2-0130" title="ThorlundK , EngstrømJ , WetterslevJ , BrokJ , ImbergerG , GluudC . User Manual for Trial Sequential Analysis (TSA). Copenhagen Trial Unit, Centre for Clinical Intervention Research, Copenhagen, Denmark.2011:www.ctu.dk/tsa. ">Thorlund 2011</a>; <a href="./references#CD008884-bbs2-0131" title="ThorlundK , ImbergerG , WalshM , ChuR , GluudC , WetterslevJ , et al. The number of patients and events required to limit the risk of overestimation of intervention effects in meta‐analysis—a simulation study. PloS One2011;6(10):e25491. ">Thorlund 2011a</a>; <a href="./references#CD008884-bbs2-0135" title="WetterslevJ , ThorlundK , BrokJ , GluudC . Trial sequential analysis may establish when firm evidence is reached in cumulative meta‐analysis. Journal of Clinical Epidemiology2008;61(1):64‐75. [PUBMED: 18083463] ">Wetterslev 2008</a>; <a href="./references#CD008884-bbs2-0136" title="WetterslevJ , ThorlundK , BrokJ , GluudC . Estimating required information size by quantifying diversity in random‐effects model meta‐analyses. BMC Medical Research Methodology2009;9(86):1‐12. [PUBMED: 20042080] ">Wetterslev 2009</a>). </p> <p>Several trials (<a href="./references#CD008884-bbs2-0008" title="GollV , AkçaO , GreifR , FreitagH , ArkiliçCF , ScheckT , et al. Ondansetron is no more effective than supplemental intraoperative oxygen for prevention of postoperative nausea and vomiting. Anesthesia and Analgesia2001;92(1):112‐7. [PUBMED: 11133611] ">Goll 2001</a>; <a href="./references#CD008884-bbs2-0009" title="GreifR , LacinyS , RapfB , HickleRS , SesslerDI . Supplemental oxygen reduces the incidence of postoperative nausea and vomiting. Anesthesiology1999;91(5):1246‐52. ">Greif 1999</a>; <a href="./references#CD008884-bbs2-0011" title="JorisJL , PothNJ , DjamadarAM , SesslerDI , HamoirEE , DefêchereuxTR , et al. Supplemental oxygen does not reduce postoperative nausea and vomiting after thyroidectomy. British Journal of Anaesthesia2003;91(6):857‐61. [PUBMED: 14633758 ] ">Joris 2003</a>; <a href="./references#CD008884-bbs2-0015" title="McKeenDM , ArellanoR , O'ConnellC . Supplemental oxygen does not prevent postoperative nausea and vomiting after gynecological laparoscopy. Canadian Journal of Anaesthesia2009;56(9):651‐7. [DOI: 10.1007/s12630‐009‐9136‐4] ">McKeen 2009</a>; <a href="./references#CD008884-bbs2-0019" title="PurhonenS , TurunenM , RuohoahoUM , NiskanenM , HynynenM . Supplemental oxygen does not reduce the incidence of postoperative nausea and vomiting after ambulatory gynecologic laparoscopy. Anesthesia and Analgesia2003;96(1):91‐6. [PUBMED: 12505931] ">Purhonen 2003</a>; <a href="./references#CD008884-bbs2-0020" title="PurhonenS , NiskanenM , WüstefeldM , HirvonenE , HynynenM . Supplemental 80% oxygen does not attenuate post‐operative nausea and vomiting after breast surgery. Acta Anaesthesiologica Scandinavica2006;50(1):26‐31. [PUBMED: 16451147] ">Purhonen 2006</a>; <a href="./references#CD008884-bbs2-0023" title="ŠimurinaT , MraovićB , MikulandraS , SonickiZ , SulenN , DukićB , et al. Effects of high intraoperative inspired oxygen on postoperative nausea and vomiting in gynecologic laparoscopic surgery. Journal of Clinical Anesthesia2010;22(7):492‐8. [DOI: 10.1016/j.jclinane.2009.10.013] ">Simurina 2010</a>; <a href="./references#CD008884-bbs2-0026" title="TuranA , ApfelCC , KumpchM , DanzeisenO , EberhartLH , ForstH , et al. Does the efficacy of supplemental oxygen for the prevention of postoperative nausea and vomiting depend on the measured outcome, observational period or site of surgery. Anaesthesia2006;61(7):628‐33. [PUBMED: 16792606] ">Turan 2006</a>) using a high fraction of inspired oxygen during surgery did not report on mortality or surgical site infection but reported exclusively on nausea and vomiting or surrogate outcomes for respiratory complications. </p> <p>The number of meta‐analyses conducted so far and the fact that meta‐analyses have been updated several times from 2007 until now underline the necessity to take into account multiple testing on accumulating data when evaluating cumulative meta‐analyses (<a href="./references#CD008884-bbs2-0129" title="ThorlundK , DevereauxPJ , WetterslevJ , GuyattG , IoannidisJP , ThabaneL , et al. Can trial sequential monitoring boundaries reduce spurious inferences from meta‐analyses?. International Journal of Epidemiology2009;38(1):276‐86. [PUBMED: 18824467] ">Thorlund 2009</a>; <a href="./references#CD008884-bbs2-0135" title="WetterslevJ , ThorlundK , BrokJ , GluudC . Trial sequential analysis may establish when firm evidence is reached in cumulative meta‐analysis. Journal of Clinical Epidemiology2008;61(1):64‐75. [PUBMED: 18083463] ">Wetterslev 2008</a>). Further, when data are sparse and have not reached the required information size, the effect on, for example, mortality (<a href="./references#CD008884-bbs2-0032" title="BrarMS , BrarSS , DixonE . Perioperative supplemental oxygen in colorectal patients: a meta‐analysis. Journal of Surgical Research2011;166(2):227‐35. [MEDLINE: 19922947] ">Brar 2011</a>) and surgical site infection (<a href="./references#CD008884-bbs2-0043" title="QadanM , AkçaO , MahidSS , HornungCA , PolkHCJr . Perioperative supplemental oxygen therapy and surgical site infection: a meta‐analysis of randomized controlled trials. Archives of Surgery2009;144(4):359‐66. [MEDLINE: 19380650] ">Qadan 2009</a>) seems to be subject to change when data from further trials are included. However, none of the previously conducted meta‐analyses or systematic reviews estimated a required information size for a realistic intervention effect on all‐cause mortality or surgical site infection. Accordingly, they were not able to adjust the CI for increased risk of random errors when data were sparse and repetitive testing due to numerous updates was performed. </p> <p>Despite discrepancies between our review and other meta‐analyses and systematic reviews, we agree strongly with recently published reviews reporting no firm evidence that a high fraction of inspired oxygen of 60% to 90% compared with 30% to 40% oxygen during surgery (and for some trials also during the recovery room period) reduces all‐cause mortality and surgical site infection. Further, meta‐analyses and reviews concluding that a high inspiratory fraction of oxygen during surgery has an effect on surgical site infection have not demonstrated this convincingly by using both fixed‐effect and random‐effects models. Moreover, our analyses did not refute a clinically relevant effect, and lack of information is not the same as information of lack of effect. Therefore, further trials with low risk of bias and many more randomly assigned participants may very well change the estimates of effects on mortality and surgical site infection of a high fraction of inspired oxygen during surgery and recovery. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD008884-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/urn:x-wiley:14651858:media:CD008884:CD008884-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/image_t/tCD008884-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: 1 60% to 90% oxygen vs 30% to 40% oxygen perioperatively, outcome: 1.5 Surgical site infection stratified according to overall risk of bias in a random‐effects model." data-id="CD008884-fig-0001" src="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/image_n/nCD008884-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Funnel plot of comparison: 1 60% to 90% oxygen vs 30% to 40% oxygen perioperatively, outcome: 1.5 Surgical site infection stratified according to overall risk of bias in a random‐effects model. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/full#CD008884-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/image_n/nCD008884-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008884-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/urn:x-wiley:14651858:media:CD008884:CD008884-AFig-FIG04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/image_t/tCD008884-AFig-FIG04.png" target="_blank"><b></b></a></p> </div><img alt="Trial sequential analysis of the effect on mortality within the longest follow‐up in trials with overall low risk of bias. With an anticipated relative risk increase (RRI) of 20%, mortality in the control group of 15.7% with a type 1 error of 5% and a type 2 error of 20%, and diversity (D2) of 57%, the required information size is 10,736 participants. The cumulative Z‐curve does not cross the conventional boundary nor the trial sequential monitoring boundary for harm. The cumulative Z‐curve does not reach the futility area. Therefore evidence of an effect on all‐cause mortality based on trials with low risk of bias is lacking, and we cannot exclude a 20% RRI due to lack of data." data-id="CD008884-fig-0002" src="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/image_n/nCD008884-AFig-FIG04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Trial sequential analysis of the effect on mortality within the longest follow‐up in trials with overall low risk of bias. With an anticipated relative risk increase (RRI) of 20%, mortality in the control group of 15.7% with a type 1 error of 5% and a type 2 error of 20%, and diversity (D<sup>2</sup>) of 57%, the required information size is 10,736 participants. The cumulative Z‐curve does not cross the conventional boundary nor the trial sequential monitoring boundary for harm. The cumulative Z‐curve does not reach the futility area. Therefore evidence of an effect on all‐cause mortality based on trials with low risk of bias is lacking, and we cannot exclude a 20% RRI due to lack of data. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/full#CD008884-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/image_n/nCD008884-AFig-FIG04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008884-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/urn:x-wiley:14651858:media:CD008884:CD008884-AFig-FIG05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/image_t/tCD008884-AFig-FIG05.png" target="_blank"><b></b></a></p> </div><img alt="Trial sequential analysis of all trials reporting all‐cause mortality. With an anticipated relative risk increase (RRI) of 20%, mortality in the control group of 15.7% with a type 1 error of 5% and a type 2 error of 20% and diversity (D2) of 65%, the required information size is 13,264 participants. The cumulative Z‐curve does not cross the conventional boundaries nor the boundaries for benefit or harm. The cumulative Z‐curve does not reach the futility area. Therefore evidence of both beneficial and harmful effects on all‐cause mortality is lacking for all trials regardless of risk of bias and with varying time to follow‐up. We cannot exclude a 20% RRI or RRR due to lack of data." data-id="CD008884-fig-0003" src="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/image_n/nCD008884-AFig-FIG05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Trial sequential analysis of all trials reporting all‐cause mortality. With an anticipated relative risk increase (RRI) of 20%, mortality in the control group of 15.7% with a type 1 error of 5% and a type 2 error of 20% and diversity (D<sup>2</sup>) of 65%, the required information size is 13,264 participants. The cumulative Z‐curve does not cross the conventional boundaries nor the boundaries for benefit or harm. The cumulative Z‐curve does not reach the futility area. Therefore evidence of both beneficial and harmful effects on all‐cause mortality is lacking for all trials regardless of risk of bias and with varying time to follow‐up. We cannot exclude a 20% RRI or RRR due to lack of data. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/full#CD008884-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/image_n/nCD008884-AFig-FIG05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008884-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/urn:x-wiley:14651858:media:CD008884:CD008884-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/image_t/tCD008884-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Trial flow diagram. We reran the search in March 2015. We found two studies of interest, which we will consider when we update the review." data-id="CD008884-fig-0004" src="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/image_n/nCD008884-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Trial flow diagram. We reran the search in March 2015. We found two studies of interest, which we will consider when we update the review. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/full#CD008884-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/image_n/nCD008884-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008884-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/urn:x-wiley:14651858:media:CD008884:CD008884-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/image_t/tCD008884-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD008884-fig-0005" src="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/image_n/nCD008884-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/full#CD008884-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/image_n/nCD008884-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008884-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/urn:x-wiley:14651858:media:CD008884:CD008884-AFig-FIG06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/image_t/tCD008884-AFig-FIG06.png" target="_blank"><b></b></a></p> </div><img alt="Trial sequential analysis (TSA) of high inspiratory supplemental oxygen fraction 60% to 90% vs 30% to 40% in surgical site infection for all trials of surgical participants within 14 to 30 days of follow‐up. The required information size to detect or reject a 20% relative risk reduction in a random‐effects model was estimated at 13,189 participants, using a control event proportion of 12.9% and diversity of 63% among included trials (I2 = 48%; 95% CI 30% to 62%; P value = 0.02). Fifteen trials with 7219 participants provided data on surgical site infection. The conventional boundary for statistical significance was not crossed (P value = 0.18) and the trial sequential monitoring boundary for benefit was not crossed, as the TSA adjusted CI for the risk ratio was as follows: RR 0.87, 95% CI 0.65 to 1.17)." data-id="CD008884-fig-0006" src="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/image_n/nCD008884-AFig-FIG06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 6</div> <div class="figure-caption"> <p>Trial sequential analysis (TSA) of high inspiratory supplemental oxygen fraction 60% to 90% vs 30% to 40% in surgical site infection for all trials of surgical participants within 14 to 30 days of follow‐up. The required information size to detect or reject a 20% relative risk reduction in a random‐effects model was estimated at 13,189 participants, using a control event proportion of 12.9% and diversity of 63% among included trials (I<sup>2</sup> = 48%; 95% CI 30% to 62%; P value = 0.02). Fifteen trials with 7219 participants provided data on surgical site infection. The conventional boundary for statistical significance was not crossed (P value = 0.18) and the trial sequential monitoring boundary for benefit was not crossed, as the TSA adjusted CI for the risk ratio was as follows: RR 0.87, 95% CI 0.65 to 1.17). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/full#CD008884-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/image_n/nCD008884-AFig-FIG06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008884-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/urn:x-wiley:14651858:media:CD008884:CD008884-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/image_t/tCD008884-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 60% to 90% oxygen vs 30% to 40% oxygen perioperatively, Outcome 1 Mortality within longest follow‐up stratified according to overall risk of bias." data-id="CD008884-fig-0007" src="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/image_n/nCD008884-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 60% to 90% oxygen vs 30% to 40% oxygen perioperatively, Outcome 1 Mortality within longest follow‐up stratified according to overall risk of bias. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/references#CD008884-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/image_n/nCD008884-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008884-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/urn:x-wiley:14651858:media:CD008884:CD008884-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/image_t/tCD008884-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 60% to 90% oxygen vs 30% to 40% oxygen perioperatively, Outcome 2 Mortality within longest follow‐up best/worst case scenario of participants lost to follow‐up." data-id="CD008884-fig-0008" src="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/image_n/nCD008884-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 60% to 90% oxygen vs 30% to 40% oxygen perioperatively, Outcome 2 Mortality within longest follow‐up best/worst case scenario of participants lost to follow‐up. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/references#CD008884-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/image_n/nCD008884-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008884-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/urn:x-wiley:14651858:media:CD008884:CD008884-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/image_t/tCD008884-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 60% to 90% oxygen vs 30% to 40% oxygen perioperatively, Outcome 3 Mortality within longest follow‐up worst/best case scenario of participants lost to follow‐up." data-id="CD008884-fig-0009" src="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/image_n/nCD008884-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 60% to 90% oxygen vs 30% to 40% oxygen perioperatively, Outcome 3 Mortality within longest follow‐up worst/best case scenario of participants lost to follow‐up. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/references#CD008884-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/image_n/nCD008884-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008884-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/urn:x-wiley:14651858:media:CD008884:CD008884-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/image_t/tCD008884-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 60% to 90% oxygen vs 30% to 40% oxygen perioperatively, Outcome 4 Mortality within 30 days of follow‐up stratified according to overall risk of bias." data-id="CD008884-fig-0010" src="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/image_n/nCD008884-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 60% to 90% oxygen vs 30% to 40% oxygen perioperatively, Outcome 4 Mortality within 30 days of follow‐up stratified according to overall risk of bias. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/references#CD008884-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/image_n/nCD008884-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008884-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/urn:x-wiley:14651858:media:CD008884:CD008884-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/image_t/tCD008884-CMP-001-05.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 60% to 90% oxygen vs 30% to 40% oxygen perioperatively, Outcome 5 Surgical site infection stratified according to overall risk of bias in a random‐effects model." data-id="CD008884-fig-0011" src="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/image_n/nCD008884-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 60% to 90% oxygen vs 30% to 40% oxygen perioperatively, Outcome 5 Surgical site infection stratified according to overall risk of bias in a random‐effects model. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/references#CD008884-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/image_n/nCD008884-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008884-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/urn:x-wiley:14651858:media:CD008884:CD008884-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/image_t/tCD008884-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 60% to 90% oxygen vs 30% to 40% oxygen perioperatively, Outcome 6 Surgical site infection stratified according to overall risk of bias in a fixed‐effect model." data-id="CD008884-fig-0012" src="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/image_n/nCD008884-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 60% to 90% oxygen vs 30% to 40% oxygen perioperatively, Outcome 6 Surgical site infection stratified according to overall risk of bias in a fixed‐effect model. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/references#CD008884-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/image_n/nCD008884-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008884-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/urn:x-wiley:14651858:media:CD008884:CD008884-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/image_t/tCD008884-CMP-001-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 60% to 90% oxygen vs 30% to 40% oxygen perioperatively, Outcome 7 Surgical site infection stratified according to use of nitrous oxide." data-id="CD008884-fig-0013" src="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/image_n/nCD008884-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 60% to 90% oxygen vs 30% to 40% oxygen perioperatively, Outcome 7 Surgical site infection stratified according to use of nitrous oxide. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/references#CD008884-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/image_n/nCD008884-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008884-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/urn:x-wiley:14651858:media:CD008884:CD008884-CMP-001-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/image_t/tCD008884-CMP-001-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 60% to 90% oxygen vs 30% to 40% oxygen perioperatively, Outcome 8 Surgical site infection stratified according to FIO2 in the intervention group higher or lower than 80%." data-id="CD008884-fig-0014" src="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/image_n/nCD008884-CMP-001-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1 60% to 90% oxygen vs 30% to 40% oxygen perioperatively, Outcome 8 Surgical site infection stratified according to FIO<sub>2</sub> in the intervention group higher or lower than 80%. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/references#CD008884-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/image_n/nCD008884-CMP-001-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008884-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/urn:x-wiley:14651858:media:CD008884:CD008884-CMP-001-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/image_t/tCD008884-CMP-001-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 60% to 90% oxygen vs 30% to 40% oxygen perioperatively, Outcome 9 Surgical site infection stratified according to use of high FIO2 during operation and the postoperative period." data-id="CD008884-fig-0015" src="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/image_n/nCD008884-CMP-001-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1 60% to 90% oxygen vs 30% to 40% oxygen perioperatively, Outcome 9 Surgical site infection stratified according to use of high FIO<sub>2</sub> during operation and the postoperative period. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/references#CD008884-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/image_n/nCD008884-CMP-001-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008884-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/urn:x-wiley:14651858:media:CD008884:CD008884-CMP-001-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/image_t/tCD008884-CMP-001-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 60% to 90% oxygen vs 30% to 40% oxygen perioperatively, Outcome 10 Surgical site infection stratified according to type of surgery." data-id="CD008884-fig-0016" src="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/image_n/nCD008884-CMP-001-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.10</div> <div class="figure-caption"> <p>Comparison 1 60% to 90% oxygen vs 30% to 40% oxygen perioperatively, Outcome 10 Surgical site infection stratified according to type of surgery. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/references#CD008884-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/image_n/nCD008884-CMP-001-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008884-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/urn:x-wiley:14651858:media:CD008884:CD008884-CMP-001-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/image_t/tCD008884-CMP-001-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 60% to 90% oxygen vs 30% to 40% oxygen perioperatively, Outcome 11 Surgical site infection according to follow‐up longer or shorter than 14 days." data-id="CD008884-fig-0017" src="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/image_n/nCD008884-CMP-001-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.11</div> <div class="figure-caption"> <p>Comparison 1 60% to 90% oxygen vs 30% to 40% oxygen perioperatively, Outcome 11 Surgical site infection according to follow‐up longer or shorter than 14 days. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/references#CD008884-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/image_n/nCD008884-CMP-001-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008884-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/urn:x-wiley:14651858:media:CD008884:CD008884-CMP-001-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/image_t/tCD008884-CMP-001-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 60% to 90% oxygen vs 30% to 40% oxygen perioperatively, Outcome 12 Surgical site infection stratified according to use of preoperative antibiotics." data-id="CD008884-fig-0018" src="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/image_n/nCD008884-CMP-001-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.12</div> <div class="figure-caption"> <p>Comparison 1 60% to 90% oxygen vs 30% to 40% oxygen perioperatively, Outcome 12 Surgical site infection stratified according to use of preoperative antibiotics. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/references#CD008884-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/image_n/nCD008884-CMP-001-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008884-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/urn:x-wiley:14651858:media:CD008884:CD008884-CMP-001-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/image_t/tCD008884-CMP-001-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 60% to 90% oxygen vs 30% to 40% oxygen perioperatively, Outcome 13 Surgical site infection stratified according to sequence generation." data-id="CD008884-fig-0019" src="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/image_n/nCD008884-CMP-001-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.13</div> <div class="figure-caption"> <p>Comparison 1 60% to 90% oxygen vs 30% to 40% oxygen perioperatively, Outcome 13 Surgical site infection stratified according to sequence generation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/references#CD008884-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/image_n/nCD008884-CMP-001-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008884-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/urn:x-wiley:14651858:media:CD008884:CD008884-CMP-001-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/image_t/tCD008884-CMP-001-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 60% to 90% oxygen vs 30% to 40% oxygen perioperatively, Outcome 14 Surgical site infection stratified according to allocation concealment." data-id="CD008884-fig-0020" src="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/image_n/nCD008884-CMP-001-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.14</div> <div class="figure-caption"> <p>Comparison 1 60% to 90% oxygen vs 30% to 40% oxygen perioperatively, Outcome 14 Surgical site infection stratified according to allocation concealment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/references#CD008884-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/image_n/nCD008884-CMP-001-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008884-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/urn:x-wiley:14651858:media:CD008884:CD008884-CMP-001-15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/image_t/tCD008884-CMP-001-15.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 60% to 90% oxygen vs 30% to 40% oxygen perioperatively, Outcome 15 Surgical site infection according to blinding of participants and personnel." data-id="CD008884-fig-0021" src="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/image_n/nCD008884-CMP-001-15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.15</div> <div class="figure-caption"> <p>Comparison 1 60% to 90% oxygen vs 30% to 40% oxygen perioperatively, Outcome 15 Surgical site infection according to blinding of participants and personnel. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/references#CD008884-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/image_n/nCD008884-CMP-001-15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008884-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/urn:x-wiley:14651858:media:CD008884:CD008884-CMP-001-16" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/image_t/tCD008884-CMP-001-16.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 60% to 90% oxygen vs 30% to 40% oxygen perioperatively, Outcome 16 Surgical site infection stratified according to outcome assessment." data-id="CD008884-fig-0022" src="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/image_n/nCD008884-CMP-001-16.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.16</div> <div class="figure-caption"> <p>Comparison 1 60% to 90% oxygen vs 30% to 40% oxygen perioperatively, Outcome 16 Surgical site infection stratified according to outcome assessment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/references#CD008884-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/image_n/nCD008884-CMP-001-16.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008884-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/urn:x-wiley:14651858:media:CD008884:CD008884-CMP-001-17" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/image_t/tCD008884-CMP-001-17.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 60% to 90% oxygen vs 30% to 40% oxygen perioperatively, Outcome 17 Surgical site infection stratified according to completeness of outcome data." data-id="CD008884-fig-0023" src="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/image_n/nCD008884-CMP-001-17.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.17</div> <div class="figure-caption"> <p>Comparison 1 60% to 90% oxygen vs 30% to 40% oxygen perioperatively, Outcome 17 Surgical site infection stratified according to completeness of outcome data. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/references#CD008884-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/image_n/nCD008884-CMP-001-17.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008884-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/urn:x-wiley:14651858:media:CD008884:CD008884-CMP-001-18" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/image_t/tCD008884-CMP-001-18.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 60% to 90% oxygen vs 30% to 40% oxygen perioperatively, Outcome 18 Surgical site infection stratified according to outcome reporting." data-id="CD008884-fig-0024" src="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/image_n/nCD008884-CMP-001-18.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.18</div> <div class="figure-caption"> <p>Comparison 1 60% to 90% oxygen vs 30% to 40% oxygen perioperatively, Outcome 18 Surgical site infection stratified according to outcome reporting. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/references#CD008884-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/image_n/nCD008884-CMP-001-18.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008884-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/urn:x-wiley:14651858:media:CD008884:CD008884-CMP-001-19" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/image_t/tCD008884-CMP-001-19.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 60% to 90% oxygen vs 30% to 40% oxygen perioperatively, Outcome 19 Surgical site infection stratified according to presence of other bias." data-id="CD008884-fig-0025" src="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/image_n/nCD008884-CMP-001-19.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.19</div> <div class="figure-caption"> <p>Comparison 1 60% to 90% oxygen vs 30% to 40% oxygen perioperatively, Outcome 19 Surgical site infection stratified according to presence of other bias. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/references#CD008884-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/image_n/nCD008884-CMP-001-19.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008884-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/urn:x-wiley:14651858:media:CD008884:CD008884-CMP-001-20" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/image_t/tCD008884-CMP-001-20.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 60% to 90% oxygen vs 30% to 40% oxygen perioperatively, Outcome 20 Surgical site infection best/worst case scenario of participants lost to follow‐up." data-id="CD008884-fig-0026" src="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/image_n/nCD008884-CMP-001-20.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.20</div> <div class="figure-caption"> <p>Comparison 1 60% to 90% oxygen vs 30% to 40% oxygen perioperatively, Outcome 20 Surgical site infection best/worst case scenario of participants lost to follow‐up. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/references#CD008884-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/image_n/nCD008884-CMP-001-20.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008884-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/urn:x-wiley:14651858:media:CD008884:CD008884-CMP-001-21" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/image_t/tCD008884-CMP-001-21.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 60% to 90% oxygen vs 30% to 40% oxygen perioperatively, Outcome 21 Surgical site infection worst/best case scenario of participants lost to follow‐up." data-id="CD008884-fig-0027" src="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/image_n/nCD008884-CMP-001-21.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.21</div> <div class="figure-caption"> <p>Comparison 1 60% to 90% oxygen vs 30% to 40% oxygen perioperatively, Outcome 21 Surgical site infection worst/best case scenario of participants lost to follow‐up. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/references#CD008884-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/image_n/nCD008884-CMP-001-21.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008884-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/urn:x-wiley:14651858:media:CD008884:CD008884-CMP-001-22" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/image_t/tCD008884-CMP-001-22.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 60% to 90% oxygen vs 30% to 40% oxygen perioperatively, Outcome 22 Respiratory insufficiency stratified according to overall risk of bias." data-id="CD008884-fig-0028" src="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/image_n/nCD008884-CMP-001-22.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.22</div> <div class="figure-caption"> <p>Comparison 1 60% to 90% oxygen vs 30% to 40% oxygen perioperatively, Outcome 22 Respiratory insufficiency stratified according to overall risk of bias. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/references#CD008884-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/image_n/nCD008884-CMP-001-22.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008884-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/urn:x-wiley:14651858:media:CD008884:CD008884-CMP-001-23" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/image_t/tCD008884-CMP-001-23.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 60% to 90% oxygen vs 30% to 40% oxygen perioperatively, Outcome 23 Serious adverse events." data-id="CD008884-fig-0029" src="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/image_n/nCD008884-CMP-001-23.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.23</div> <div class="figure-caption"> <p>Comparison 1 60% to 90% oxygen vs 30% to 40% oxygen perioperatively, Outcome 23 Serious adverse events. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/references#CD008884-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/image_n/nCD008884-CMP-001-23.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008884-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/urn:x-wiley:14651858:media:CD008884:CD008884-CMP-001-24" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/image_t/tCD008884-CMP-001-24.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 60% to 90% oxygen vs 30% to 40% oxygen perioperatively, Outcome 24 Length of stay after surgery." data-id="CD008884-fig-0030" src="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/image_n/nCD008884-CMP-001-24.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.24</div> <div class="figure-caption"> <p>Comparison 1 60% to 90% oxygen vs 30% to 40% oxygen perioperatively, Outcome 24 Length of stay after surgery. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/references#CD008884-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/media/CDSR/CD008884/image_n/nCD008884-CMP-001-24.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD008884-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Summary of findings in randomized clinical trials with overall low risk of bias and in all trials</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Fraction of inspired oxygen of 60% to 90% compared with 30% to 40% oxygen during anaesthesia, surgery and recovery</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> surgical patients with need for abdominal, caesarean section, orthopaedic or breast surgery </p> <p><b>Settings:</b> perioperative and postoperative </p> <p><b>Intervention:</b> high fraction of inspired oxygen of 60% to 90% during and after surgery and anaesthesia </p> <p><b>Comparison:</b> fraction of inspired oxygen of 30% to 40% during and after anaesthesia and surgery </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Number of participants<br/> (studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk*</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk<sup>#</sup> </b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Inspired fraction of oxygen (30% to 40%)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Inspired fraction of oxygen (60% to 90%)</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Mortality within the longest follow‐up in trials with overall low risk of bias</b> </p> <p>(follow‐up: 30 days to a median of 3.9 years)</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>High‐risk population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.12</b> </p> <p>(0.93 to 1.36)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>4758</p> <p>(3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low<sup>a</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>TSA (<a href="./full#CD008884-fig-0001">Figure 1</a>) shows that the required information size of 10,736 for a 20% RRI has not been achieved, and that no trial sequential monitoring boundaries have been crossed. The TSA adjusted CI for the RR is 0.73 to 1.60. The required information size is even greater for a lower effect on mortality than a 20% RRI. We therefore downgraded by 1 level for imprecision and by 1 level for attrition bias (<a href="./references#CD008884-fig-0008" title="">Analysis 1.2</a>; <a href="./references#CD008884-fig-0009" title="">Analysis 1.3</a>) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>185 per 1000</b> <br/> (168 to 203) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>208 per 1000</b> <br/> (190 to 226) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mortality within the longest follow‐up, irrespective of risk of bias</b> (14 days to median of 3.9 years) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>164 per 1000</b> <br/> (150 to 180) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>175 per 1000</b> <br/> (143 to 218) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>RR 1.07</b> </p> <p>(0.87 to 1.33)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4525</p> <p>(6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊝⊝⊝</p> <p><b>Very low<sup>b</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>TSA (<a href="./full#CD008884-fig-0002">Figure 2</a>) shows that the required information size for a 20% RRI has not been achieved, and that no trial sequential monitoring boundaries have been crossed. The required information size for a lower excess mortality than a 20% RRI is even greater. We therefore downgraded by 1 level for imprecision, by 1 level for high risk of attrition bias (<a href="./references#CD008884-fig-0008" title="">Analysis 1.2</a>; <a href="./references#CD008884-fig-0009" title="">Analysis 1.3</a>) and by 1 level for overall risk of bias </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mortality within 30 days of follow‐up with overall low risk of bias</b> </p> <p>(14 days to 30 days)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>18 per 1000</b> </p> <p>(13 to 25)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>18 per 1000</b> </p> <p>(13 to 25)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>POR 0.99</b> </p> <p>(0.61 to 1.60)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4758</p> <p>(3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊕⊝<br/> <b>Moderate<sup>c</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The required information size for a 20% RRI has not been reached, and no trial sequential monitoring boundaries have been crossed </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mortality within 30 days of follow‐up, irrespective of risk of bias</b> (14 days to 30 days) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>20 per 1000</b> </p> <p>(15 to 27)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>17 per 1000</b> </p> <p>(11 to 26)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>POR 0.83</b> </p> <p>(0.54 to 1.29)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4525</p> <p>(6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝<br/> <b>Low<sup>d</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>TSA shows that the required information size for a 20% RRI has not been achieved, and that no trial sequential monitoring boundaries have been crossed. The required information size for a lower excess mortality than a 20% RRI is even greater. We therefore downgraded by 1 level for imprecision and by 1 level for overall risk of bias </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Surgical site infection within 30 days in trials with low risk of bias</b> </p> <p>(14 days to 30 days)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>140 per 1000</b> </p> <p>(126 to 155)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>119 per 1000</b> </p> <p>(106 to 134)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>RR 0.86</b> </p> <p>(0.63 to 1.17)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4201</p> <p>(5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝<br/> <b>Low<sup>a</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>TSA (<a href="./full#CD008884-fig-0003">Figure 3</a>) shows that the required information size of 13,189 participants for a 20% RRR has not been achieved, and that no trial sequential monitoring boundaries have been crossed. The required information size is even greater for a lower effect on mortality than a 20% RRR. Best/worst and worst/best case scenarios indicate possible attrition bias. Therefore we downgraded by 1 level for imprecision and by 1 level for attrition bias </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Surgical site infection within 30 days, irrespective of risk of bias</b> (14 days to 30 days) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>129 per 1000</b> </p> <p>(118 to 140)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>112 per 1000</b> </p> <p>(92 to 138)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>RR 0.87</b> </p> <p>(0.71 to 1.07)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7229</p> <p>(15)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝<br/> <b>Low<sup>e</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>TSA (<a href="./full#CD008884-fig-0003">Figure 3</a>) shows that the required information size of 13,189 participants for a 20% RRR of surgical site infection has not been reached, and that no trial sequential monitoring boundaries have been crossed. The required information size for a lower effect on surgical site infection than a 20% RRR is even greater. As the result of overall risk of bias and imprecision, we downgraded by 2 levels </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Respiratory insufficiency</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>44 per 1000</b> </p> <p>(31 to 62)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>55 per 1000</b> </p> <p>(35 to 88)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>RR 1.25</b> </p> <p>(0.79 to 1.99)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1386</p> <p>(1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊕⊝<br/> <b>Moderate<sup>c</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Information size is too small to be conclusive. We downgraded by 1 level for imprecision</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>LCL:</b> Lower confidence limit; <b>MD:</b> Mean difference; <b>POR:</b> Peto odds ratio; <b>RR:</b> Risk ratio; <b>RRR:</b> relative risk reduction; <b>RRI:</b> relative risk increase; <b>TSA:</b> trial sequential analysis; <b>UCL:</b> Upper confidence limit. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence.<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p>*Mean of mortality in groups of included trials with 30% to 40% inspiratory fraction of oxygen. </p> <p>#Calculated from: RR × assumed risk (95% CL: LCL of RR × assumed risk to UCL of RR × assumed risk). </p> <p><sup>a</sup>Downgraded by 2 levels because of risk of attrition bias and imprecision. </p> <p><sup>b</sup>Downgraded by 3 levels because of risk of attrition bias, imprecision and overall risk of bias.<br/> <sup>c</sup>Downgraded by 1 level because of imprecision. </p> <p><sup>d</sup>Downgraded by 2 levels because of overall risk of bias and imprecision. </p> <p><sup>e</sup>Downgraded by 2 levels because of overall risk of bias and imprecision. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Summary of findings in randomized clinical trials with overall low risk of bias and in all trials</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/full#CD008884-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD008884-tbl-0002"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">60% to 90% oxygen vs 30% to 40% oxygen perioperatively</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Mortality within longest follow‐up stratified according to overall risk of bias <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4918</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.07 [0.87, 1.33]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Trials with overall low risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4058</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.12 [0.93, 1.36]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Trials with overall unclear or high risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>860</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.43 [0.15, 1.20]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Mortality within longest follow‐up best/worst case scenario of participants lost to follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4918</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.56 [0.25, 1.25]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Mortality within longest follow‐up worst/best case scenario of participants lost to follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4918</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.50 [1.04, 2.15]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Mortality within 30 days of follow‐up stratified according to overall risk of bias <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4918</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.83 [0.54, 1.29]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Trials with overall low risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4058</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.61, 1.60]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Trials with overall high or unclear risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>860</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.37 [0.13, 1.05]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Surgical site infection stratified according to overall risk of bias in a random‐effects model <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>7219</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.87 [0.71, 1.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Trials with low risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4201</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.86 [0.63, 1.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Trials with high or unclear risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3018</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.87 [0.64, 1.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Surgical site infection stratified according to overall risk of bias in a fixed‐effect model <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>7219</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.87 [0.77, 0.99]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Trials with low risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4201</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.86 [0.73, 1.00]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 Trials with high or unclear risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3018</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.74, 1.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Surgical site infection stratified according to use of nitrous oxide <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>7159</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.87 [0.71, 1.08]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 No use of nitrous oxide</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4739</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.88 [0.71, 1.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 Use of nitrous oxide</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2420</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.85 [0.45, 1.61]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Surgical site infection stratified according to FIO<sub>2</sub> in the intervention group higher or lower than 80% <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>7219</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.87 [0.71, 1.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 FIO2 in the intervention group 80% or higher</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4216</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.87 [0.66, 1.15]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2 FIO2 in intervention group lower than 80% and higher than 60%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3003</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.81 [0.65, 1.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Surgical site infection stratified according to use of high FIO<sub>2</sub> during operation and the postoperative period <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>7219</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.87 [0.71, 1.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1 Use of high FIO2 during both surgery and the postoperative period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6725</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.87 [0.70, 1.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.2 Use of high FIO2 only during surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>494</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.88 [0.45, 1.73]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Surgical site infection stratified according to type of surgery <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>7219</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.87 [0.71, 1.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.1 Colorectal and abdominal surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2761</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.74 [0.50, 1.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.2 Caesarean section</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1719</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.21 [0.91, 1.60]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.3 Orthopaedic surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>233</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.71 [0.37, 1.34]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.4 Breast surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 7.87]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.5 Mixed types of surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2446</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.76 [0.59, 0.99]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Surgical site infection according to follow‐up longer or shorter than 14 days <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>7219</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.87 [0.71, 1.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.1 Follow‐up longer than 14 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6141</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.87 [0.72, 1.05]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.2 Follow‐up of 14 or fewer days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1078</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.84 [0.48, 1.47]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Surgical site infection stratified according to use of preoperative antibiotics <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>7219</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.87 [0.71, 1.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.1 Use of preoperative antibiotics</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5440</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.76 [0.60, 0.97]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.2 Lack of use or lack of reporting use of preoperative antibiotics</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1779</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.20 [0.91, 1.58]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Surgical site infection stratified according to sequence generation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>7219</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.87 [0.71, 1.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.1 Adequate sequence generation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6155</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.71, 1.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.2 Unclear/inadequate sequence generation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1064</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.69 [0.36, 1.31]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Surgical site infection stratified according to allocation concealment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>7264</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.87 [0.71, 1.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.1 Adequate allocation concealment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5894</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.85 [0.67, 1.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.2 Unclear/inadequate allocation concealment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1370</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.66, 1.40]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 Surgical site infection according to blinding of participants and personnel <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>7219</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.87 [0.71, 1.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.1 Adequate blinding of participants and personnel</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4668</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.79 [0.61, 1.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.2 Unclear/inadequate blinding of participants or personnel</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2551</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.70, 1.37]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16 Surgical site infection stratified according to outcome assessment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>7219</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.87 [0.71, 1.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.1 Adequate blinding of outcome assessment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6414</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.79 [0.66, 0.96]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.2 Unclear/inadequate blinding of outcome assessment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>805</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.57 [1.04, 2.37]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">17 Surgical site infection stratified according to completeness of outcome data <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>7219</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.87 [0.71, 1.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>17.1 Complete outcome data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5841</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.71, 1.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>17.2 Incompete outcome data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1378</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.77 [0.41, 1.43]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">18 Surgical site infection stratified according to outcome reporting <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>7219</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.87 [0.71, 1.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.1 Adequate outcome reporting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>7219</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.87 [0.71, 1.07]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.2 Unclear/inadequate outcome reporting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">19 Surgical site infection stratified according to presence of other bias <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>7219</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.87 [0.71, 1.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>19.1 No presence of other bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6489</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.71, 1.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>19.2 Unclear or definite presence of other bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>730</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.72 [0.48, 1.07]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">20 Surgical site infection best/worst case scenario of participants lost to follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>7219</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.71 [0.54, 0.93]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">21 Surgical site infection worst/best case scenario of participants lost to follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>7219</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.78, 1.42]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">22 Respiratory insufficiency stratified according to overall risk of bias <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1588</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.25 [0.79, 1.99]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>22.1 Trials with low risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1386</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.25 [0.79, 1.99]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>22.2 Trials with unclear or high risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>202</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">23 Serious adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3558</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.65, 1.43]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>23.1 Trials with low risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3398</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.63, 1.31]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>23.2 Trials with high risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>160</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.0 [0.60, 41.85]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">24 Length of stay after surgery <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4702</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.06 [‐0.44, 0.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>24.1 Trials with low risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4041</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.13 [‐0.49, 0.24]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>24.2 Trials with high or unclear risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>661</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.69 [‐0.82, 2.20]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">60% to 90% oxygen vs 30% to 40% oxygen perioperatively</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD008884.pub2/references#CD008884-tbl-0002">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD008884.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD008884-note-0003">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD008884-note-0007">فارسی</a> </li> <li class="section-language"> <a class="" href="hr#CD008884-note-0002">Hrvatski</a> </li> <li class="section-language"> <a class="" href="pt#CD008884-note-0001">Português</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008884\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD008884\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008884\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD008884\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008884\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD008884\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008884\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD008884\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008884\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD008884\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008884\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD008884\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008884\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD008884\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008884\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD008884\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008884\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD008884\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=Xx9QLps0&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD008884.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD008884.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD008884.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD008884.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD008884.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740715449331"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD008884.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740715449335"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD008884.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918d875e6e3d9374',t:'MTc0MDcxNTQ0OS4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 